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Post-translational modification of cysteine residues can regulate protein 
function and is essential for catalysis by cysteine-dependent enzymes. Covalent 
modifications neutralize charge on the reactive cysteine thiolate anion and thus 
alter the active site electrostatic environment. Although a vast number of enzymes 
rely on cysteine modification for function, precisely how altered structural and 
electrostatic states of cysteine affect protein dynamics, which in turn, affects 
catalysis, remains poorly understood.  
Here we use X-ray crystallography, computer simulations, site directed 
mutagenesis and enzyme kinetics to characterize how covalent modification of the 
active site cysteine residue in the enzyme, isocyanide hydratase (ICH), affects the 
protein conformational ensemble during catalysis. Our results suggest that 
cysteine modification may be a common and likely underreported means for 
regulating protein conformational dynamics. This thesis will also include ongoing 
work with ICH homologs, showing that Cys covalent modification-gated helical 
dynamics in Cys dependent enzymes is common to enzymes of this family.  
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Table 1: Pseudomonas ICH Enzyme kinetic parameters 
 
 
*measured at 160 μM p-NPIC and [enzyme]=50 nM. 
 
Standard deviations are derived from the fit; data measured n≥3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PfICH Enzyme WT G150A G150T 
Steady State Kinetics 
kcat (sec-1) 0.248±0.031 0.025±0.002 0.046±0.003 
KM (μM) 9.262±3.250 1.208 ±0.6134 8.892±1.529 
kcat/KM (M-1 sec-1) 2.68x104 2.07x104 5.21x103 
Stopped Flow mixing 
Burst rate constant (sec-1)* 11.395±0.120 11.882±0.071 4.255±0.187 
Second order rate constant for 
burst (M-1 sec-1) 
4.85x104±943 5.51x104±557 1.11x104±999 
Steady state rate kobs (sec-1)* 0.268±0.001 0.046±0.002 0.095±0.003 
x 
 
Table 2: Pseudomonas ICH Crystallographic Data Statistics 
 
Values for the highest resolution bins are shown in parenthesis 
1 RT, Room temperature synchrotron radiation collection; XFEL, X-ray free electron laser  
2 CC1/2 (31) was used to determine the high resolution cutoff.  
3 Rsplit is provided only for XFEL serial crystallographic data 
4 Dataset from PDB 3NON, processed before the introduction of CC1/2 
5 N/A=not applicable for serial crystallographic data 
  
Sample 
WT ICH 
RT1 
(less 
oxidized) 
WT ICH 
RT1 (more 
oxidized) 
G150A 
ICH 
G150T 
ICH 
WT ICH 
XFEL: 
Apo1 
 
WT ICH 
XFEL: 15 
sec 
Thioimida
te1 
WT ICH 
XFEL: 5 
min1 
 
WT ICH 
cryo 
Diffraction 
source 
SSRL 
12-2 
SSRL 
7-1 
SSRL 
12-2 
SSRL 
7-1 
LCLS 
MFX 
LCLS 
MFX 
LCLS 
MFX 
APS 
14BM-C 
Wavelength 
(Å) 
0.827 0.975 0.827 0.975 1.305 1.305 1.305 0.900 
Temperature 
(K) 
274 277 274 277 298 298 298 100 
Detector Pilatus 6M 
ADSC 
Q315 
Pilatus 6M 
ADSC 
Q315 
Rayonix 
MX170-
HS 
Rayonix 
MX170-
HS 
Rayonix 
MX170-
HS 
ADSC 
Q315 
Space group P21 P21 P21 C2 P21 P21 P21 P21 
a, b, c (Å)  
57.24   
58.03   
69.09 
57.15   
57.97   
69.09 
57.04   
57.90   
69.11 
72.11   
59.74   
56.13 
56.88   
57.68   
68.78 
56.77   
57.42   
68.79 
56.81   
57.64   
68.76 
56.58 
56.47 
68.23 
α, β, γ (°)  
90.00 
112.83  
90.00 
90.00 
112.77  
90.00 
90.00 
112.55  
90.00 
90.00 
115.86  
90.00 
90.00 
112.74  
90.00 
90.00 
112.74  
90.00 
90.00 
112.74  
90.00 
90.00 
112.49  
90.00 
Mosaicity (°)  0.08 0.08 0.08 0.07 N/A5 N/A5 N/A5 0.27 
Resolution 
range (Å) 
39.04-1.20 
(1.22-1.20) 
42.87-1.15 
(1.17-1.15) 
38.96-1.30 
(1.32-1.30) 
35.45-1.10 
(1.12-1.10) 
20.13-1.55 
(1.57-1.55) 
20.09-1.55 
(1.57-1.55) 
20.1-1.55 
(1.57-1.55) 
37-1.05 
(1.09-1.05) 
Total no. of 
observations 
363112 
(16358) 
517060 
(15585) 
327591 
(13542) 
224032 
(2017) 
3032726 
(18818) 
3185312 
(16342) 
2648001 
(38049) 
1077211 
(79769) 
No. of unique 
observations 
126373 
(5922) 
145885 
(6657) 
100249 
(4568) 
84423 
(1216) 
60075 
(2983) 
60053 
(2970) 
60082 
(2988) 
179423 
(17341) 
Completeness 
(%) 
97.4 (92.7) 98.9 (91.2) 98.1 (90.1) 97.2 (95.9) 99.9 (99.8) 99.9 (99.4) 99.9 (100) 97.1 (94.2) 
Multiplicity  2.9 (2.8) 3.5 (2.3) 3.3 (3.0) 2.7 (2.0) 50.5 (6.3) 53.0 (5.5) 44.1 (12.7) 6.0 (4.6) 
〈I/σ(I)〉 10.4(1.8) 12.5 (0.8) 9.1 (1.2) 9.7 (1.4) 60.5 (2.0) 58.4 (1.8) 73.1 (3.4) 22.8 (2.1) 
CC1/22 
0.991 
(0.225) 
0.999 
(0.488) 
0.996 
(0.318) 
0.999 
(0.690) 
0.962 
(0.16) 
0.963 
(0.14) 
0.937 
(0.36) 
N/A4 
Rmeas (Rsplit for 
XFEL data)3 
0.072 
(1.689) 
0.059 
(0.959) 
0.066 
(1.513) 
0.045 
(0.545) 
0.196 
(0.862) 
0.197 
(0.905) 
0.232 
(0.658) 
0.07 (0.70) 
         
xi 
 
Table 3: Pseudomonas ICH Crystallographic Refinement Statistics 
 
Model 
WT ICH 
RT1 (less 
oxidized) 
WT ICH 
RT1 
(more 
oxidized) 
G150A 
ICH  
G150T 
ICH  
WT 
ICH 
XFEL: 
Apo1 
 
WT ICH 
XFEL: 
15 sec 
Thioimid
ate1 
WT ICH 
XFEL: 5 
min1 
 
WT ICH 
RT1 (less 
oxidized) 
qFit 
model 
WT 
ICH 
cryo 
with 
helix 
disorde
r 
PDB code 6NI6 6NI7 6NI5 6NI4 6NPQ 6UND 6UNF 6NI9 6NJA 
Temperature (K) 274 277 274 277 298 298 298 274 100 
Refinement 
program 
PHENIX 
1.9 
PHENIX 
1.9 
PHENI
X 1.9 
PHENI
X 1.9 
PHENI
X 1.9 
PHENIX 
1.9 
PHENIX 
1.9 
PHENIX 
1.9 
PHENI
X 1.9 
Resolution range 
(Å) 
31.84-
1.20 
38.53-
1.15 
33.56-
1.30 
35.14-
1.10 
20.13-
1.55 
20.09-
1.55 
17.46-
1.55 
31.84-
1.20 
37.82-
1.05 
Completeness (%) 95.17 98.87 97.83 97.16 99.93 99.86 99.96 95.00 97.11 
No. of reflections  123572 145829 99966 84275 59628 59214 59498 123572 179399 
No. of reflections, 
test set 
6203 7300 4970 4186 2002 1986 1995 6203 8979 
Rwork  
0.1140 
(0.2281) 
0.1128 
(0.2633) 
0.1192 
(0.2745) 
0.1098 
(0.2294) 
0.1560 
(0.3075) 
0.1636 
(0.3244) 
0.1727 
(0.2777) 
0.1078 
(0.2207) 
0.1170 
(0.2105) 
Rfree  
0.1398 
(0.2611) 
0.1353 
(0.2607) 
0.1519 
(0.3159) 
0.1283 
(0.2332) 
0.1864 
(0.3244) 
0.1906 
(0.3177) 
0.1918 
(0.2836) 
0.1402 
(0.2628) 
0.1342 
(0.2487) 
No. of non-H atoms 
 Protein 4486 4446 4892 1868 3475 3449 3500 6192 4551 
 Water 342 323 323 149 298 271 272 382 484 
 Total 4828 4769 5215 2017 3773 3720 3772 6574 5035 
Average R.M.S. deviations   
 Bonds (Å) 0.007 0.008 0.014 0.011 0.007 0.004 0.005 0.011 0.009 
 Angles (°) 0.909 1.020 1.290 1.376 0.850 0.729 0.801 1.399 1.111 
Average B factors (<Biso>;Å2)   
 Protein 17.34 19.57 21.12 17.21 24.18 24.97 25.78 15.92 11.91 
 Water 36.77 37.40 39.73 31.30 38.83 38.61 44.80 36.74 26.43 
Average ADP anisotropy2  
 Protein 0.396 0.481 0.400 0.502 0.599 0.553 0.626 0.394 0.407 
 Water 0.327 0.415 0.353 0.439 1 1 1 0.354 0.408 
MolProbity 
clashscore 
1.1 2.2 4.1 0.8 2.0 1.6 1.3 2.4 3.2 
Ramachandran plot   
Outliers (%) 0.5 0.3 0.5 0.0 0.4 0.4 0.4 0.3 0.3 
Allowed (%)  1.4 1.4 2.0 1.2 1.3 1.3 1.8 1.1 1.9 
Favored (%) 98.1 98.3 97.5 98.8 98.2 98.2 97.8 98.6 97.8 
 
Values for the highest resoltions bin shown in parenthesis 
1 RT, Room temperature synchrotron radiation collection; XFEL, X-ray free electron laser  
2 Anisotropy is defined as the ratio of the smallest to largest eigenvalue of the ADP tensor 
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Table 4: Ralstonia ICH Enzyme kinetic parameters 
 
Standard deviations are derived from the fit; data measured n≥3 
 
*measured at 80 μM p-NPIC 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RsICH Enzyme WTRsICH E122D E122Q E122T 
Steady State Kinetics  
kcat (sec-1) 75.65 0.15 0.37 0.34 
KM (μM) 116.9 1.28 6.79 27.59 
kcat/KM (μM-1 sec-1) 0.65 0.12 0.05 0.01 
Stopped Flow mixing*  
Pre steady state rate 
constant (sec 1) 
          0.11274           11.882±0.071 4.255±0.187 0.16851 
xiii 
 
 
Table 5: Ralstonia ICH Crystallographic Refinement Statistics 
Data collected at University of Nebraska Macromolecular Structural Core Facility 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Model WT RsICH 
(plate) 
WT 
RsICH 
(rod) 
WT RsICH 
(tetragonal) 
E122T 
(plate) 
E122D 
(plate) 
 
PDB code NA NA NA NA NA 
Temperature (K) 110 110 110 110 110 
Detector Raxis IV++  Raxis 
IV++  
Raxis IV++  Raxis 
IV++  
Raxis IV++  
Refinement 
program 
Refmac5 
(CCP4) 
Refmac5 
(CCP4) 
Refmac5 
(CCP4) 
Refmac5 
(CCP4) 
Refmac5 
(CCP4) 
Resolution range 
(Å) 
40.21-1.50 38.52-1.46 44.9-1.63 38.42-
1.46 
33.46-1.46 
Completeness 
(%)(overall) 
100.0 94.7 100.0 96.0 99.5 
Space Group P 21 21 21 P 21 21 21 P 41 21 2 P 21 21 
21 
P 21 21 21 
a, b, c (Å) 47.84   
89.17   
93.04 
48.13   
89.04   
92.77 
63.50   
63.50  
121.46 
47.90   
89.19   
92.88 
48.20   
89.20   
92.96 
α, β, γ (°) 90.00   
90.00   
90.00 
90.00   
90.00   
90.00 
90.00   
90.00   
90.00 
90.00   
90.00   
90.00 
90.00   
90.00   
90.00 
〈I/σ(I)〉 
11.0 (1.1) 13.6 (3.5) 21.0 (4.3) 26.8 
(4.7) 
22.5 (5.5) 
CC1/2 (overall) 
0.997 
(0.581) 
0.995 
(0.891) 
0.999 
(0.97) 
0.998 
(.949) 
0..999 
(0.952) 
No. of unique 
observations 
65123 65535 31929 66459 69583 
No. of 
observations 
(overall) 
362961 341308 394901 888305 817104 
Rfree  0.1975 0.1812 0.2002 0.1931 0.19308  
Rmerge 0.73 
(0.926) 
0.66 
(0.302) 
0.62 
(0.308) 
.057 
(0.528) 
.066 (0.34) 
MolProbity 
clashscore 
2.45 2.25 2.82 2.84 4.75 
Ramachandran  
Favored (%) 
97.95 97.95 96.8 97.72 97.49 
Ramachandran  
Outliers (%) 
0.46 0.91 1.37 0.68 1.14 
xiv 
 
 
 
Table 6: Ralstonia ICH Crystallographic Refinement Statistics 
Data collected at SSRL beamline 12-2 from single crystal with 0.2°/ image and 0.15 sec/image 
Values for the highest resolution bin shown in parenthesis 
*pending refinement 
 
 
 
 
 
 
 
Model WT RsICH 
 
E122D E122Q E122T 
PDB code NA NA NA NA 
Temperature 
(K) 
100K 100K 100K 100K 
Detector Pilatus 6M Pixel 
Array Detector 
(PAD) 
Pilatus 6M Pixel 
Array Detector 
(PAD) 
Pilatus 6M Pixel 
Array Detector 
(PAD) 
Pilatus 6M Pixel 
Array Detector 
(PAD) 
Wavelength 
(Å) 
0.729 
0.729 0.729 0.729 
Attenuation 
(%) 
96% 96% 96% 96% 
Refinement 
program 
XDS, Aimless, 
CCP4 (Refmac 5) 
XDS, Aimless, 
CCP4 (Refmac 5) 
XDS, Aimless, 
CCP4 (Refmac 5) 
XDS, Aimless, 
CCP4 (Refmac 5) 
Resolution 
range (Å) 
38.58 (0.74) 38.6 (0.82) * 38.51 (0.95) 
Completenes
s 
(%)(overall) 
98.0 (89.5) 99.8 (97.4) * 99.8 (98.7) 
Space Group P 21 21 21 P 21 21 21 P 21 21 21 P 21 21 21 
a, b, c (Å) 48.23, 89.15, 92.81 48.22, 89.2, 93.01 * 48.03, 89.39, 92.93 
α, β, γ (°) 90.00   90.00   90.00 90.00   90.00   90.00 90.00   90.00   90.00 90.00   90.00   90.00 
〈I/σ(I)〉 
19.7 (0.9) 20.1 (1) * 14.6 (1.2) 
CC1/2 (overall) 
1.0 (0.322) 1.0 (0.346) * 0.999 (0.492) 
Mosaicity 0.06 0.09 * 0.05 
No. of 
unique 
observations 
517136 389097 * 250613 
No. of 
observations 
(overall) 
3554784 3315656 * 2754808 
Rfree  0.1259 0.1155 * 0.13364 
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Chapter 1: Introduction 
Isocyanides as natural products 
Isocyanides, also referred to as isonitriles or carbylamines, are isomers of 
cyanides (-C≡N). Isocyanide is the IUPAC approved nomenclature for these compounds, 
although the word “isonitriles” is still widely used, but not preferred.  Isocyanides 
possess the functional group N≡C, with the organic moiety connected to the isocyano 
group (N≡C) via the N atom. The discovery of this unusual class of compounds was an 
accident; in 1859 Lieke 1 reacted allyl iodide with silver cyanide, intending to produce 
cyanide, but instead, ended up with a foul-smelling compound that converted to formic 
acid upon acid hydrolysis2. This particularly vile smelling product was recognized as a 
member of a new class of compounds, termed “Isomeric to Nitrile”, or “Isonitrile”3. The 
newly discovered isocyanides were unique in that they were the only stable organic 
entities whose carbon was bonded to a single atom.  
Isocyanides are highly reactive; the carbon atom of the isocyano group possesses both 
electrophilic as well as nucleophilic character. This makes isocyanides ideal for synthetic 
applications4, such as multicomponent condensation reactions5,6,7, carbohydrate and co-
ordination chemistry8,9,10, addition reactions11,12 etc. Several studies have been performed 
to understand their electronic and geometric structures in order to explain their dual 
electrophilic and nucleophilic characters. For a while, the two most widely accepted 
forms of isocyanides were the carbenic form 13 and the zwitterionic form14 (Fig. 1). 
Fig. 1: Zwitterionic and carbene 
representations of the isocyano group. 
 
2 
 
These, however, are not without their individual caveats; the carbenic form was not 
consistent with the dipole moment and the IR- C-N stretching band at 2130 cm-115, 
whereas the zwitterionic form could not explain the electrophilic character of 
isocyanides. This structural disparity was finally addressed by performing Valence bond 
calculations, which supported a predominantly carbenic structure for isocyanides, with 
the zwitterionic resonance form being a secondary contributor. The unusual isocyano 
group allows isocyanides to function as biologically active naturally derived compounds 
such as chelators of transition metals, antibiotics, antiviral agents, marine sponge derived 
metabolites etc16. 
In 1948, Rothe 17 isolated the first naturally occurring isocyanide, Xanthocillin, 
from the fungus Penicillium notatum. Xanthocillin was structurally characterized by 
Hagedorn and Tonjes 18,19 in 1957, almost 100 years after Lieke’s “accidental” chemical 
synthesis of the first allyl isocyanides. The first marine-type isocyanide to be isolated was 
axisonitrile-1, from the marine sponge Axinella cannabina 20. Since then, a multitude of 
isocyanides and related compounds have been isolated from both marine and non-marine 
sources. The division of isocyanide natural products into terrestrial and marine clades has 
its roots in the history of their discovery as well as differences in their biosynthetic 
precursors, where known.  This thesis will adhere to this overarching classification 
scheme for isocyanide natural products, although we note that other chemical taxonomies 
for these compounds are possible and perhaps desirable.   Here, we will cover the 
biochemistry of isocyanide natural products, including their biological targets, 
biosynthetic and degradative pathways in marine vs non-marine sources as well as 
identifying areas where open questions invite future inquiry. 
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1.1.1 Terrestrial isocyanides: Many isocyanides have been isolated from non-marine 
microbial sources. Terrestrial isocyanides can be classified into three primary classes 
based on their structures: xanthocillins, cyclopentyls and assorted others 2,19. 
1.1.1.a Biosynthesis of terrestrial isocyanides: Isocyanides are naturally produced in 
certain microbes as secondary metabolites.  Remarkably, fundamental questions remain 
about the installation of the isocyanide moiety, including the still-unknown mechanisms 
of most validated isocyanide biosynthetic enzymes.  
 Isocyanides, as mentioned previously, possess a unique functional group and are 
naturally produced in certain microbes as secondary metabolites.  Because of their value 
as bioactive natural products, there is significant interest in delineating the biosynthetic 
mechanisms of this unusual class of compounds. The primary difference between the 
biosynthetic origins of marine vs non-marine isocyanides is that the former are derived 
from terpenoids while terrestrial isocyanides are mostly derived from amino acids19. Most 
of the backbone of these terrestrial isocyanides (the xanthocillins, the cyclopentanes and 
others), as well as the nitrogen atoms in the isocyanide group, originate primarily from 
tyrosine 21–28. However, the origin of the carbon atom of the isocyanide group remained a 
mystery for some time. Puar et al 21 attempted to address this issue by synthesizing 
hazimicins from cultures of Micrococcus luteus that were fed 14C-labelled precursors; 
their findings indicate that the isocyanide carbon in hazimicins originates from 
methionine 21–23,29. Investigations into the source of the isocyanide carbon atoms of 
Xanthocillin X monomethyl ether (XME) in glucose-starved cultures of fungus 
Dichotomomyces cejpii via [U-13C] glucose feeding experiments revealed that the 
isocyanide carbon atoms were derived from glucose metabolism rather than pathways 
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involving tetrahydrofolate metabolism such as methionine, glycine, serine, TCA cycle, 
cyanides, cyanates or carbamoyl phosphate22,29. 
The specific precursor of the isocyanide carbon remained unknown still. Interestingly, 
Penicillium notatum produces a di formamide compound, which appears in the culture 
before Xanthocillin and, which when added to the fungal culture, boosts the production 
of Xanthocillin X2,30. This suggests that formamides might be the precursors of 
isocyanides via dehydration reactions. This notion is debatable, as the discovery of the 
enzyme isocyanide hydratase (ICH) shows that formamides can the metabolic products of 
isocyanide, rather than precursors. ICH hydrates the isocyano groups in isocyanides to 
synthesize the corresponding formamides, which are then degraded to the corresponding 
amines and formates31–33. Therefore, formamide is one product of isocyanide degradation 
rather than a synthetic precursor, although not all biosynthetic routes to isocyanides are 
known.  
Fig. 2: Biosynthesis of isocyanides and origin of the isocyano group; the carbon atom of the isocyano 
group comes from ribulose-5-phosphate, the nitrogen atom can originate from tryptophan (A) or tyrosine 
(B). Chemical structures constructed using ChemDraw (Perkin Elmer). 
 
5 
 
Clardy et al 34 made significant headway into solving the mystery of the origin of 
the carbon atom of the isocyanide group when they developed a novel approach of 
cloning and heterologous expression of eDNA.   eDNA is DNA from environmental 
samples (uncultured soil bacterium) that can be transformed into easily cultured lab 
bacteria, permitting the identification and characterization of antibiotics from 
“antibacterially active eDNA clones using a high-throughput phenotypic screen”.  They 
isolated an eDNA clone, CSLG18, which produces an indole-based isocyanide in E. Coli 
and identified its biosynthetic genes, isocyanide synthase (IsnA) and ɑ ketoglutarate-
dependent oxygenase (IsnB) (Fig. 2). They observed that all the nitrogen atoms in this 
novel isocyanide are derived from the amino acid tryptophan. The source of the carbon 
atom of the isocyanide was identified as the C2 atom of Ribulose-5-phosphate 
35. The 
biosynthetic reaction proceeds via attachment of the carbonyl carbon of ribulose-5-
phosphate to the ɑ amine of L-Tryptophan, catalyzed by isocyanide synthase (IsnA). The 
resulting intermediate is then resolved to the isocyanide product by hydroxylation and 
decarboxylative desaturation by the oxygenase (IsnB) (Fig. 2). 34–36. During this process, 
the carbonyl carbon of ribulose-5-phosphate undergoes a 2-electron oxidation to become 
the isocyanide carbon atom, catalyzed by IsnA and B acting co-operatively 36.  
1.1.1.b Identification of IsnA/B homolog gene clusters: The identification of 
biosynthetic genes and a biosynthetic pathway of an isocyanide was an important 
discovery. This opened the door to a large number of isocyanide biosynthetic studies 
involving IsnA/B homologs when a BLAST search of sequenced bacterial genomes 
revealed several IsnA homolog operons 37. One class of isocyanide natural products 
whose biosynthesis was clarified by the discovery of IsnA/B is the hapalindoles. 
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Hapalindoles are terpenoid indole-containing bioactive alkaloids produced by 
cyanobacteria belonging to the order of Stigonemataceae (Fischerella sp. and 
Hapalosiphon sp.); these compounds are divided into several classes, including the 
welwitindolelinones 38,39 and 
ambiguines40,41(Fig. 6). (covered in more detail below). Investigations into the 
biosynthetic genes for these isocyanide hapalindoles revealed a 42Kbp ambiguine (amb) 
biosynthetic gene cluster in cyanobacterium Fischerella ambigua UTEX1903.  This 
cluster encode the enzymes AmbI1-3, responsible for the isocyanide group assembly 39. 
Interestingly, AmbI1-3 are close homologs of IsnA/B (46% identity), with AmbI1-2 
sharing homology with IsnA and AmbI3 with IsnB. AmbI1-2 can functionally 
complement IsnA in vitro, converting L-tryptophan and ribulose-5-phosphate into the 
same intermediate as in Fig. 2. This intermediate is then resolved by AmbI3 into Z-3-(2-
Fig. 3: The PvcABCD operon in 
Pseudomonas aeruginosa synthesizes 
the isocyanide metabolite, 
Paerucumarin and its corresponding 
hydration product, Pseudoverdine from 
Tyrosine and Ribulose-5-phosphate. 
Paerucumarin signals the upregulation 
of biofilm development gene cluster 
cupB/C in pathogenic P. aeruginosa 
either by directly targeting the histidine 
kinases RocS1 and S2 or indirectly by 
activating an undetermined 
transcriptional activator “Y”. RocS1 
and RocS2 signaling results in 
activation of cupC/B genes. Chemical 
structures constructed using 
ChemDraw (Perkin Elmer). 
 
 
. 
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isocyanovinyl)-1 H indole, instead of the isomeric E-3-(2-isocyanovinyl)-1 H indole 
synthesized when the intermediate is resolved by IsnB 36. This indicates that IsnB is 
specific to the E isomer while AmbI3 is specific to the S form (Fig. 2). Investigations into 
the biosynthetic genes for welwitindolinone-type isocyanides revealed a 36Kbp gene 
cluster in Hapalosiphon welwitschii UTEX B183042 containing the proteins WelI1,2,3 
which are close homologs of AmbI1,2,3 from the amb operon. Whether WelI1,2,3 
proteins can attach the nitrogen atom from L-tryptophan with the carbonyl carbon from 
ribulose-5-phosphate to generate a vinyl isocyanide, as done by AmbI1,2,3, remains 
untested.  
Other homologs of IsnA/B include PvcA/B; IsnA has a 33% sequence identity 
with pvcA which is involved in C-N bond formation34,43. IsnB shows sequence similarity 
to non-heme Fe2+ ɑ-ketoglutarate-dependent oxygenases, including pvcB 44. The PvcA 
and B genes are a part of the Pvc gene cluster, which is a four gene (Pvc A, B, C, D) 
operon in Pseudomonas aeruginosa. P. aeruginosa is a human pathogen and its in vivo 
growth and pathogenesis are promoted by the synthesis of two siderophores, pyoverdine 
and pyochelin43. Initially the Pvc gene cluster was implicated in the synthesis of the 
pyoverdine chromophore, hence the name of the operon, but later this claim was refuted 
as the major product of this operon is a cyclized tyrosine derived isocyanide containing 
cumarin, paerucumarin (2-isocyano-6,7-dihydroxycoumarate) 44,45. The biosynthetic 
reaction was proposed by Brady and Clarke-Pearson45 (Fig. 3). The pvc genes were also 
shown to be involved in the synthesis of pseudoverdine, a pyoverdine-related fluorescent 
bicyclic compound. Paerucumarin is an unstable compound and can easily decompose 
into pseudoverdine by hydration (the isocyanide group is simply replaced by N-formyl 
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group in pseudoverdine) 46. Interestingly, the Pvc gene cluster is negatively regulated by 
the presence of iron. Under conditions of iron limitation, the Pvc operon is upregulated to 
either synthesize the siderophore pyoverdine in certain strains of Pseudomonas, or to 
synthesize paerucumarin and pseudoverdine, which are potentially siderophores. 
Moreover, the Pvc gene cluster in P. aeruginosa is positively regulated by the LysR 
family transcription factor PtxR 45, which also  upregulates the expression of the toxA 
gene encoding exotoxin A under conditions of iron limitation47.  In addition, PtxR 
regulates the expression of other virulence factor genes that promote quorum sensing in 
P. aeruginosa48. However, the role of the Pvc gene cluster in promoting P. aeruginosa 
pathogenicity remains unexplored. Moreover, PvcA and B homologs are found in a large 
number of human, insect and plant pathogenic microbes, such as, Legionella 
pneumophila, Vibrio cholerae, Burkholderia mallei, Photorhabdus luminescens, 
Xenorhabdus nematiphila, Erwinia carotovora, Bdellovibrio bacteriovirus, etc. 45.  
Legionella pneumophila, the causative agent of Legionnaire’s disease, is an 
infectious bacterium that possesses a five gene biosynthetic gene cluster (BGC) 
containing homologs of isnA and B named lpg0174 and lpg0175 49. Moreover, this gene 
cluster is upregulated during the growth of the bacteria in human host macrophages, 
which suggests its potential role in virulence, possibly as siderophores to promote iron 
uptake by the pathogen. The BGC operon encodes four novel N-acyl-L-histidines 
(primarily by the lpg0178 gene), consistent with the observation 50 that L-histidine 
biosynthesis in upregulated during the growth of the pathogen within human 
macrophages.  
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E. coli cells expressing the Legionella BGC operon (lpg0173-177)  were capable 
of synthesizing the isocyanide rhabduscin (Fig. 2) 49 51, although rhabducin was not 
detected in wild type Legionella cells. Possible explanations for this are that rhabducin is 
unstable and rapidly converted to some other untraceable metabolite or that other 
experimental conditions are required for expression of the BGC biosynthetic operon. 
Rhabduscin is also produced by the insect pathogens Xenorhabdus nematophila and 
Photorhabdus luminescens.  The Xenorhabdus nematophila ATCC19061 genome 
contains a rhabduscin biosynthetic gene cluster comprising the IsnA and B homologs 
XNC1_1221 and XNC1_1222 as well as a glycosyltransferase gene (XNC1_1223) 51,  
similar to a biosynthetic gene cluster in Photorhabdus luminescens TT01 51. 
Heterologous expression of the rhabduscin biosynthetic transgenes in E. coli resulted in 
the synthesis of the minor isocyanide functionalized glycoside, byelyankacin, and 
rhabduscin, although the latter could not be detected in most cases owing to sensitivity of 
the isocyanide group to hydrolysis to yield formamide derivatives. It would be interesting 
to know if hydrolysis of the isocyanide group in rhabduscin in E. coli is controlled by a 
Pseudomonas ICH homolog enzyme.  
Byelyankacin, or E-4-(2-isocyanivinyl) phenyl ɑ-L-rhamnopyranoside, was first 
isolated from Enterobacter sp, and was shown to be an inhibitor of phenoloxidase-type 
enzyme tyrosinase and melanin synthesis in humans51,52. This, along with the observation 
that isocyanides are produced by a large number of pathogens, has directed attention 
towards the potential role of Rhabduscin, and other isocyanide natural products, in the 
suppression of host innate immunity.  
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 In addition to the discussed mechanism of biosynthesis of isocyanides involving IsnA 
and B and their homologs, another mechanism was proposed involving a biosynthetic 
gene cluster in Mycobacterium. Mycobacterium tuberculosis, the causative agent for 
tuberculosis, contains a biosynthetic operon, Rv0096-0101, encoding five enzymes 
conserved across pathogenic mycobacterium as well as Streptomyces, Nocardia, 
Rhodococcus etc. These enzymes are an iron(II) and α-ketoglutarate (α-KG)- dependent 
oxidase, fatty acyl-CoA thioesterase, acyl-acyl carrier protein ligase (AAL), acyl carrier 
protein (ACP) and non ribosomal peptide synthase. Co-expression of these genes from 
Mycobacterium marinum (mma-E) and Streptomyces coeruleorubidus (scoA-E), in E. 
coli resulted in the synthesis of two isocyanide-functionalized lipopeptides (INLP 1 and 
2). INLP1 and INLP2 are structurally similar to two known isocyanide antibiotics 
(SF2768 and SF2369) from Actinomycetes sp 53.  Investigation into the biosynthetic 
Fig. 4. Role of (left) ScoB-E 
(Actinomycetes sp) and 
(right) MmaB-E 
(Mycobacterium marinum) 
in INLP1-2 biosynthesis. 
 
 
. 
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mechanism revealed a multistep process (Fig. 4), starting with the adenylation of crotonic 
acid by ScoC, which is then transferred to an acyl carrier protein (ScoB); a lyase (ScoD) 
attaches a glycine to the β position of the ɑ, β unsaturated fatty acyl-ACP which then 
undergoes oxidation and dephosphorylation by the oxidase (ScoE) to form the isocyanide 
group. A similar biosynthetic mechanism exists in M. marinum with MmaC that favors 
longer chained fatty acid substrates, in contrast with ScoC53(Fig. 4).  
The previously mentioned di-isocyanide antibiotic SF2768, is produced by the 
Actinomycetes Streptomyces thioluteus, which contains an isocyanide biosynthetic 
operon (sfa) encoding a dioxygenase (SfaA), an AMP ligase (SfaB), a peptidyl carrier 
protein (SfaC), a nonribosomal protein synthetase (SfaD) and a hydroxylase (SfaE) 54 
(Fig. 5). Interestingly, production of this di-isocyanide is often accompanied by mixed 
isocyanide-formamides and even di-formamides; this led to the discovery of another gene 
in the sfa operon, SfaF that encodes an isocyanide hydratase. Isocyanide hydratase adds 
water to the isocyano groups  to yield formamides (SfaF has a 32% sequence identity to 
InhA, encoding the first characterized isocyanide hydratase from Pseudomonas putida. 
32,55.  
The identification of so many isocyanide synthase (IsnA/B) homologs in 
sequenced bacterial genomes suggests the possibility that several more isocyanide 
biosynthetic gene clusters reside in the genomes of uncultured bacteria. A total of 12 
IsnA containing biosynthetic gene clusters were identified and isolated from 
approximately 400,000 screened eDNA cosmid clones. Some of these operons contained 
simply the IsnA and B domains, while others were more complex and contained 
additional genes encoding biosynthetic enzymes 37. The gene clusters were amplified and 
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expressed in E. coIi or Pseudomonas aeruginosa to identify the clone-specific 
metabolites, 4 of which were shown to contain isocyanide groups 37. Importantly, one of 
these four isocyanides is Paerucumarin, a previously described isocyanide natural product 
(Fig. 3). 
The first isocyanide biosynthetic pathway in a fungus, Aspergillus fumigatus, was 
identified very recently56. The genome of Aspergillus fumigatus AF293 contains four 
isocyanide synthases (ICS), namely, CrmA, IcsA, IcsB and XanB, spread between three 
biosynthetic gene clusters (ICS3G, ICS4G and ICS5G). Under conditions of copper 
limitation, the ICS5G gene cluster containing the isocyanide synthase XanB produces 
four Xanthocillin derived isocyanides in A. fumigatus: a diformamide, a fumiformamide, 
BU 4704, and Xanthocillin monomethyl ether (XME)56 (Fig. 6). Inspection of the 
Xanthocillin biosynthetic pathway in A. fumigatus reveled a multistep process beginning 
with the conversion of L-tyrosine to an intermediate by XanB, similar to isocyanide 
synthase IsnA/PvcA in bacteria; this intermediate then undergoes an oxidative 
dimerization to Xanthocillin catalyzed by a cytochrome P450, XanG; Formyl and methyl 
derivatives of Xanthocillin are synthesized by XanA (homologue of InhA from 
Pseudomonas sp) and the methyltransferase XanE respectively56 (Fig. 2.B). An 
analogous biosynthetic pathway has been observed in yeast Saccharomyces cerevisiae, 
involving the sporulation specific genes, Dit1 and Dit2. Dit1, which is homologous to 
XanB, converts tyrosine into an isocyanide-functionalized, tyrosine-derived precursor 
and ultimately to N-formyl tyrosine; this is then converted to N,N-bisformyl dityrosine 
by Dit2 which is a member of the cytochrome P450 family and a XanG homolog56–58 
(Fig. 2.B). It is important to note here that the existence of the isocyanide formed in the 
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first step of the biosynthetic reaction catalyzed by Dit1 has not been observed in yeast, 
although it is entirely possible that the isocyanide group is rapidly hydrated to formyl 
group by a hydratase in yeast. This provides mechanistic rationale for the observation that 
isocyanide synthases and isocyanide hydratases often exist in pairs and the synthesis of 
the latter is often induced by the presence of isocyanide32. A better understanding of 
isocyanide biosynthesis and metabolism may elucidate the ways in which soil-dwelling 
microbes balance defense and stress response in the soil microbiome.   
1.1.1.c Biological targets of terrestrial isocyanides: The pvcA-D gene cluster in 
Pseudomonas aeruginosa encodes the isocyanide natural product paerucumarin, as 
mentioned previously. Interestingly, mutations in the pvc gene operon in P. aeruginosa 
MPAO1 resulted in downregulation of the expression of another gene cluster, the cup 
operon (cupB, cupC).  Cup proteins are responsible for attachment to abiotic surfaces and 
biofilm development in various infection sites. This indicates that the pvc gene cluster 
controls biofilm formation in P. aeruginosa by regulating the cup gene operon using 
paerucumarin as a signaling molecule59. The transcriptional factor Ptxr upregulates the 
pvc gene cluster to synthesize paerucumarin, which in turn activates either the CupB/C 
two component regulatory system or the roc system.  This occurs with the help of 
histidine sensor kinases, RocS1 and RocS2, which either directly activate RocA1 and an 
unknown effector “X” or indirectly via, an unknown transcriptional activator “Y”; this in 
turn upregulates cupC1-3 and cupB1-6 expressions respectively59,60 (Fig. 3). 
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There is an intriguing possible connection between isocyanide natural products and 
biofilm formation mediated by iron availability. Biofilm development in several 
pathogenic bacteria, such as L. pneumophila 61,  P. aeruginosa 62, S. aureus 63,64, etc, is 
induced by low levels of intracellular iron. Under conditions of iron limitation, P. 
aeruginosa synthesizes two endogenous siderophores, pyoverdine and pyochelin, which 
are responsible for iron acquisition from the host 65 and subsequent biofilm development 
around infection sites66–68. As mentioned previously, under conditions of iron limitation 
the Pvc gene cluster directs the synthesis of the siderophores pyoverdine and pyochelin as 
well as the isocyanide paerucumarin and its formyl form pseudoverdine 45. It would be 
interesting to determine if paerucumarin and pseudoverdine can chelate iron, possibly 
pointing to an interaction between these isocyanide and isocyanide-derived natural 
Fig. 4: Isocyanide SF2768 is synthesized by the SfaABCDE operon in S. thioluteus. This isocyanide is 
a chalkophore; it is transported outside the cell membrane by Orf12 where in, it chelates copper (I) and 
transports it into the cell via ABC transporters (Orf 9-21). Inside the cell, the chalkophore bound 
copper is released and SF2768 is regenerated for another cycle of copper chelation.  
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products and the expression of genes critical for biofilm development in P. 
aeruginosa62,69. If validated, isocyanide-induced biofilm development would be a novel 
mechanism for biofilm formation in P. aeruginosa and other pathogenic strains 
possessing the pvcA-D operon homologs. Moreover, Ferric uptake regulator (Fur) is an 
iron dependent transcription factor that regulates the expression of genes critical for 
biofilm development, and the major intracellular iron regulator in P. aeruginosa62,69.As 
such, it would be interesting to analyze the interplay between the cup genes (CupB1-6 
and CupC1-3) and the fur responsive genes in promoting pathogenesis and biofilm 
synthesis.  
The notion that isocyanides may act as siderophores is supported by their intrinsic 
ability to form complexes with a variety of transition metals70,71, inherent affinity towards 
hemoproteins72,73, and also by a large body of correlative experimental evidence 
suggesting that pathogenic bacteria synthesize isocyanides to chelate metals and promote 
survival in hosts. As mentioned previously, Mycobacterium tuberculosis, the causative 
agent for tuberculosis, contains the Rv0096-0101 biosynthetic operon that encodes two 
isocyanide-functionalized lipopeptides,INLP1 and 2; these two show structural homology 
to isocyanide antibiotics SF2768 and SF2369 from Actinomecetes sp53.  This conserved 
biosynthetic operon (Rv0096-0101) appears critical for survival and pathogenesis of M. 
tuberculosis in macrophages. While the mechanism of this remains undiscovered, there is 
the possibility that the Rv0096-0101 encoded genes facilitate metal uptake, transport, and 
homeostasis in the pathogenic bacteria.  
Additional evidence for an isocyanide-transition metal connection is provided by 
CtpA and CtpB: two heavy metal-translocating ATPases located near the isocyanide 
16 
 
biosynthetic gene cluster in the genome of M. tuberculosis. The expression of CtpB is co-
upregulated with the isocyanide biosynthetic gene cluster (Rv0096-0101) under 
conditions of zinc limitation 53,74,75. Deletion mutations in this conserved isocyanide 
biosynthetic gene cluster (mmaA-E) in the pathogenic mycobacterium M. marinum 
resulted in a significant drop in intracellular zinc accumulation, consistent with the 
observation that this isocyanide biosynthetic gene operon is important for metal uptake 
and transport in pathogenic mycobacterium53.  However, there is currently no direct 
evidence of metal chelation by the encoded isocyanide lipopeptides and a detailed 
mechanism of metal uptake and the resulting interactions between the isocyanides and the 
components responsible for regulating metal homeostasis in these pathogens is unknown.  
There is a more direct connection to metal binding in the isocyanide antibiotic 
SF2768 produced by Streptomyces thioluteus.   SF2768 is a chalkophore, that is, a 
molecule that binds to and facilitates acquisition of extracellular copper. To acquire 
extracellular copper, SF2768 (Fig. 5) is transported across the cell membrane by Orf12, a 
member of the major facilitator superfamily (MFS) exporters.  SF2768 chelates and 
converts environmental copper (Cu2+) to Cu+ to form an SF2768-Cu+ complex, which is 
then transported inside the cell by an ABC transporter encoded by genes Orf9-21 in the 
isocyanide biosynthetic (sfa) gene cluster. Once inside the cell, the chelated Cu+ is 
released binds to several Cu-dependent enzymes critical for growth and development as 
well as secondary metabolite synthesis (by tyrosinase-like copper containing 
monooxygenases) in Streptomyces species 54,76–78.The SF2768 is regenerated and ready 
for another cycle of copper acquisition54 (Fig. 5). SF2768 derivatives are also copper 
chelators; the isocyanides have the highest copper chelating activities, followed by the 
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partially hydrated metabolites. The diformamides have no detectable copper chelating 
activity, indicating that the presence of isocyano group(s) is directly responsible for 
copper binding and transport 55.  
Unsurprisingly, SF2768 and its derivatives are not the only instances of 
isocyanides potentially acting as chalkophores.  Human pathogen Aspergillus fumigatus 
AF293 genome contains four isocyanide synthases (ICs), CrmA, IcsA, IcsB and XanB, 
spread across three biosynthetic gene clusters (ICS3G, ICS4G and ICS5G), as mentioned 
previously 56.  The biosynthetic gene cluster ICS3G, consists of four genes (crmA, B, C 
and D), referred to as the crm cluster, which are expressed only in copper limited 
conditions and their expression patterns are strikingly similar to that of high affinity 
copper transporter ctrC. The expression of crmA-D is not upregulated in iron deplete 
conditions, thus indicating their specific transcriptional response to copper. MacA, AceA 
and CufA are three copper binding transcription factors present in most pathogenic fungi, 
including Aspergillus sp, involved in copper uptake during copper depletion, 
detoxification of copper at toxic levels and both, respectively56,79. MacA induces the 
expression of the crm cluster under copper depleted and replete conditions56 while AceA 
and CufA has no effect. Interestingly, out of the four crm genes, crmC and crmD encode 
copper and iron transporters respectively, but the mechanism of copper or iron uptake and 
transport by crmD and crmC encoded transporters remain unclear.  
Promoting virulence of a pathogen in a host requires survival of the pathogen 
inside the host. An important determinant of pathogenicity is to overcome the host’s 
natural immune defense. 80 One commonly used mechanism for subverting the host 
defense is disruption of host redox homeostasis79,81. Isocyanides have been shown to 
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promote pathogenicity by inhibition of copper-containing enzymes. Copper plays an 
essential role in the host’s innate immunity, either by serving as cofactor to 
physiologically important enzymes,  promoting differentiation, maturation and 
proliferation of leukocytes, or by ensuring proper neutrophil and macrophage functions 
against pathogens82–86. Therefore, isocyanides chalkophores can inactivate the host’s 
innate immune defense machinery by disruptive copper sites in these proteins.   
An example of an isocyanide that inactivates copper-dependent enzymes involved 
in mediating proper host immune functioning is rhabduscin. Rhabduscin is synthesized 
by insect pathogens Xenorhabdus nematophila and Photorhabdus luminescens (Fig. 2.B) 
and can inhibit the copper-dependent enzymes phenoloxidase and tyrosinase at 
nanomolar concentrations 51.  These metalloenzymes contribute to the immune defense of 
an insect host by synthesizing and depositing melanin, which insects use as protective 
layer to seal out pathogens87,88.  Therefore, rhabduscin promotes pathogenesis both by 
disrupting the host’s ability to synthesize melanin and through its antimicrobial properties 
that kill competitors and enhance pathogen survival in host insect cadavers.  
Other isocyanides also inhibit tyrosinase.  For example, melanocin A (Fig. 6) an 
isocyanide antibiotic isolated from Eupenicillium shearii, inhibits mushroom tyrosinase 
and subsequently melanin biosynthesis (IC50 of 9nM). Structurally related compounds 
lacking the isocyanide functional group, namely, Melanocin B and C, failed to inhibit 
tyrosinase, thus indicating that the isocyanide group is essential for inhibition89. Several 
cyclopentyl-type isocyanides from Trichoderma harzianum MR304, were all inhibitors of 
melanogenesis in Streptomyces bikinienesis and B16 melanoma cells; they inhibited 
mushroom tyrosinase, and consequently melanogenesis, with IC50 values of  0.25 µg/ml 
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and 0.05µg/ml respectively 90. The precise mechanism by which isocyanides inhibit 
tyrosinase is unclear, but competitive binding of the isocyano group of the inhibitor to the 
copper in the active site of tyrosinase has been speculatively proposed 91. It is not known 
if there are isocyanides that inhibit metalloenzymes involved in the human immune 
system or are implicated in protection against other human diseases, which is an avenue 
for future research.  
1.1.1.d Types of terrestrial isocyanides (Fig. 6): 
i. Xanthocillin-class isocyanides: Xanthocillin was isolated from Penicillium notatum 
by Rothe, as a complex mixture of xanthocillins X, Y1, Y2 and Z. The members of this 
group are all structurally related to xanthocillin (Fig. 6), with variations in the groups on 
their aromatic rings 2. Interestingly, studies show that xanthocillin has also been produced 
outside the planet Earth, in space; Penicillium expansum 2-7 and Penicillium 
chrysogenum,  resident strains of the orbital complex, Mir, which became the dominant 
strains at the end of a long term space flight, produced secondary metabolites, 
xanthocillin X and questiomycin A92,93. Aspergillus is another important source of 
xanthocillin and its derivatives 94,95,96  such as xanthocillin X dimethylether (XDE) and 
xanthocillin X monomethylether (XME) (Fig.6).  XME has also been isolated from 
Dichotomomyces cejpii, where it acts as an inhibitor of prostaglandin biosynthesis and 
platelet aggregation 94,97. Other important xanthocillin-derived isocyanides include 
xanthoascin, isolated from Aspergillus candidus 2,94,98 and emerin, a naturally existing di-
cyano analogue of xanthocillin2, isolated from the mycelium of Aspergillus nidulans 94,99 
(Fig. 6).  BU 4704 is another xanthocillin-type isocyanide which was isolated from 
Aspergillus sp by Tsunakawa et al 100.  Aspergillus fumigatus co cultured with 
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Streptomyces peucetius resulted in the synthesis of a formyl xanthocillin analogue, 
known as fumiformamide 101.  
Biological activity of Xanthocillin class isocyanides: 
Xanthocillins as antibacterial and antiviral agents:  Isocyanides are natural products 
produced by certain microbes in secondary metabolism and almost all of them are potent 
antibiotic agents. The Xanthocillin complex (X, Y1, Y2, Z) exhibits a wide range of 
activity against both gram positive and negative bacteria as well as fungi and yeasts2. 
This broad spectrum antimicrobial property of Xanthocillin may be the reason that the 
producer fungal strain, Penicillium, was the dominant surviving fungus on the Mir space 
station after long term flight92,93.Three di-hydrogenated forms of Xanthocillin, namely 
NK372135 A, B and C, isolated from the fungus Neosartoria fischeri var. glabra 
IFO9857, strongly inhibits the growth of Candida albicans in vitro with IC50 values of 
Fig. 5: TOP: Xanthocillin type isocyanides; BOTTOM: Cyclopentyl type isocyanides. Together, 
xanthocillins and cyclopentyls cover the largest percentage of non-marine isocyanide natural 
products. Structures constructed using ChemDraw (PerkinElmer). 
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2.12, 0.53 and 0.27 µg/ml respectively 102, thus providing potential therapies against 
candidiasis. 
The xanthocillin mono methylester (XME), xanthocillin dimethylester (XDE) and 
methoxy xanthocillin dimethylether derivated isolated from Apergillus sp. exhibit anti-
viral activity.  These xanthocillin derivatives are active against Newcastle disease virus 
(NDV), the causative agent for Newcastle disease, a contagious bird disease that is 
easily transmissible to humans. Xanthocillin esters are effective against herpes simplex 
virus and Bacillus subtilis 103. They are, however, not effective against the plant 
pathogen tobacco mosaic virus (TMV) 104. This suggests that xanthocillin-derived 
antibiotics may be generally less effective against plant viruses, potentially owing to 
impaired diffusion of these antibiotics across the protective plant leaf cuticle layer104.   
More studies are required to confirm this hypothesis.  
The mechanism of action of XME against NDV in cultured cells involves the 
reversible inhibition of the synthesis of hemagglutinnin in NDV-infected cells 95 at 15 
µg/ml concentration.  XME is one of the most effective antiviral inhibitors of protein 
synthesis, effectual at low concentrations and with low cytotoxicity 95. Identification of 
XME’s physiological targets, inhibitory mechanism against hemagglutinin synthesis, 
and role in prevention of hemagglutination requires further study.  
A new type of xanthocillin-like antibiotic was isolated from Leptosphaeria sp. L-
179 in 1990 and named MK4588 or Leptocillin. MK4588 shows strong activity against 
several infectious bacterial species (Klebsiealla, Proteus mirabilis, Providencia rettgeri, 
Morganella morganii kono) at concentrations ranging from 0.78-12.5µg/ml, but no 
activity against E. coli at concentrations as high as 100µg/ml 105. Two other xanthocillin-
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derived compounds, darlucins A and B (Fig. 6), were isolated from Darluca filum.  They 
exhibit antibacterial (MIC: 2.5-20µg/ml), antifungal (MIC: 2.5-50µg/ml), as well as low 
cytotoxic effects against various cell lines, and no phytotoxic effects 106. 
Xanthocillins inhibit prostaglandin biosynthesis: Prostaglandins are a family of fatty 
acid-derived molecules that are powerful vasodilators and are primarily involved with 
causing fever, pain, and inflammation. In 1982, Vane 107 won the Nobel prize in medicine 
for his discovery of the mechanism of action of non-steroidal anti-inflammatory drugs or 
NSAIDs  in the inhibition of prostaglandin biosynthesis, The classical NSAID Aspirin 
(acetyl salicylic acid) inhibits the enzyme cyclooxygenase (COX), thereby preventing the 
conversion of the fatty acid (arachidonic acid) to prostaglandins, thus providing relief 
from pain and inflammation108. Around the same time, Kitahara et al 97 observed that  
xanthocillin monomethylether (XME), isolated from cultures of Dichotomomyces cejpii, 
reduced prostaglandin (specifically prostaglandin H2) biosynthesis from Arachidonic acid 
by 50%. The mechanism of inhibition of PGH2 biosynthesis by XME is unknown. 
CSBP is a protein kinase, involved in the biosynthesis of inflammatory cytokines 
IL-1 and TNF as a response to a large number of inflammatory signals. There are several 
classes of imidazole CSBP ligands which are capable of binding to CSBP and inhibiting 
LPS stimulated synthesis of inflammatory cytokines. They also show variable extent of 
inhibition of arachidonic acid metabolism by inhibiting the enzymes prostaglandin H 
synthase 1 (PGH1) or COX1 and Arachidonate 5-lipoxygenase (5-LO) 109. Boehm et al 
synthesized a new class of CSBP ligand, 1substituted-4-aryl-5-piridinylimidazoles from 
isocyanides (tolyl sulfide isocyanide) utilizing van Leusens’ methodology 110 and 
observed that it inhibits 5-LO and Cycloxygenase activity with low potency109. 
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Nevertheless, this warrants investigations into the potential inhibitory effect of 
isocyanides on cyclooxygenase activity and their possible utility as anti-inflammatory 
drugs and analgesics. 
Xanthocillins are thrombopoietin receptor agonists: Thrombopoietin (TPO) is a 
cytokine that is responsible for the regulation of megakaryocyte and platelet production 
via activation of its receptor, MPL or TPO-R 111,112. Recombinant human TPO (rh-TPO) 
is currently used for the treatment of chemotherapy-induced thrombocytopenia, a 
potentially fatal condition characterized by low platelet count 113,114.  However, some 
serious limitations with the use of rh-TPO include development of neutralizing antibodies 
against TPO and limitation with oral administration (rh-TPO- in unstable in the intestine) 
115,116. Sakai et al, reported that four xanthocillin derivatives, including XDE as the first 
natural TPO mimetics, These exhibit TPO receptor agonist activity115,117 and promote the 
proliferation of TPO-sensitive human leukemia cell line (UT-7/TPO) in a dose dependent 
manner. Yamaguchi et al studied the contribution of the chemical structure of 
xanthocillin derivatives towards their TPO-R agonist activity. They observed that TPO-R 
agonist activity of these isocyanides are enhanced by alternations in the olefin geometry 
and by hydrophobic substitutions on benzene rings 115 but high concentrations of these 
compounds inhibit cell proliferation, potentially due to the cytotoxicity of vinyl 
isocyanide groups required for their bioactivity. More dose optimization and structure- 
activity studies of these TPO mimetics are need in order to diminish their toxic effects 
and to generate potent replacements of rh-TPO in the treatment of thrombocytopenia.  
Complications from the hepato- and cardio-toxicity of Xanthocillins: Townsend et al 
classified xanthocillin as “too hepatotoxic for use” 118. Xanthoascin (Fig.5). isolated from 
24 
 
Aspergillus candidus, has been shown to exhibit hepato- and cardio-toxicity and to 
induce teratogeneicity in mice  119,120. It also causes severe hepatic injury, jaundice, and 
focal or confluent necrosis of hepatocytes in mice121,122 , followed by myocardial 
degeneration. In addition, xanthoascin generates unique lesions in the liver and the heart, 
which are caused by vacuolation of the lung alveolar and myocardial interstitial cell 
nuclei 122. Since Aspergillus candidus is an extremely common soil fungus known to 
contaminate food, xanthoascin poses a serious risk of food borne liver and heart diseases. 
While xanthoascin poses a potentially serious human health risk, there might be other 
bioactive isocyanide products, such as the darlucins, which exhibit low cytotoxicity 
against various cell lines, and no phytotoxic effects 106; these isocyanides are attractive 
targets for therapeutic interventions and drug design. Several isocyanides, such as, 
brasilidine A, from Actinomycete Nocardia brasiliensis 123, exhibits significant 
cytotoxicity against various tumor and multidrug resistance cell lines124 and can be used 
as anti-cancer agents.  
Xanthocillins as anti-malarials and inhibitors of melanin biosynthesis:  The 
xanthocillin-type alkaloid, cordyformamide, was isolated from the fungus Cordyceps 
brunnearubra and is toxic to the malarial parasite Plasmodium falciparum but has low 
toxicity to human breast cancer cells.  It is not cytotoxic towards other cancer cells, such 
as small cell lung cancer, epidermoid carcinoma, etc 125. Cordyformamide has a structure 
similar to that of melanocin A, a melanin biosynthesis inhibitor (IC50 of 9nM)  isolated 
from the fungus Eupenicillium shearii 89. Cordyformamide possesses two formamide 
groups instead of the isocyanide group found in xanthocillin Y2, while melanocin A 
possesses one formamide and one isocyanide group (Fig.5). 125. Interestingly, melanocin 
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B and C, which are structurally related to Melanocin A but do not possess isocyanide 
groups, failed to inhibit tyrosinase.  Because tyrosinase is involed in the biosynthesis of 
melanin,  the isocyanide moiety in the compounds appears to be critical for their 
inhibitory effect on melanin production89.    
Xanthocillins as anti-tumor agents: Xanthocillin dimethyl ether (XDE) inhibits the 
proliferation of liver HepG2, breast cancer MCF-7, and human oral carcinoma KB cells 
with IC50 values of 0.18, 0.38 and 0.44 µg/ml respectively 
126. Investigation into the 
mechanism of action of XDE against tumor cells revealed activation of pro-apoptotic 
pathways and  increased levels of reactive oxygen species (ROS) 126. It is possible that 
XDE targets ROS-regulated apoptotic pathways in cancer cells. A xanthocillin-derived 
compound isolated from the marine organism Penicillium commune, SD118-xanthocillin, 
inhibits the growth of a large number of cancer cell lines in a dose dependent manner. Its 
mechanism involved inducing autophagy by downregulating the MEK/ERK pathway 
along with upregulating PI3K/Beclin 1 signaling 127.  
ii Cyclopentyl-type isocyanides: Trichoderma, a common soil fungus, is the primary 
source of all cyclopentyl-type isocyanides. The first isocyanide of this type to be reported 
was dermadin (previously known as U-21963). It was isolated from Trichoderma viride 
in 1966 128,129, almost 10 years after the discovery of Xanthocillin in the fungus 
Penicillium notatum. The members of this group of isocyanides vary primarily in their 
oxidation levels and degrees of hydration 2 (Fig.5). Dermadin and another related 
isocyanide, Trichoviridine, were also isolated from Trichoderma koningii 130 128. 
Trichoviridine has also been isolated from various other sources and called different 
names, including compound 142B from Tricoderma sp, and isonitrin B from strain 
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OMRL 3200 (Trichoderma hamatum) 2,128,131.  An isomer of isonitrin B has been isolated 
from Trichoderma harzianum l2.  Isonitrins A and D were isolated from Trichoderma 
harzianum and Trichoderma hamatum respectively 2,132. Two new cyclopentyl-type 
isocyanides were isolated from Trichoderma hamatum133 , a spirolactone and a methyl 
ester2 (Fig.5). Several volatile isocyanides have been isolated from Trichoderma 
koningee, named homothallin 1, homothallin 2, and their related amine and N-formyl 
derivatives 134 2,135.  Homothallin 2 has also been isolated from a mutant strain of 
Trichoderma harzianum (the wildtype strain was not a producer of homothallin 2) 136.   
Biological activity of Cyclopentyl-type isocyanides: 
Antibacterial and antifungal properties of cyclopentyls: Cyclopentyl-type isocyanides 
are antibacterial (effective against both Gram negative and positive) and antifungal 
agents, similar to the previously discussed xanthocillins2,132. Trichoderma, the primary 
source of these cyclopentyl-type isocyanides, is widely used as a biocontrol agent; it 
inhibits the growth of other organisms in its vicinity. It is possible that the biochemical 
mechanism of this competitive advantage might include the biosynthesis of toxic 
secondary metabolites including isocyanides 135,137.   
Cyclopentyl isocyanides contribute to ill thrift disease and alteration of rumen 
bacterial metabolism: “Ill thrift” (failure to thrive or FTT) is a common disease in 
ruminating animals 138, and is characterized by impaired growth, muscular dystrophy, 
anemia, and ketosis of the affected animal. Ovine ill thrift is contracted when sheep feed 
on pastures contaminated with Trichoderma. Cyclopentyl-type isocyanides secreted by 
Trichoderma sp, such as trichoviridin, dermadin, and 3-(3-isocyanocyclopent-2-
enylidene)-propionic acid (Fig.5) from Trichoderma hamatum 139,140  cause ill thrift 
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disease.  The primary target of these Trichoderma metabolites is the bacteria that digest 
the cellulose in ruminating animals.  The cyclopentyl isocyanides deplete beneficial 
rumen bacteria in the affected animal, causing disease 141. The inhibitory mechanism of 
these toxic Trichoderma isocyanide metabolites on beneficial rumen bacteria has been 
studied extensively. 3-(3 isocyanocyclopent-2-enylidene)-propionic acid induces 
carbohydrate fermentation changes in the rumen that are related to ill thrift disease 142,143 
by increasing the production of acetate from carbohydrates for most of the 11 tested 
strains of rumen bacteria. However, some strains showed a net decrease of acetate 
production relative to the synthesis of other acidic fermentation products. 3-(3 
isocyanocyclopent-2-enylidene)-propionic acid  also causes nutritional deprivation of the 
animal 142. 
 Digestion of the cellulose in timothy hay, a type of grass was inhibited by 2-5 
µg/ml of 3-(3-isocyanocyclopent-2-enylidene)-propionic acid in a mixed culture of 
rumen bacteria. 12 µg/ml of 3-(3-isocyanocyclopent-2-enylidene)-propionic acid 
inhibited the fermentation activity of rumen fluid, measured by its dehydrogenase activity 
(DHA); DHA of rumen fluid decreases by 50% upon a 30-minute incubation with this 
metabolite, thus indicating that the primary inhibitory step is extremely rapid 144.  
Interestingly, this inhibitory effect of the isocyanide on rumen fluid fermentation and 
cellulose digestion by rumen bacteria is significantly reduced by the introduction of 
equimolar amounts of Nickel (Ni2+) and Cobalt (Co2+) respectively, into the system. 
Palladium and chromium ions are also capable of reducing the inhibition. Given the 
known affincity of isocyanides for metals, these metal ions may polymerize144 the 
isocyanide, thereby reducing its concentration and anti-bacterial effects.  
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 One of the causes of ill thrift is cobalt deficiency 145. Cobalt is converted to 
Vitamin B12 (cobalamin) by the rumen bacterial flora of ruminating animals 146. A 
deficiency in the production of vitamin B12 resulting from lack of cobalt causes impaired 
propionic acid metabolism in the liver, hepatic dysfunction, suppressed appetite, and 
impaired growth, ultimately resulting in ill thrift 147,148. This finding is consistent with 
other results that point to transition metal biochemistry as an important axis of isocyanide 
natural product activity. 
Cyclopentyl isocyanides inhibit pleiotropic resistance (PDR) in bacteria and possibly 
multidrug resistance (MDR) in humans: One of the major persistent issues with the 
use of anti-cancer drugs is a phenomenon called multidrug resistance (MDR). In MDR, 
the ATP binding cassette (ABC) transporter proteins expel a wide variety of anti-cancer 
drugs from the cells. Because MDR reduces chemotherapy efficacy, developing 
inhibitors of these drug efflux pumps is a high priority 149. Pleotropic drug resistant 
protein 5 (Pdr5p) is an ABC transporter that acts as a drug efflux pump and is implicated 
in pleiotropic resistance (PDR) in Saccharomyces cerevisiae. This phenomenon is 
functionally similar to multidrug resistance (MDR) in mammals caused by the ABC 
transporter protein P-glycoprotein 150,151. The cyclopentyl-type isocyanide 3-(3-
isocyanocyclopent-2-enylidene)-propionic acid was isolated from cultures of 
Trichoderma sp. P24-3 while screening for inhibitors of MDR in tumors.  In Pdr5p 
overexpressing cells, this isocyanide is capable of inhibiting Pdr5p-mediated efflux of 
cerulenin , a fatty acid synthase inhibitor 152. 3-(3-isocyanocyclopent-2-enylidene)-
propionic acid is also capable of inhibiting efflux by the Pdr5p homologs Cdr1p and 
Cdr2p in the pathogenic yeast, Candida albicans. 151  The mechanism of inhibition of 
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Pdr5p by the isocyanide is unknown, although it does not appear to be due to the 
downregulation of PDR5 gene expression or Pdr5p protein levels. Therefore, isocyanide 
inhibition must specifically targeting Pdr5p function 151. There is also a need to determine 
the effect of 3-(3-isocyanocyclopent-2-enylidene)-propionic acid on mammalian drug 
efflux pumps, and to determine the role of this cyclopentyl-type isocyanide in 
overcoming multidrug resistance in humans as a viable cancer treatment strategy.  
Cyclopentyl isocyanides inhibit tyrosinase and melanin biosynthesis:  Tyrosinase is a 
copper-dependent enzyme found in both prokaryotes and eukaryotes that is responsible 
for the biosynthesis of melanin 91. During the late 1990s and early 2000s, many research 
groups focused on screening microbes for the production of secondary metabolites which 
inhibit the process of melanin synthesis (melanogenesis) by directly inhibiting tyrosinase 
153.  Several tyrosinase inhibitors were isolated 90  from Trichoderma harzianum MR304, 
two of which were novel.  All of the identified inhibitors were cyclopentyl isocyanide 
compounds and inhibited melanogenesis in Streptomyces bikinienesis and B16 melanoma 
cells with submicromolar IC50 values. The two newly discovered isocyanides were named 
MR566A or 1-(3-chloro-1,2 dihydroxy-4-isocyano-4-cyclopenten-1-yl) ethanol and 
MR566B or 1-(1,2,3—tri-hydroxy-3-isocyano—4-cyclopenten-1-yl) ethanol. The other 
isolated isocyanides included 1-(1,4,5-trihydroxy-3-isocyanocyclopenten-2-
enyl)ethanol, 2-hydroxy-4-isocyano-α-methyl-6-oxabiocyclo[3.1.0]hex-3-ene-
3methanol, 4-hydroxy-8-isocyano-1-oxaspiro[4.4]cyclonon-8-en-2-one, MR304A, 
methyl-3-(1,5-dihydroxy-3-isocyanocyclopent-3-enyl)prop-2-enoate90,90,154. The 
mechanism of inhibition of tyrosinase by these isocyanides is unknown, although the 
copper in the active site of the tyrosinase enzyme is a likely target.  The inhibition of 
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tyrosinase by several isocyanides, including the homothallin 2 structural analog isolated 
from marine Trichoderma viride H1-7 91,155, suggests a shared mechanism.  
Possible involvement of cyclopentyl isocyanides in fungal reproduction: 
Phytophthora cinnamomi Rands is a soil-borne fungus and a plant pathogen responsible 
for the widespread root rot disease in plants. This fungus is heterothallic with compatible 
mating strains A1 and A2 156. Brasier 157,158 observed  that certain volatile metabolites 
from Trichoderma viride were able to stimulate oospore production by the A2 mating 
type and not the A1 mating type of Phytophthora cinnamomi Rands following a 
homothallic pattern. Pratt et al 134 observed the same oospore induction in the A2 mating 
strain of Phytophthora cinnamomi Rands by metabolites from Trichoderma koningii. 
These volatile metabolites from Trichoderma koningii were identified as the cyclopentyl 
isocyanides homothallins 1 and 2 2.  The mechanism of induction of homothallic 
oospores in Phytophthora cinnamomic A2 mating type by homothallins remains unclear.  
iii Assorted other terrestrial isocyanides: Non-marine natural isocyanides that do not 
fall into either the Xanthocillin or Cyclopentyl classes are discussed below. 
Mannitol-containing isocyanides, A32390A and brassicicolin A: 1,6-di-O-92-
isocyano-3-methylcrotonyl-mannitol or A32390A is a novel antibiotic and antifungal 
agent isolated from the culture of the fungus Pyrenochaeta sp.  A32390A is effective 
against the pathogenic yeast Candida albicans, the causative agent of the Candidiadis 
infection in humans 159,160. A32390A is also a dopamine beta hydroxylase (DBH) 
inhibitor with an IC50 value of 1.7µg/ml 
161.  Like several other molecular targets of 
isocyanide natural products, DBH is a copper-containing oxygenase. DBH catalyzes the 
conversion of dopamine and other phenylethylamine derivatives to the neurotransmitter 
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norepinephrine using ascorbic acid as a cofactor 162,163. Deficiency of DBH results in 
impaired synthesis of catecholamines such as norepinephrine and epinephrine in the 
central and peripheral nervous system with a concurrent increase in serum dopamine 
levels 164. This condition of increased dopamine/norepinephrine ratio is known as 
“norepinephrine deficiency” and it affects the autonomic nervous system.  Physiological 
effects of norepinephrine deficiency include perturbed blood pressure regulation, elevated 
serum dopamine levels, and certain mental disorders 165–168. When injected 
intraperitoneally or subcutaneously, A32390A reduces heart and adrenal norepinephrine 
levels with a concurrent decline in blood pressure without any hepatotoxicity in DOCA 
hypertensive rats.  It does not affect brain norepinephrine levels when injected and is 
ineffective when administered orally 161,169–171. Oral administration of isocyanides is 
likely to be generally problematic, as the isocyanide moiety is acid-labile and unlikely to 
survive passage through the stomach. Like most other isocyanides, the mechanism of 
A32390A inhibition of DBH is unknown but likely involves interaction of the isocyanide 
moiety with the active site copper ion of DBH.  Research is also required regarding the 
potential effect of A32390A in the induction of the mentioned disorders.   
Another structurally similar isocyanide with a d-mannitol core is brassicicolin A, 
isolated from the plant necrotrophic fungus Alternaria brassicicola172. It is a potent 
antibiotic against Bacillus subtilis and Staphylococcus aureus 173. Interestingly, 
brassicicolin A is a phytotoxin (up to a concentration of 5mM) and a phytoalexin, which 
is a defensive chemical produced by plants as a defense mechanism against pathogenic 
infections, produced by infected Brassica juncea plants, unlike the other isocyanides 
discussed so far 174,175. 
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Indole-containing isocyanides: B371 is a novel indole containing isocyanide antibiotic 
isolated from Pseudomonas sp. 176. A similar isocyano indole metabolite, brasilidine A, 
was isolated from Actinomycete Nocardia brasiliensis 123 and possesses significant 
cytotoxicity against various tumor and multidrug resistance cell lines124. 
 Hazimicin factors 5,6: The hazimicins are a novel class of isocyanide antibiotics 
(hazimicin factors 5 and 6), isolated from Micromonospora echinospora var challisensis 
SCC 1411 177 ; they are isomers that are interconvertible in presence of water 2,21,178.  
Aerocyanidine and Aerocavin: Aerocyanidine, an isocyanide antibiotic primarily 
effective against gram positive bacteria, was isolated from cultures of Chromobacterium 
violaceum ATCC 53434 179. In the same year, another isocyanide anttibiotic called 
aerocavin was isolated from the same bacterium and is effective against both gram 
positive and negative bacteria180. 
1.1.2 Non-terrestrial isocyanides: All isocyanide natural products produced by marine 
organisms are terpenoids (isoprenoids), and maybe diterpenoids (4 isoprene units) or 
sesquiterpenoids (3 isoprene units). The first marine isocyanide to be discovered was 
axisonitrile 1, a sesquiterpenoid, from the sponge Axinella cannabina 20. This portion of 
the review will focus primarily on the types of marine isocyanides and their biological 
roles, biosynthesis and biochemical targets.  
1.1.2.A Types of marine isocyanides: Depending on the number of isoprene units in 
their structures, marine based isocyanides can be classified into monoterpenoids, 
diterpenoids and sesquiterpenoids. This next section will briefly cover the different types 
of marine isocyanides and their biological roles.  A more in depth and comprehensive 
coverage of this topic is available in previously published reviews 2,19,124,181,182.   
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i. Monoterpenoid marine isocyanides: This group mainly consists of monoterpenoid 
indole containing isocyanide alkaloids, synthesized primarily by blue green algae of the 
stigonemataceae family. Hapalindole A was the first such monoterpenoid indole 
isocyanide to be discovered from the cyanophyte Hapalosiphon fontinalis (Ag.) Bornet 
192. This was followed by the discovery of eighteen additional isocyanide functionalized 
indole alkaloids from the same cyanophyte, named hapalindoles C-Q and T-V 183. The 
monoterpenoid type isocyano alkaloids can be classified into three primary groups124:  
(a) the C21 indole alkaloids, which includes the hapalindoles, maybe further classified 
into tetracyclic and tricyclic depending on the presence or absence of a C4-C16 bond. 
Other C21 type of isocyanides are the fischerindoles, which are basically tetracyclic 
hapalindoles modified to possess a C2-C16 bond rather than the C4-C16 bond. 
(b) the oxindoles and the oxygenated C21 indoles which include the hapaloxindoles, the 
hapalonamides, the hapalindolinones, and the welwitindoles.  
(c) the C26 indole alkaloids which include the ambiguines.  
A thorough account of these indole isocyano alkaloids can be found in the 
reviews published by C.W.J Chang124 and by Bhat et al 185. These monoterpenoid 
isocyanide natural products are bioactive agents, primarily exhibiting antimicrobial 
properties, just like the terrestrial isocyanides40,185–187. Most of these natural metabolites 
are antifungal agents41,188,189; Ambiguines A-F and hapalindoles G and H were isolated 
from Fischerella ambigua 190 185; Ambiguines H and I exhibit both antifungal as well as 
antibacterial properties with MIC values comparable to streptomycin, puromycin and 
amphotericin41. Ambiguine isocyanides A,  K and M show potent inhibitory activity 
against M. tuberculosis and B. anthracis 40.  The terrestrial cyanobacterium Fischerella 
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sp is responsible for the synthesis of several isocyanide alkaloids which exhibit potent 
antimicrobial activities, such as Hapalindole A and Fischerindole L isolated from the 
cyanophyte Ficherella muscicola, shown to inhibit the growth of A. oryzae, P. notatum, 
S. cerevisiae etc  191. Hapalindole T, isolated from the cyanobacterium Fischerella sp that 
grows in the bark of the Neem tree, is active against multiple pathogenic bacterial species 
such as M. tuberculosis, S. aureus, P aeruginosa, S. typhi, E. aerogens, E. coli, etc 192. 
Hapalindoles A-H inhibit the growth primarily of pathogenic gram positive bacteria such 
as, Streptococcus sp (S. pneumoniae, S. faecium, S. pyogenes, S. epidermidis etc) 185. 
Fischerella ambigua UTEX 1903 synthesizes several hapalindole type isocyanides, 
namely fischambiguines A and B, ambiguines P, Q and G, out of which fischambiguine 
B shows strong inhibitory activity against M. tuberculosis 40. The welwitindolinone 
isocyanide alkaloids, including welwitindolinone A isocyanide, are known for their 
antifungal and anti-larval properties and are produced principally by the blue green algae 
Hapalosiphon welwitschii 38. The welwitindolinones are not the only isocyanide natural 
products with insecticidal activities; Hapalindole L, 12- epi hapalindole C, 12-epi 
hapalindole E and 12-epi hapalindole J all kill Chironomus riparius larvae 185,193. A more 
detailed account of the antimicrobial activity of this class of isocyanides is discussed by 
Bhat et al 185. Surprisingly, some of these alkaloids are also phytotoxic185. Matsumoto et 
al isolated ambiguine D from Hapalosiphon sp, which inhibited the growth of plants via 
an indirect inhibition of mitosis. This mitotic block was created by the accumulation of 
reactive oxygen species (ROS), mainly superoxide anion, generated via ROS-mediated 
lipid peroxidation 194–196.  
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The fact that most of these isocyanide alkaloids inhibit the growth of pathogenic 
microbes is a sharp contrast to some of the previously discussed isocyanides which 
potentially help in promoting pathogenicity and survival within the hosts. 
Welwitindolinones and ambiguines are isocyanides that are synthesized by two separate 
gene operons, well and amb respectively (the well operon encodes well1-3 proteins 
which are homologs of the amb products amb1-3, mentioned previously). Both the well 
and the amb operon proteins are homologs of the pvcA-D proteins in P. aeruginosa. Most 
of the pvcA-D products (including the two siderohphores pyoverdine and pyochelin, the 
isocyanide paerucumarin, and exotoxins) have been implicated in the promotion of 
pathogenicity and survival within hosts, whereas the homologous welwitindolinones and 
the ambiguines products kill pathogenic bacteria and fungi rather than promote their 
survival.   
Interestingly, welwitindolinones and their analogues have been shown to reverse 
P glycoprotein-mediated multiple drug resistance (MDR)124,197–199 in human ovarian 
adenocarcinoma cell line (SK-OV 3), thereby preventing the expulsion of anti-cancer 
drugs. More details about the ability of welwitindolinones and their derivatives to reverse 
MDR can be found in the comprehensive review by Bhat et al 185. Most of the 
hapalindole-type antibiotics possess anti-cancer properties as well. Kim et al 187 reported 
the cytotoxicity of several hapalindoles against different human cancer cell lines, 
including HT 29 (colon adenocarcinoma), MCF 7(breast carcinoma), NCI-H460 (large 
cell lung carcinoma), SF268 (glioblastoma) and IMR90 (lung fibroblast normal cell) cell 
lines. The mechanism of inhibition of cancer cell proliferation by hapalindoles remains 
unclear, although it might be a combination of different mechanisms including reversal of 
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MDR in drug-sensitive cancers. Another potential mechanism might be via inhibition of 
RNA polymerase. Evidence to support this conjecture is provided 12 epi hapalindole E 
from Fischerella sp, which acts as an inhibitor of mRNA biosynthesis 200 by targeting 
RNA polymerase.  The consequences of inhibition of RNA polymerase are manifold, 
including the treatment of African trypanosomiasis 201 and  the activation of p53-
mediated apoptosis of cancer cells 202–205. Hapalindoles are also antagonists of the 
antidiuretic hormone arginine vasopressin; hapalindole A inhibits vassopressin binding to 
the kidney as well as inhibiting kidney vasopressin-stimulated adenylate cyclase185,206,207.   
 12 epi hapalindoles can be biosynthesized via two pathways185 : L-tryptophan 
reacts with geranyl pyrophosphate to form a terpene ((3-Z-20-isocyanoethyl indole) 
which can either undergo cyclization with geranyl pyrophosphate or undergo a 
chloronium ion mediated reaction with Z-3,7-dimethyl-1,3,6 octatriene to synthesize the 
chlorinated hapalindoles (such as 12-epi hapalindole E isocyanide). 12 epi hapalindole E 
is the precursor for all chlorinated isocyanide metabolites from H. welwitschii; details of 
biogenesis of these indole alkaloids can be found in Moore and Stratmann et al’s study 38 
as well as in the review by Richter et al 208. The indole groups of hapalindole alkaloids 
are installed by the indolyl vinyl isocyanide synthases (Ambl1-3 and WelI1-3)  using the 
substrates L- tryptophan and ribulose-5-phosphate 209. Welwitindolinones and 
ambiguines have operons (well and amb respectively) which encode isocyanide synthase 
(isnA) and oxygenase (isnB) homologs (this has been covered in detail previously). A 
thorough description of the biological and chemical synthesis of these monoterpenoid 
alkaloids can be found in published reviews 185 124. 
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ii. Diterpenoid marine isocyanides: The first reported diterpenoid type isocyanide was 
3- isocyano-3,7,11,15-tetramethylhexadeca-1,6,10,14-tertaene 210 from the marine sponge 
Halichondria sp, almost a decade before the discovery of the previously described 
monoterpenoids. There are three classes of isocyanide diterpenoids:  
 (a) The acyclic diterpenoids: The first and the only observed acyclic isocyanide 
diterpenoid is 3- isocyano-3,7,11,15-tetramethylhexadeca-1,6,10,14-tertaene, isolated 
from a mixture of its corresponding isothiocyanate and formamide in Halichondria sp. 
Out of all of these compounds which possess antimicrobial properties, this is the only 
isocyanide diterpenoid that is acyclic; all other diterpenoid iscocyanides are cyclic124,210.   
(b) The kalihinanes: The second class of diterpenoid isocyanide natural products are the 
kalihinanes. These are bicyclic organic compounds which possess different types of 
tetrahydropyran (THP), tetrahydrofuran (THF) and dihydropyran (DHP) appendages 
attached to the carbon 7 position 124.  Eleven different types of kalihinanes alcohols 
(kalihinols) 124 were isolated from the sponge Acanthella sp by Patra and Chang et al 
211,212.  Kanihinols can also possess chloro, or alkene functional groups, and they 
constitute about 50% of all diterpenes isocyanides212. A thorough description of 
kalihinanes can be found in reviews published by Chang 124 and Garson and Simpson et 
al 181. All of the kalihinane isocyanides possess antimicrobial properties 213. Kalihinol A 
and F inhibit the growth of bacteria and fungi, such as, S. aureus, C. albicans, B. subtilis 
2. Kalihinol A and two new isocyanide-containing diterpenoids, isokalihinol B and 
kalihinene, were isolated from the marine sponge Acanthella klethra. All three 
compounds are toxic to fungi such as Mortierella ramannianus and Penicillium 
chrysogenum. They are also cytotoxic to P388 murine leukemia cells 214. In addition, 
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some of these diterpenoids possess the ability to kill parasitic worms 215,216 and malarial 
parasites 217,218. Kalihinenes X,Y,Z, Kalihinol A and 10- formamidokalihinene from 
Acanthella cavernosa exhibit antifouling activity against the larval settlement and 
metamorphosis of Balanud amphitrite 181,219,220.  
 (c) The amphilectanes:  These are isocyanide-containing alcohols isolated from the 
marine sponge, Hymeniacidon amphilecta 221. All of the these diterpenoids are potent 
antimicrobial agents and may be further classified into the following types124: 
isocycloamphilectanes (primarily isolated from the marine sponge Cymbastela hooperi 
222), cycloamphilectanes (primarily isolated from the sponges Amphimedon sp223, 
Halichondria sp 224 , Adocidae sp 225 and Cymbastela hooperi 222) and neo- and pre-
amphilectanes124. The last type of amphilectanes includes only two compounds, 7-
isocyano isocycloamphilecta-11,15-diene from the sponge Adocidae sp 225 and 7-
isocyano neoamphilecta-1,15-diene from Cymbastela hooperi 222. The 
isocycloamphilectane isocyanide, isocycloamphilectane-7,20-diisocyanoadociane from 
the sponge Amphimedon sp, 226 shows antimalarial activity181,222, along with several other 
marine isocyanide secondary metabolites 227,228. Although the mechanism of malaria 
prevention by these isocyanides is unclear, it may include the ability of isocyanides to 
bind iron porphyrins.  This is consistent with the aforementioned ability of isocyanide 
natural products to act as siderophores.  Additionally, isocycloamphilectane isocyanides 
may prevent conversion of hemozoin to beta hematin229,230; accumulation of the toxic 
heme then leads to disruption of the membranes of the malarial parasite181,231.    
iii. Sesquiterpenoid marine isocyanides: Sesquiterpenoids are principally isolated from 
marine sponges and molluscs, like the diterpenoids covered in the previous section.   
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Unlike the diterpenoids, sesquiterpenoids have only one nitrogenous moeity (-NC, -NCS, 
-NHCHO, -SCN or -NCO). There are 105 of these sesquiterpenoids, of which only 35 are 
isocyanides while 35 others are isothiocyanates124. Sesquiterpenoids often are present 
with diterpenoids in the same organisms and have eight different skeleton types, 
discussed below124.  One of the most prolific producers of sesquiterpenoids is the sponge 
Axinella cannabina, which synthesizes about 33 different sesquiterpenoids, all of which 
belong to the P-U skeleton types. The different skeletal types are mentioned below: 
(a) Axanes: These were the first marine isocyanide isoprenoid natural products 
discovered. The first two sesquiterpenoids bearing the axane skeleton to be isolated were 
axionitrile 1 and axisothiocyanate-1 from the sponge Axinella cannabina 20. Since then, 
several other axane natural products have been isolated from Axinella cannabina as well 
as from a different sponge, Acenthella cavernosa. 
(b) Aromadendranes: The first aromadendrane type (Q type) sesquiterpenoids to be 
reported were axisonitrile 2 along with its isothiocyanate and amide derivatives, 
axisothiocyanate 2 and axamide 2 respectively from the sponge Axinella cannabina 232.  
(c) Eudesmane: Acanthellin 1 was the first isocyanide sesquiterpenoid of the eudesmane 
type to be isolated from the sponge Acanthella acuta 233. Its corresponding isothiocyanate 
and formamides were isolated from a different sponge, A. cannabina 234.  
 (d) Epimaaliane: First isolated from the nudibranch Cadlina luteomarginata feeding on 
the sponge Axinella sp 235,  these sesquiterpenoids are also found in the sponge A. 
cannabin.A detailed account of these compounds can be found in Chang’s review 124. 
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 (e) Cadinane: Candinanes are synthesized from amorphene, (-) -10 isocyani-4-
amorphene, and have been isolated from nudibranches (Phyllidia sp) as well as sponges 
(Axinyssa sp, A. cannabina, A. pulcherrima)124. 
(f) Spiroaxanes: These types of sesquiterpenoids were first isolated from the sponge 
Axinella cannabina, the same sponge that synthesizes the axanes axionitrile 1 and 
axisothiocyanate-1. These three novel sesquiterpenoids possess an isocyano, 
insothiocyano, or amide groups and were named axisonitrile 3, axisothiocyanate 3 and 
axamide 3 respectively 236. Spiroaxane sesquiterpenoids have subsequently been isolated 
from several marine sponges, including Acanthella acuta237, A. klethra238, Axinyssa 
aplysinoides239, A. cavernosa 240,241, and somes nudibranches, such as Phyllidiia 
pustulosa and P. ocellate 240,242.  
(g) Bisbolanes: The first sesquiterpenoid of this skeleton type was isolated from the 
sponge Theonella swinhoei 243. Of all known bisbolanes, only two have been identified to 
possess an isocyanide group 124, although isocyanates and formamides of this type are 
frequently found in nature. 
(h) Pupukeananes: The first pupukeanane isocyanides were discovered from the 
nudibranch P. viscosa feeding on the sponge Hymeniacidon sp. The isolated isocyanides 
were 9-isocyanopupukeanane and its isomer 2-isocyanopupukeanane, both toxic to fishes 
244,245.   
Like most other isocyanide natural products, almost all sesquiterpenoid isocyanides are 
antimicrobial agents221,233,246–248. Metabolites of the marine sponge, Acanthella 
pulcherrima, including the isocyanide (-)-8 isocyano-7-aromadendrane, inhibit the 
growth of Bacillus subtilis 249. The sponge Axinella sp produces several isocyanide 
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sesquiterpenoids, including axisonitrile 2, which exhibit antimicrobial properties and 
protect the sponge from being eaten or overgrown248,250. Some of the sesquiterpenoids 
also exhibit antimalarial activities similar to the diterpenoids discussed previously.  
Axisonitrile 3, its corresponding isothiocyanate, and three other eudesmane 
sesquiterpenoids show promise against Plasmodium falciparum, the causative agent of 
malaria 238.  
 Axisonitrile 2 and other sesquiterpenoid metabolites of the sponge Axinella spare 
antifouling agents; they prevent the settling and metamorphosis of the larvae of P. 
pacifica, S. tribranchiata, H. refescens in marine environments 248,250. Terpenoids from 
the sponge Acanthella cavernosa also show antifouling activity against the larvae of the 
barnacle Balanus amphitrite, as covered in the section detailing the kalihinanes241.  
Nudibranches of the family Phyllidiidae synthesize isocyanide sesquiterpenoids, which 
also exhibit antifouling properties against larval attachment and metamorphosis of 
Balanus Amphitrite242. Sesquiterpenoids are toxic to fishes as well; for example,  
axisonitrile 2 and other metabolites of Axinella sp are poisonous to goldfishes250, (-) 8-
isocyano-7 aromadendrane and other metabolites from Acanthella sp are toxic to guppies 
251,252. This toxicity may result from isocyanide-induced suppression of feeding in 
fishes250 by a mechanism that remains unclear. This isocyanide-induced toxicity of fishes 
may bolster the survival of marine sponges by killing off competition, as we have seen in 
the case of terrestrial isocyanides conferring survival advantage to isocyanide-producing 
microorganisms in the soil microbiome. Nudibranches typically feed on sponges that 
synthesize these piscicidal agents, allowing them to use these toxins as defense 
mechanisms235,245.   Accounts detailing the chemical and biological synthesis of 
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isocyanide functionalized di- and sesqui- terpenoids already exist 151 2,124,181,182 and 
therefore won’t be covered in details in this review.  
1.1.3 Degradation of isocyanides by Isocyanide hydratase (ICH)  
Isocyanide hydratase (ICH) (EC 4.2.1.103) was isolated by the Kobayashi group 
from Pseudomonas putida N19-2 32. This was the first enzyme discovered that could 
convert a wide range of isocyanides into their corresponding formamides via addition of 
water to the isocyanide moiety. ICH is induced by the presence of isocyanides in the 
growth medium, confirming that isocyanide detoxification activity is not adventitious but 
is a specific response to isocyanides.   Therefore, ICH plays a key role in the microbial 
defense against isocyanide natural products.    
Further investigations into this enzyme revealed that it is a ~60 kDa homodimeric 
protein encoded by the 684-nucleotide long inhA gene. ICH is a cysteine-dependent 
enzyme whose active site Cys101 residue is essential for catalysis. Cys101 initiates 
nucleophilic attack at the isocyanide carbon resulting in the formation of a proposed 
thioimidate intermediate which is ultimately hydrolyzed to the corresponding 
formamide31,253. The thioimidate intermediate in ICH has not been previously observed 
using any technique, but it was assumed to be a mandatory intermediate formed by the 
nucleophilic attack of Cys 101 on the isocyanide carbon. The work described in this thesis 
will describe the first successful visualization of the thioimidate reaction intermediate 
during enzyme catalysis in microcrystals using serial femtosecond mix and inject 
crystallography.  
Kobayashi et al isolated another protein with isocyanide hydratase activity from 
Arthrobacter pascens F164. This second ICH enzyme is accompanied by a deformylase 
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that acts on isocyanide-derived formamides to give formate and amines 33.  Therefore, 
this two-enzyme system suggests that Arthrobacter pascens F164 does not simply detoxif 
isocyanide natural products but can convert them to common metabolites with well-
defined catabolic pathways. A comparison between the Pseudomonas putida N 19-2 ICH 
and the Arthrobacter pascens F164 ICH revealed no significant sequence similarity 
between the two as well as different structural, biochemical and immunological 
properties254. 
Previously the Wilson group determined the crystal structure of the 48 kDa 
wildtype ICH isolated from Pseudomonas fluorescens at resolution 1.0 Å (PDB: 
3NON)31. Site-directed mutagenesis in that study confirmed that Cys101 is catalytically 
essential, as mutations at Cys101 (C101S, C101A) resulted in inactive ICH.  The active 
site Cys101 interacts with Asp17 and Thr102 in the ICH active site. The T102V mutation 
results in substrate inhibition, whereas the D17V, D17E and D17E mutations severely 
reduce the catalytic ability of ICH. Based on analysis of COOH bond lengths in these 
atomic resolution structures, Asp17 was shown to be protonated (neutral) and was 
proposed to activate an ordered water that hydrates the thioimidate intermediate. Another 
catalytically important residue is Arg214, which was reported to be important for anion 
binding near the active site by interacting with anions via its cationic side chain; 
suggesting that substrates for ICH may possess an anionic moiety. Interestingly, the ICH 
structure is similar to that of human DJ-1, however differences in the to the active sites of 
ICH of DJ-1 render DJ-1 incapable of degrading isocyanides. Moreover, these variations 
in the ICH active site also disfavor oxidation of Cys101, whereas the active site of DJ-1 
44 
 
strongly favors oxidation of Cys106 to Cys106 -sulfinic acid, enabling DJ-1 to sense ROS 
levels cells.  
The work described in this thesis clarified several outstanding mechanistic 
questions regarding ICH catalysis by directly observing catalytic turnover using serial 
mix-and-inject serial crystallography. In addition, this technique observed non-
equilibrium motions in ICH that were activated by covalent modification of Cys101 that 
are functionally important for turnover. 
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Chapter 2: Introduction 
 
The relationship between internal enzyme conformational dynamics and catalysis. 
The role of protein conformational dynamics in enzyme catalysis has been a topic 
of much heated debate for several decades 255–258.  The central question of this debate is: 
do enzyme dynamics contribute directly to transition state barrier crossing (the chemical 
event) or are they involved only in substrate binding and product release? Because the 
physiochemical basis of enzyme catalysis is still incompletely understood, internal 
protein motions and their contributions to effective substrate turnover has garnered much 
attention in the past two decades. Motions of amino acid residues, in or around the active 
sites, can have significant impact on substrate turnover. As such, the identification and 
characterization of such motions and their overall catalytic consequences has become of 
paramount significance259,260. This section of the thesis will describe some examples 
where internal dynamics in enzymes effect their overall catalysis258,261,262 and delineate 
mechanistically how such events affect passage along the reaction coordinate263.This 
topic is important for this thesis, which addresses how covalent modifications of the 
active site reactive cysteine 101 in Isocyanide Hydratase (ICH) enzyme triggers a charge-
gated conformational switching of a nearby helix H. This catalysis-activated motion of 
helix H is important for efficient ICH catalysis. We propose that several enzymes may 
rely on internal active site dynamics for catalysis, particularly when triggered by active 
site   modification. ICH is the first system, to our knowledge, where cysteine non-
disulfide covalent modification directly gates conformational dynamics essential for its 
function.  
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2.1. How internal protein motions effect enzyme catalysis. 
 During a catalytic cycle, enzymes can undergo conformational changes during 
any of the key catalytic steps, including substrate binding, intermediate 
formation/resolution, product formation/release, etc. These motions, which occur on 
timescales ranging from milliseconds to seconds264, often define the rate limiting steps 
and thus the overall rates of the reactions258,265–269. A common way to estimate the degree 
of transition state stabilization by an enzyme is to compare the overall rates of the 
enzyme-catalyzed vs uncatalyzed reactions261. However, a limitation of this approach is 
that it provides a lower limit for transition state stabilization, as the rate-limiting step may 
not be the chemical step.   One example of the interplay of enzyme conformational 
changes and catalytic rate is the enzyme Ribonuclease A (RNase A)270–272, which 
catalyzes cleavage of P–O5′ bonds in RNA272. The enzyme contains two mobile loops, 
Loop1 and Loop4. These loops undergo a 2-3 Å conformational change upon 
substrate/ligand binding, resulting in switching from the “open” form (optimal for 
substrate / ligand binding) to the “closed” form to facilitate catalysis. This conformational 
switching, coupled to product release, is the rate limiting step of the reaction273–275,275–284. 
However, whether this intrinsic conformational flexibility in RNase A aids catalysis by 
stabilizing the transition state remains unclear. 
Transition state stabilization could potentially be affected by protein motions, 
providing a direct connection between enzyme dynamics and the mechanism(s) by which 
enzymes achieve their catalytic effects263,285–287. Transitions states are “balance points of 
catalysis” 288, when chemical bonds are being made/broken and the reaction has an equal 
probability of going in either direction; it is that fleeting unstable state where a molecule 
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is no longer a substrate but is not yet a product 289. All enzymes must stabilize the 
transition state for efficient catalysis16–23,23–27, or in other words, minimize the activation 
energy of the reaction (energy of the highly unstable transition state) to begin substrate 
turnover. Linus Pauling proposed that this likely occurs via selective, tight binding of the 
enzyme to the transition state species285. Specific mechanisms that enzymes use to 
stabilize the transition state include pre-organizing active site electrostatic 
environments302,303, and specific arrays of active site hydrogen bonds that favor binding 
to the transition state over the substrate 261,304. As an example that combines these 
strategies, Schowen et al’s minireview 305 describes transition state stabilization by 
proton bridging in enzymes involved in general acid-base catalysis306. Therefore, enzyme 
dynamics may be able to impart dynamic electronic microenvironments to active sites 
that are conducive to the formation/stabilization of the transition state species.307  
The enzyme Dihydrofolate reductase (DHFR) has been proposed as an example 
of enzyme dynamics directly assisting transition barrier passage. E. coli DHFR enzyme 
possesses a highly conserved mobile loop308,309310, called the Met20 loop,  whose 
mobility regulates access of substrate, solvent, and co-factor accessibility to active site 
pocket. The open conformation of the Met20 loop facilitates the binding of both NADP+ 
and folate. Upon binding, the disordered portion of the Met20 loop (residues 16- 20) 
undergoes a conformational change to form a hairpin turn that ensures proper alignment 
of the nicotinamide and pteridine rings in the active site310. This conformation also 
positions residues Ile14 and Met 20 near the active site they exclude water and stabilize 
the Michaelis complex via a network of hydrogen bonds and hydrophobic interactions.  
To test the influence of Met20 loop mobility on E. coli DHFR catalysis, a mutant that 
48 
 
deleted four critical hairpin forming residues (16-19) from the Met20 loop (called DL1) 
was made.  In wild type DHFR, product release is the rate limiting step311. In the DL1 E. 
coli DHFR mutant, hydride transfer becomes rate limiting (rate decreases from 950 sec-1 
in wildtype to 1.7 sec-1 in DL1 mutant DHFR), arguing that the Met20loop is important 
for rate acceleration261,310.  
It is possible that the mobile Met20 loop residues in E. coli DHFR play an 
important role in “compacting” the active site to correctly position the substrate and the 
co-factor and to reduce the total distance between donor and acceptor atoms to promote 
hydride transfer 312. Internal active site dynamics in DHFR supports a model of catalysis 
where the “open” active site can easily access and bind the substrate and co-factor, 
following which the disordered central portion of the Met20 loop adopts a hairpin turn 
which stabilizes the transition state310; inability to switch between open and hairpin 
conformations in mutant DL1 has a detrimental effect on catalysis310.   As such, E. coli 
DHFR has been subject to a number of combined experimental and computational studies 
to investigate the controversial role of enzyme dynamics in catalysis185,264,278,312–315. 
Several of these studies by the Benkovic, Hammes-Schiffer, and Wright groups have 
proposed that collective motions in E. coli DHFR can serve as “promoting motions” that 
directly facilitate transition state barrier passage, although this is currently debated 
288,316,317.  
Other researchers have argued that, although such conformational dynamics can 
affect the overall rate of reaction or the rate limiting step of the reaction, they cannot 
contribute to catalysis via transition state stabilization or enhancing rates of barrier 
passage beyond what is permitted by equilibrium and the Eyring rate theory258,307,318–323.  
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One of the primary opponents of dynamical contributions to enzyme catalysis is Arieh 
Warshel, who argues that in DHFR and other enzymes, catalysis is achieved by adoption 
of a specific electrostatic microenvironment in the enzyme’s active site, not by internal 
millisecond conformational dynamics317,324,325. Since most enzymatic reactions involve 
polar transition states, enzymes can decrease the activation energy barrier of the reaction 
by fashioning active site electrostatics to stabilize these transition states291,299,324,326,327.  
Investigations into the connection between protein dynamics and the probability of 
reaching the transition state reveal a dominant role for the electrostatic fluctuations of the 
protein; if these electrostatic fluctuations differ in enzyme and in solution, they can 
contribute to catalysis321,328, otherwise not.  
Reconciling the computational finding that dynamical events likely cannot 
contribute to catalysis with the results of studies on DHFR (and other enzymes) 
indicating that dynamics are important for catalysis is challenging.  A plausible model is 
that dynamics are important for progress along the reaction coordinate, although they do 
not aid barrier crossing per se. In this thesis, we find that the enzyme Isocyanide 
Hydratase (ICH) facilitates catalysis via changes in conformational ensembles that are 
gated by the formation of a catalytic intermediate. In ICH, the formation of a thioimidate 
catalytic intermediate eliminates negative charge on the active site cysteine thiolate that 
alters the dynamics of ICH, facilitating subsequent steps of catalysis.  
A central concern when considering the connection between conformational 
dynamics and catalysis is correlating the timescales of these conformational dynamic 
events to key steps in catalysis. If such correlations exist, then the internal protein 
motions whose timescales correspond to key steps in catalysis are candidates for 
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functionally important motions. Generally, there are three types of protein motions. The 
first type is the local motion(s) (10−15 to 10−1sec) which include atomic fluctuations and 
side chain mobility. The second type of motions are rigid body motions (10−9 to 1 sec) 
which involve the movement of small parts of the protein; they include helix mobility, 
domain and subunit motions etc. The third and final type of motion is the large-scale slow 
motions (10−7 to 10 sec), which involve helix coil transformations, folding/unfolding etc. 
Since the overall enzyme catalyzed reaction rate is related to the activation free energy 
barrier height, hypothetically one of the ways in which internal motions could potentially 
affect the catalytic rate is by decreasing the height of the activation energy barrier with 
the previously mentioned local (10−15 to 10−1sec) or rigid body motions (10−9 to 1 sec). In 
most cases, however, the enzyme transition state formation/existence is a femtosecond 
(fs) timescale event.  Therefore, these rigid body motions (conformational dynamics) are 
too slow to stabilize the transition state. In several enzymes, such as DHFR, Triose 
phosphate isomerase (TIM), Lactate dehydrogenase (LDH) and beta lactamase, the 
internal motions implicated in contributing to catalysis are of the rigid body type and 
therefore are too “slow” and cannot stabilize the transition state, but can potentially 
facilitate the later steps of catalysis.  
Motions that involve substrate/ligand binding and organization of the active site 
electrostatic microenvironment to make it conducive for transition state binding, as well 
as internal dynamics that enhance populations of transition state accessible 
conformations, are slow, often in the scale of microseconds to milliseconds307,329. Faster 
fs motions occur after these slower protein motions and can stabilize the transition state 
to facilitate product release and to regenerate the native enzyme. However, there is no 
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evidence currently available to indicate that these fast motions are actually “directly 
linked to the bond breaking and forming process of the transition state”262. 
Transition states have lifetimes on the timescale of single bond vibrational 
frequencies and as such, coupling of femtosecond (fs) bond vibrations to conformational 
motions of the millisecond (ms) scale is highly unlikely329.  Warshel et al 330 have 
demonstrated that the kinetic energy of the conformational motion associated with 
substrate binding is entirely dissipated before the chemical step begins and therefore 
cannot affect it. Combined with computer simulations, they establish that in case of 
enzyme catalyzed reactions where the chemical barrier is greater than a few Kcal/mol, 
there exists no coupling between the chemical step(s) of catalysis and internal protein 
conformational dynamics.   
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Chapter 3: Introduction 
 
Biochemistry of reactive cysteine residues in enzymes 
 
3.1: The relationship between cysteine covalent modification gated enzyme 
dynamics and catalysis. 
Although protein dynamics are not likely to contribute to barrier crossing directly, 
they can facilitate catalysis by promoting progress along the reaction coordinate. In this 
thesis, we explore how conformational dynamics can aid enzyme turnover using 
Isocyanide Hydratase (ICH) as a model system. The present study involves reactive 
cysteine covalent modification(s) which alter the active site electrostatic 
microenvironment, resulting in helical dynamics important for efficient catalysis by ICH. 
Having discussed the relationship between internal dynamics and enzyme catalysis in 
Chapter 2, we will make an in-depth investigation into how protein dynamics can be 
coupled to cysteine covalent modification(s) in cysteine dependent enzymes in this 
section. 
A multitude of post-translational protein modifications exist and are essential in 
mediating proper function for many proteins 331–334. Out of the 20 frequently occurring 
amino acid residues in human proteins, cysteine (Cys) is the most reactive due to its 
strongly nucleophilic thiolate side chain when ionized332. Cys residues are usually 
reactive, redox sensitive, polarizable and extremely sensitive to local microenvironment 
electrostatics335. Although cysteine makes up only about 2% 336 of protein amino acids in 
mammals, covalent modifications of cysteines have important consequences for protein 
function that affect essential processes such as cell growth, repair and death. As a result, 
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reactive cysteine residues are frequently located at functionally important sites in proteins 
and act as regulatory switches that can controls multiple downstream processes335,337.  
Cysteines can be classified into several functional categories, such as catalytic, redox 
active, regulatory, structural, metal-coordinating, and some without any  known role; a 
mini review detailing the description of these classes of cysteine residues is available by 
Fomenko et al 337.   
Cysteines that control downstream metabolic signaling processes in response to 
covalent modifications are widely studied337,338. These modifications arise naturally, as a 
consequence of reaction of cysteines with pools of reactive electrophilic metabolites in 
the cell 331,339,340. Some common cysteine covalent modifications include alkylation, 
oxidation, formation of metal (electrostatic) complexes, etc. Below I delineate the most 
common cysteine modifications and review examples of such modification(s) and their 
functional effects in cysteine dependent enzyme catalysis.  
3.2.a) Unmodified cysteine (neutral thiol/negative thiolate). 
 An important regulator of the activity of cysteine-dependent enzymes is the redox 
state of their immediate microenvironment, which can be altered by the generation of 
reactive oxygen species (ROS)341. The d-orbitals of the sulfur atom of the thiol group 
allows for numerous oxidation states, permitting a multitude of possible oxidative 
posttranslational modifications. Reactive oxygen and nitrogen species can participate in 
signal transduction pathways via the reversible or irreversible oxidation of cysteine thiol 
groups in redox sensitive proteins, including several cysteine-dependent enzymes 
342,343,92–94. The anionic sulfur atom in cysteine thiolates (R-S-) is the reactive form and is 
susceptible to oxidation by a large variety of ROS. Cys can be oxidized to various 
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species, discussed in detail later. Therefore, cysteines impart oxidant sensitivity to a 
multitude of proteins, with diverse regulatory and signaling consequences 347,348. There 
are several examples of cysteine-dependent enzymes of biomedical relevance that have 
redox sensing as a primary and secondary activity347. Reversible modifications are often 
held to be the most valuable for signaling, and both cysteine sulfenic acid and disulfides 
are reversible oxidative modifications that cause active site structural and functional 
changes in proteins 349, allowing thiols to act as redox regulatory switches350. 
 
The reactive form of thiols (R-SH) is the deprotonated form; the negatively charged 
thiolate ion (R-S-) 346. Therefore, thiol pKa value is commonly used to determine if a 
particular cysteine residue is likely to be reactive.  Because the pKa of an unperturbed 
cysteine residue is ~8.5, the electrostatic microenvironment of the active site can easily 
promote ionization of a cysteine to the thiolate in the physiological pH range. For 
cysteine-dependent enzymes, this pKa depression is important for nucleophilic 
catalysis.351. In the work described in this thesis, ICH undergoes active site 
conformational switching in response to catalytic cysteine modification, which changes 
the active site electrostatic microenvironment. As noted above, the ability to manipulate 
Figure 1: Major oxidation states 
of cysteines 
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the reaction buffer pH to control the extent of reactive cysteine protonation state provided 
us with a useful tool to fine tune the internal CH motions. This portion of the work is 
explained in more detail in Chapter 4 of this thesis.  
3.2.b) Oxidative cysteine modifications. 
As discussed in the previous section, cysteines can act as redox sensing switches via their 
ionizable thiol groups. As such, cysteine-dependent enzymes can play important roles in 
redox regulation and diseases with a redox component.  
Oxidative phosphorylation is the process by which ATP is synthesized in the 
mitochondria by the reduction of molecular oxygen to water through a series of electron 
transfer events. However, during this process, a small portion of the oxygen does not 
convert to water, but is incompletely reduced to generate reactive oxygen and nitrogen 
species (ROS/RNS) such as peroxides, superoxides, hydroxyl radicals, peroxynitrite etc. 
352, 353, 354.  This induces oxidative stress by perturbing the normal redox state of the cells 
and can damage  DNA, proteins and lipids, impair cell signaling, energy metabolism, and 
cause overall dysfunction of biological activity 355. During oxidative stress, increased 
levels of ROS/RNS target cysteine thiols for reversible or irreversible oxidation or 
glutathionylation338,356–359 and affect redox sensing and signaling. Fig. 1 summarizes the 
major oxidation forms of cysteines. As mentioned above, reversible oxidized species of 
thiols with known redox signaling roles are Cys-sulfenic acid and intra/intermolecular 
disulfide bonds, including glutathionylation349,360–362.   
A) Disulfide formation: Disulfide bonds, or disulfide bridges or S-S bonds (R-S-S-R) 
are reversible covalent bonds that form between two proximal cysteine thiols within or 
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between individual polypeptide chains, by the oxidation of sulfhydryl groups under 
mildly oxidizing conditions359,363–365 (Reaction I).  
                           2 R-SH→ R-S-S-R +2 H+ +2 e-      …………………………. (I) 
Disulfide bonds can also form from pre-existing disulfide bonds by the exchange of a 
thiol group (R-SH) with the disulfide (R’-S-S-R’) in a reaction called “thiol-disulfide 
exchange” or “disulfide scrambling”, catalyzed by various oxidoreductase enzymes 366–
368.  This results in the generation of a new thiol group (R’-SH) containing cysteine and a 
new disulfide (R-S-S-R’)369–371 (Reaction II). This is often the rate determining step in the 
folding process of certain proteins344 and can occur in several cellular compartments 
incluing the ER, the mitochondrial inner membrane space (IMS) in eukaryotes, and the 
periplasm in prokaryotes344,372–374.  
                            R′-S-S-R′ + R-SH → R-S-S-R′ + R′-SH …………………. (II) 
The comprehensive review by Ziegler depicts a complete list of enzymes whose 
functions rely upon disulfide-thiol exchanges375. Elevated H2O2 levels in E. coli cause the 
cysteine-dependent OxyR transcription factor to upregulate the expression of antioxidant 
genes such as oxyS, katG and gorA to combat the effects of hydrogen peroxide.376. OxyR 
is activated by a conformational change resulting from the formation of an intramolecular 
disulfide bond between the cysteines Cys199 and Cys208376. OxyR is one of the best-
studied examples of disulfide bond-mediated regulation of the cellular antioxidant 
response during oxidative stress. Disulfide bond formation can also promote bacterial 
pathogenicity and virulence377. While formation of S-S bonds confers structural stability 
to the enzyme, it can also act as a redox sensitive regulatory switch (breaking and 
remaking of disulfide bonds can regulate enzyme function)364,368,378–381.  Moreover, the 
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ratio of cysteine to the disulfide (RS-SR)/cystine (CysSSCys) form has been shown to be 
dysregulated in several diseases in humans, including atherosclerosis379,382,383 and 
cancer384–387. Some examples of established disulfide bond regulation349 include 
activation of tissue factor (TF)388, redox sensing and allosteric monitoring in human 
carbamoyl phosphate synthetase389, redox sensitive global regulator in Staph. Aureus390, 
and allosteric control of S1A serine proteases391. Formation of disulfide bonds depends 
on three key factors392; the availability of a proximal partner cysteine with correct 
geometry for disulfide formation, the pH of the local microenvironment (pH> pKa of the 
cysteine thiols favors reactivity) and the redox state of the local microenvironment 
(oxidizing conditions favor S-S bond formation). Since the likelihood of disulfide bond 
formation is strongly influenced by local cellular conditions, specific cellular 
compartments have evolved in both prokaryotes and eukaryotes to support this 
phenomenon. In bacteria, disulfide bond formation mostly occurs in the periplasm393, 
while in eukaryotes, disulfide bond breaking and making is most common in the 
endoplasmic reticulum (ER)392,394,395. The cytosol, being a more reducing environment 
compared to the ER, rarely facilitates disulfide bond formation, although there are 
exceptions. We discuss one such exception in Chapter 5, where the Isocyanide Hydratase 
(ICH) enzyme from Ralstonia sp. contains two non-catalytic cysteines, Cys147 and 
Cys220 which form disulfide bonds despite ICH being a non-ER protein.  
Protein disulfide isomerase (PDI) is a family of endoplasmic reticulum (ER) 
enzymes that oxidize cysteine thiols, which then form disulfides with other nearby 
cysteines364,373,396–398. Extensive reviews have covered the topic of formation of disulfide 
bonds, the enzymes involved, and their mechanisms in both prokaryotes and 
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eukaryotes364,373,399–403. Even though the biochemistry of disulfide bond formation is well 
described, there is comparatively little known about the process of regulated disulfide 
bond reduction in the ER of mammals. Currently, there are no known PDI reductases or a 
glutathione reductases in the ER to reduce the disulfide bonds364,404.  In contrast to 
mammals, the bacterial periplasmic reductive mechanism of disulfide breaking is very 
well characterized364,405–407.  
B) Sulfenic, Sulfinic, Sulfonic acid formation: Oxidation of the sulfur atom in cysteine 
results in the formation of a series of organosulfur acids with progressively increasing 
oxidation states; they are cysteine sulfenic, sulfinic and sulfonic acids respectively408–410 
(Fig. 1). 
Sulfenic acids are reactive, unstable oxyacids generated as a result of oxidation of 
cysteine thiols (R-SH/RS-) with oxidants such as H2O2 
359,410–414, alkylhydroperoxides 
and peroxynitrites359,411. They may also form as a result of oxidation of the cysteine with 
molecular oxygen, catalyzed by the cysteine dioxygenase enzyme415. These transient 
compounds can exhibit both electrophilic as well as nucleophilic characteristics416; they 
can react with neighboring thiols to form disulfides359,416,417 (Reaction III) or with 
nitrogen nucleophiles to generate the rarer sulfenamides410,418–421. Sulfenic acids (R-SOH) 
can be converted back to thiol (R-SH) by Thioredoxins (Trx)410 or other disulfide-based 
reduction strategies involving transient glutathionylation followed by reduction. In the E. 
coli periplasm, several proteins possess cysteine residues which form disulfide bonds. In 
periplasmic proteins with single cysteines (lacking disulfide bond forming partner), these 
residues are protected against oxidation to sulfenic, sulfinic and sulfonic acids by two 
thioredoxin related proteins, DsbG and DsbC422.   
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Sulfenic acids may also self-condense to form thiosulfinates359,423 (Reaction IV). 
Since these sulfenic acid derivatives are also unstable, they have proven difficult to 
isolate and study359,424,425.  
2 R-SOH + R-SH→ R-S-S-R +H2O      …………………………. 
(III) 
2 R-SOH→ R-S(O)-S-R +H2O           ………………………. 
(IV) 
Table 1 of Lo Conte and Carroll’s review 410 contains a list of biologically important 
proteins that form cysteine sulfenic acids and the authors discuss the regulatory 
implication of some of these sulfenic acids in cellular signaling 426–429. Protein tyrosine 
phosphatases420,421,430, cysteine proteases, papain, and glyceraldehyde-3-
phosphate347,359,410,425, NADH oxidases and peroxidases, peroxiredoxins431, glutathione 
reductases, and human serum albumin (HA) are all regulated by sulfenylation412,432,433. 
Other examples include the reversible oxidation of key cysteine-S- residues in 
transcription factors Fos and Jun (activator protein 1) and bovine papillomavirus1 E2 
protein, which inhibits DNA binding in response to intracellular redox sensing359,425. 
Sulfenic acid formation also helps in CD8+ T cell activation and proliferation434. Roos 
and Messens’ review 435 presents some of the most important biological roles of sulfenic 
acids in living systems. 
 Sulfenic acids can be further oxidized to more stable sulfinic acids (R-SO2H) 
(Table 2 of Lo Conte and Carroll’s review 410). Some examples of biologically relevant 
proteins whose functions are mediated by formation of sulfinic acids, include 
peroxiredoxins359,436–438, peroxidase (Prx)437, DJ-1 439–442, and hydratases (Nitrile 
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Hydratase, SCNase) 410,443,444. Inactivation of peroxiredoxins by the formation of Cys-
sulfinic acids438 can be reversed by the ATP-dependent enzyme Sulfiredoxin445–450, 451,452. 
Sulfinic acids can be further oxidized to form the most oxidized form of cysteine in 
proteins, sulfonic acid (R-SO3H). An example of possible biological relevance of 
cysteine sulfonic acids is found in the peroxiredoxins, which  converts to a dodecameric 
oligomer that exhibits enhanced chaperone activity when the active site cysteine to 
oxidized to the sulfonate, although the relevance of this activity is debated453,454.  
Protein tyrosine phosphatases (PTPs) catalyze the dephosphorylation of 
phosphotyrosine in proteins455. PTPs are redox regulated by oxidation of the catalytic 
cysteine, which  abrogrates enzyme activity456–458.  While sulfenic acid can be easily 
reduced, reduction of the more stable sulfinic acid requires the dedicated sulfiredoxin 
enzyme and sulfonic acids cannot be reduced under intercellular conditions421. The 
oxidized cysteine in PTP, however, is capable of forming a sulfenyl-amide (-SN-) bond 
with the nitrogen atom in the polypeptide backbone, thereby protecting the cysteine from 
further oxidation455,459. Protein tyrosine kinase (PTK) can also be regulated by ROS and 
oxidative stress conditions. PTKs in the Src and Fibroblast Growth Factor Receptor 
(FGFR) families are inactivated in response to oxidation of their reactive cysteine 
(Cys277)460.  The epidermal Growth Factor Receptor (EGFR) family of receptor tyrosine 
kinases mediate several important biological functions in the body, such as growth, 
differentiation, proliferation, protection from cancers. Activation of EGFR results in 
generation of ROS (H2O2), which in turn, oxidizes cysteine residues within redox 
sensitive proteins. Moreover, EGFR itself is regulated via oxidation of its active site 
Cys797461. 
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The thioredoxin (TRX) and Nucleoredoxin (NRX) family of proteins undergo 
similar redox regulation as PTPs, by virtue of their reactive cysteines455. TRX is the 
archetypal thiol-disulfide oxidoreductase whose reversible disulfide formation is essential 
for its catalytic activity as a thiol reductant. In addition to its primary role in maintaining 
redox homeostasis, the oxidation of the cysteine pair 462,463 in TRX to form 
intramolecular disulfide bonds causes its disassociation from the enzyme Apoptosis 
signal regulating kinase 1 (ASK1)349. TRX is an inhibitor of ASK1, and its oxidation-
regulated dissociation activates ASK1 to induce ROS and apoptosis455,459,464,465.  NRX 
negatively regulates Wnt signaling by binding to and inhibiting DvI (dishevelled), which 
is an essential adaptor protein involved in Wnt signaling 466. When the catalytic cysteine 
pair in NRX is oxidized, binding to DvI is abolished and Wnt signaling is promoted,; 
therefore, NRX plays a redox responsive role in mediating DvI activity similar to the 
TRX/ASK1 interaction455,467–470.  
Another protein family with prominent roles in intracellular redox signaling is the 
peroxiredoxin (PRX) family of proteins. These proteins reduce hydrogen peroxide to 
water simultaneously with the oxidation of a reactive cysteine (peroxidatic cysteine, CP) 
to sulfenic acid (CP-SOH), which then reacts with another cysteine (resolving cysteine, 
CR) to form a disulfide bond
471. Depending on the presence or absence of the CR, PXS 
enzymes can be classified into 2-Cys or 1-Cys PRX subfamilies472–474. Oxidized 2-Cys 
PRX is then reduced and recycled by the TRX system and 1-Cys PRXs by glutaredoxin 
474–476. Under conditions of high oxidative stress, PRX forms homo oligomers which bind 
and activate mammalian Ste20 like kinase 1 (MST1), leading to cell death and 
apoptosis455,477–479. Irreversible oxidation of PRX cysteines into the hyperoxidized 
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sulfinic and sulfonic acid forms inactivates PRX and serves as a cellular marker for 
oxidative damage454.   
Cysteine oxidation has consequences in energy metabolism as well. 
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH), a critical glycolytic enzyme, can 
be oxidized at its active site cysteine residue to form a sulfenic acid or mixed disulfides 
with glutathione or other proteins. This oxidation prevents glycolysis and perturbs energy 
homeostasis and glucose metabolism349,480,481.  Therefore, proteins containing reactive 
cysteine residues can be modified by a range of electrophilic species produced by 
metabolism or stress and thus can participate in multiple biochemical and signaling 
pathways. 
C) Other thiol oxidation processes: In addition to ROS, cysteine thiols (R-SH) are 
oxidized by glutathione (S- glutathionylation: S-SG) and nitric oxide (S- nitrosylation: S-
NO) (Fig. 1). 
 S- nitrosylation is the process of covalent attachment of nitric oxide (NO) group 
to a cysteine thiol (R-SH) group to form a cysteine-nitosothiol (R-SNO) 482–484. 
Nitrosylation has emerged as an important redox regulatory mechanism for mediating 
cGMP-independent NO signaling effects 485–487 as well as for combating nitrosative 
stress486,488. 
  Cys-nitrosothiols (R-SNO) are involved in multiple biological processes489, 
including apoptosis447, cardiovascular signaling485,490, combating cold stress in plants491, 
HIV-1 protease inactivation492, transient receptor potential (TRP) channel activation493, 
ion channel regulation, signal transduction, neurotransmission, DNA repair, etc489. In 
protein tyrosine phosphatase 1B (PTP1B),  S-nitrosylation inhibts irreversible oxidation 
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of the catalytic cysteine (Cys215) into sulfinic and sulfonic acid species, thereby 
protecting the enzyme from irreparable oxidative damage487. S-nitrosylation has also 
been implicated in defense against microbial infections and cancer494. An excellent 
account of the biological functions of cysteine nitrosothiols is available in Broillet’s 
extensive review489.  
 Glutathionylation of cysteines is another mechanism by which cysteine-
containing proteins/enzymes act as redox signal transduction switches495,496. Cysteine 
sufenic and sulfinic acids can be enzymatically (glutathione-s-transferases, glutaredoxins) 
or non-enzymatically reduced and conjugated to glutathione (GSH) to form S-
glutathionylated cysteines497 (Fig.1). Under conditions of nitrosative stress, cysteines can 
be nitrosylated, as discussed previously; the nitrosothiols can then be converted into S-
glutathionylated cysteines with or without S-nitrosoglutathione (GSNO) as a reaction 
intermediate497 (reactions V-VII).  
PS-N = O+ GSH→ P-S-S-G +HNO      …………………………. (V) 
PS-N = O+ GSH→ PSH + GSNO      …………………………. (VI) 
PSH + GSNO → P-S-S-G +HNO      …………………………. (VII) 
Inside a cell, the ratio of reduced glutathione (GSH) to oxidized glutathione (GSSG) is 
known as the GSH/GSSG ratio which informs on the redox capacity or balance of the 
cell. This balance is kept in check by redox reactions catalyzed by oxidoreductases such 
as GSH peroxidase and GSH reductase. Disturbance of the GSH/GSSG ratio by increased 
concentrations of ROS and RNS results in several pathological conditions such as 
apoptosis and necrosis497. Proteins that undergo S-glutathionylation are typically 
cytoskeletal, glycolytic, or involved in energy metabolism, signaling pathways, calcium 
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homeostasis etc497. Some of the signaling pathways impacted by glutathionylation of 
reactive cysteines include mitogenic signaling pathways (Ras MEK ERK pathway, PTPs, 
Protein kinase A)498–501,  PI3K signaling498,502–505, I κB kinase-nuclear factor κB 
pathway497,506–508,  pro apoptotic JNK-c-Jun pathway in cancer cells497,506,509–517. 
Townsend et al. provide a detailed review of the biological and physiological mechanistic 
impact of cysteine glutathionylation497. Redox regulation of mitochondrial functions by 
glutathionylation of mitochondrial proteins and their effect on energy metabolism is 
comprehensively reviewed by Mailloux et al518. 
3.2.c) Other cysteine modifications:  
 Other cysteine modifications include metal-mediated modifications and 
desulfurization (removal of cysteine thiol, including oxidative elimination of cysteine to 
form dehydroalanine (DHA)519. These type of cysteine modifications are reviewed by 
Chalker et al 65.  
3.3. Cysteine covalent modification and internal enzyme dynamics: 
Covalent modification is a common and physiologically important perturbation to 
proteins.  Reactive residues such as cysteine are prone to diverse covalent modifications 
with catalytic or regulatory consequences. In the work described in this thesis, charge 
neutralization of the reactive Cys101thiolate in Isocyanide hydratase (ICH) enzyme 
triggers active site helical dynamics important for efficient substrate catalysis. The 
cysteine modification in ICH remodels active site H-bonding networks and gates 
catalytically important changes in protein dynamics with a clearly defined mechanism. It 
is very common for protein structures to fluctuate owing to thermal motion and in 
response to functional changes such as ligand binding. As a consequence, it is 
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challenging to determine which protein motions are functionally most important at 
equilibrium. Enzymes that are transiently and covalently modified during catalysis offer a 
way to identify functional motions, as the modification can trigger catalytically important 
conformational changes. The covalent modification of the active-site cysteine in 
isocyanide hydratase weakens a critical hydrogen bond required for reactivity. Hydrogen 
bond disruption triggers a cascade of conformational changes whose modulation by 
mutation is detrimental to enzyme turnover. Most enzymes that form catalytic 
intermediates will experience similar transient changes in active-site electrostatics, 
suggesting that modification-gated conformational dynamics is common in enzymes. 
Notably, all cysteine thiolates will experience a similar loss of negative charge upon 
covalent bond formation. Because cysteine residues can have multiple roles in a protein, 
including acting as a catalytic nucleophile, metal ligand, acylation target, redox target, 
and others, many different modification-mediated signals may be transduced through 
altered cysteine electrostatics to impact protein dynamics and function. Thus, cysteine 
can potentially significantly expand the ways in which protein biophysical properties are 
coupled or respond to cellular needs. 
Enzymes catalyze biochemical reactions by binding, conformationally organizing, 
and lowering the activation energy barrier of reactants 520. Aside from accelerating 
certain biochemical reactions, enzymes also inhibit undesired, off-pathway reactions 
involving highly reactive intermediate species521. The collective dynamics of enzyme and 
substrate are often tightly coupled to the catalytic cycle 521–525. For example, substrate 
binding can shift the enzyme’s conformational distribution to structurally and 
electrostatically re-organize the active site. More controversially, the coupling of 
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conformational dynamics and electrostatics has been proposed to directly contribute to 
the chemical step of enzyme catalysis, although their precise roles remain actively 
debated256,264,523,526–529 . Formation of catalytic intermediates transiently modifies the 
enzyme and may lead to a new protein motion regime that facilitates later steps of 
catalysis. These motions often span vastly different time-scales, from fs-ns for barrier 
crossing to ms or longer for product release. While functionally important motions may 
be present even in a resting enzyme530 , distinguishing functional motions from the many 
other fluctuations of a macromolecule at equilibrium is challenging523, leaving major 
questions about the role of dynamics in catalysis unanswered. For example, how do 
catalytic intermediates reorganize an enzyme’s conformational landscape to facilitate 
later steps in the catalytic cycle? Integrating recent developments in serial and 
conventional RT crystallography with advanced computational methods531 can offer new, 
exciting opportunities to reveal enzyme mechanism and interrogate the consequences of 
cysteine modification on protein dynamics. 
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CHAPTER 4: 
 
Mix and Inject Serial Femtosecond Crystallography at XFEL reveals gated 
conformational dynamics during ICH catalysis. 
 
Note: The results described in this chapter have been published, all text is modified from the 
original version “Mix-and-inject XFEL crystallography reveals gated conformational dynamics 
during enzyme catalysis”. 
https://doi.org/10.1073/pnas.1901864116 
 
 
The catalytic cycle of ICH.  
Isocyanide substrate binds with ICH Cys101-S− poised for nucleophilic attack and with the Cys101-Ile152 H-bond intact. 
Formation of the thioimidate intermediate weakens the Cys101-Ile152 H-bond and causes helical motion (magenta helices 
H and I) that promotes intermediate hydrolysis (red sphere; curved arrow). Hydrolysis of the thioimidate intermediate 
restores the reactive C101-S− and strengthens the Cys101-Ile152 H-bond, favoring the strained helical conformation. 
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4.1 Abstract: 
How changes in enzyme structure and dynamics facilitate passage along the 
reaction coordinate in catalysis is a fundamental, unanswered question. Here, we use 
time-resolved, Mix-and-Inject Serial Crystallography (MISC) at an X-ray Free Electron 
Laser (XFEL), ambient temperature X-ray crystallography, mutagenesis and enzyme 
kinetics to characterize how covalent catalysis modulates isocyanide hydratase (ICH) 
conformational dynamics throughout its catalytic cycle. We visualize this previously 
hypothetical reaction mechanism, directly observing formation of a thioimidate covalent 
intermediate in microcrystals during catalysis. ICH exhibits a concerted helical 
displacement upon active-site cysteine modification that is gated by changes in hydrogen 
bond strength between the cysteine thiolate and the backbone amide of the highly 
strained Ile152 residue. These catalysis-activated motions permit water entry into the ICH 
active site for intermediate hydrolysis. Mutations at a Gly residue (Gly150) that modulate 
helical mobility reduce ICH catalytic turnover and alter its pre-steady-state kinetic 
behavior, establishing that helical mobility is important for ICH catalytic efficiency. 
These results demonstrate that MISC can capture otherwise elusive aspects of enzyme 
mechanism and dynamics in microcrystalline samples, resolving long-standing questions 
about the connection between nonequilibrium protein motions and enzyme catalysis. 
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4.2. Introduction:  
Protein dynamics play an important role in enzyme catalysis523–525,532. Many 
enzymes form covalent catalytic intermediates that can alter enzyme structure and 
conformational dynamics269,533–535. Because catalytic intermediates transiently modify 
enzymes, they may activate a new protein motion regime that facilitates later steps of 
catalysis. Determining how these transient changes in enzyme structure and dynamics 
facilitate passage along the reaction coordinate is a topic of intense interest in structural 
enzymology 525,535. Of all amino acids in proteins, reactive cysteine residues are subject 
to the most diverse set of covalent modifications348,536. Moreover, the targeted 
modification of cysteine residues proximal to active sites has become a frontline strategy 
for the development of covalent enzyme inactivators as tools for chemical biology and 
drugs537. Therefore, understanding how the H-bonding environment of active-site 
cysteine residues modulates their reactivity and how the covalent modification of 
cysteine thiolate anions controls protein conformational dynamics can provide general 
insights into the functions of many proteins whose activities require or are regulated by 
covalent modifications. 
X-ray crystallography provides an atomically detailed ensemble and time-
averaged view of protein conformational dynamics in the lattice environment538–541. 
Technological advances in X-ray sources, detectors, and sample delivery have enabled a 
new class of crystallography experiments that report on nonequilibrium protein motions 
in response to external perturbations542. Because these perturbations can be selected for 
functional relevance (e.g., by the infusion of substrate or induction of a particular 
modification), the resulting nonequilibrium changes often correspond to functionally 
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important protein motions. In parallel, advances in computer modeling of multiple 
conformational substates now enable visualizing minor populations of crystalline protein 
structural ensembles. These approaches have permitted identification of networks of side-
chain disorder543, allowed refinement of whole-protein ensemble models544, aided 
identification of minor binding modes of therapeutic ligands545, and characterized spatial 
correlations in protein mobility546. 
The enzyme studied here is isocyanide hydratase (ICH; EC 4.2.1.103) 
(PDB:3NON), a homo-dimeric cysteine-dependent enzyme in the DJ-1 superfamily that 
irreversibly hydrates a wide range of isocyanides to yield N-formamides32(Fig. 1A). Prior 
crystallographic studies of ICH showed evidence of helical mobility near the active-site 
cysteine101 residue (Fig. 1C), which coincided with photooxidation of C101 to sulfenic 
acid (C101-SOH)31. C101 accepts an S−-HN hydrogen bond from the severely strained 
(φ = 14°, ψ = −83°) backbone amide of Ile152. When this hydrogen bond is disrupted in 
an engineered C101A mutant (Fig. 1C), Ile152 relaxes to an unstrained backbone 
conformation concomitant with displacement of the helix31,547.  
The relevance of these motions for ICH function was not established in these 
prior studies. Here, we use X-ray crystallography, molecular dynamics simulation, 
mutagenesis, and enzyme kinetics to characterize a set of correlated conformational 
changes that remodel the ICH active site and propagate across the dimer interface in 
response to cysteine modification. Using time-resolved mix-and inject serial 
crystallography (MISC) at an X-ray free electron laser (XFEL), we directly observe 
formation of a covalent intermediate and transient, functionally important motions during 
ICH catalysis. Pre-steady-state kinetics of wild-type and mutant ICH suggests that 
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cysteine-gated conformational changes are important for water to access and hydrolyze 
the catalytic intermediate. The prominence of conformational dynamics in ICH and the 
tractability of this protein using multiple biophysical techniques make ICH a valuable 
model system for understanding how cysteine modification can modulate functional 
protein dynamics. 
4.3 Materials and Methods: 
Crystallization, data collection, and processing: Pseudomonas fluorescens ICH 
enzyme was expressed from pET15b constructs in E. coli BL21DE3 cells as a thrombin-
cleavable, N-terminally 6xHis-tagged protein and purified as previously described31.  The 
G150A and G150T mutants were made by site directed mutagenesis using mutagenic 
primers and were verified by DNA sequencing (Eurofins). All of the final proteins 
contain the vector-derived amino acids “GSH” at the N-terminus. Wild-type ICH, the 
G150A, and the G150T mutants were crystallized by hanging drop vapor equilibration by 
mixing 2 μL of protein at 20 mg/ml and 2 μl of reservoir (23% PEG 3350, 100mM Tris-
HCl, pH 8.6, 200 mM magnesium chloride and 2 mM dithiotheritol (DTT)) and 
incubating at 22°C.  Spontaneous crystals in space group P21 appear in 24-48 hours and 
were used to micro-seed other drops after 24 hours of equilibration. Micro-seeding was 
used because two different crystal forms of ICH crystals grow in the same drop and those 
in space group P21 are the better-diffracting crystal form.  Notably, seeding G150T ICH 
using wild-type ICH crystals in space group P21 results exclusively in G150T crystals in 
space group C2 with one molecule in the asymmetric unit (ASU). 
Cryogenic (100K) synchrotron data (PDB 3NON) were collected at the Advanced 
Photon Source beamline 14BM-C from plate-shaped crystals measuring ~500x500x150 
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μm that were cryoprotected in 30% ethylene glycol, mounted in nylon loops, and cooled 
by immersion in liquid nitrogen as previously described31. Ambient temperature (274 K 
and 277 K) synchrotron data sets were collected at the Stanford Synchrotron Radiation 
Lightsource from crystals mounted in 0.7 mm diameter, 10 μm wall thickness glass 
number 50 capillaries (Hampton Research) with a small volume (~5 μl) of the reservoir 
to maintain vapor equilibrium. Excess liquid was removed from the crystal by wicking, 
and the capillary was sealed with beeswax.  For the 274 K dataset, the crystal was 
mounted with its shortest dimension roughly parallel to the capillary axis, resulting in the 
X-ray beam shooting through the longest dimensions of the crystal during rotation. For 
the 277 K dataset, a large single capillary-mounted crystal was exposed to X-rays and 
then translated so that multiple fresh volumes of the crystal were irradiated during data 
collection.  This strategy reduces radiation damage by distributing the dose over a larger 
volume of the crystal.  This translation of the sample was factored into the absorbed dose 
calculation by assuming every fresh volume of the crystal received no prior dose, which 
is a best-case scenario. 
The 100 K and 277 K datasets were collected on ADSC Q4 CCD detectors using 
the oscillation method.  Separate low- and high-resolution passes were collected with 
different exposure times and detector distances and merged together in scaling, as the 
dynamic range of the diffraction data was larger than that of the detector.  For the 274 K 
data, a Pilatus 6M pixel array detector (PAD) was used with shutterless data collection.  
Because of the very high dynamic range of the detector, a full dataset was collected in a 
single pass ~5 minutes. The 274 K datasets were indexed and scaled using XDS548 while 
the 277K datasets were indexed and scaled and HKL2000549.  The 100 K dataset was 
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processed as previously described 31. See Tables 2-3 for Crystallographic data refinement 
statistics. 
Microcrystal growth and XFEL sample delivery. For the XFEL experiment, 
microcrystals of ICH (~10-20µm) were grown by seeding.  Initial seeds were obtained by 
pulverizing macroscopic crystals via vortexing with 0.5 mm stainless steel balls for 5 
minutes.  A dilution of this seed stock was added to 31% PEG 3350, 250 mM MgCl2, 125 
mM Tris-HCl pH=8.8 and then an equal volume of 40 mg/ml ICH was added and rapidly 
mixed.  The dilution of the seed stock dictated the final size of the microcrystals and was 
optimized to produce crystals measuring ~20 μm x 20 μm x 2 μm. The mixture was 
incubated at room temperature with shaking for ~20 minutes until microcrystal growth 
stopped.  
Samples were delivered to the beam using the concentric-flow microfluidic 
electrokinetic sample holder (coMESH) injector550 under atmospheric pressure conditions 
at room temperature and under normal atmosphere. The sample was loaded in a custom 
stainless steel sample reservoir. A Shimadzu LD20 HPLC pump hydraulically actuated a 
teflon plunger to advance the sample slurry. A stainless steel 20 µm frit filter (IDEX-HS) 
was placed after the reservoir in order to ensure smaller crystal sizes and mitigate 
clogging. The reservoir and filters were connected to the coMESH via a 100 µm x 160 
µm x 1.5 m fused silica capillary (Molex). This capillary continued unobstructed through 
the center of the microfluidic tee (Labsmith) and terminated at 0 mm, 2 mm, or 200 mm 
recessed from the exit of a concentric 250 µm x 360 µm capillary, corresponding to Free 
(Apo), 15 s and 5 min time delays, respectively. The capillaries were optically aligned to 
obtain a 0 offset, then were recessed and measured externally to achieve the 2 mm and 
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200 mm recess. In the case of the longer 200 mm offset, an additional tee (IDEX-HS) 
was added to increase the length. The outer line of the coMESH flowed the stabilizing 
solution (31% PEG 3350, 250 mM MgCl2, 125 mM Tris-HCl pH=8.8) in the case of the 
Free (Apo) structure and flowed ~2 mM p-NPIC substrate in stabilizing solution for the 
15 s and 5 min timepoints. DTT was omitted from all solutions as p-NPIC is not stable its 
presence and the p-NPIC substrate was at saturation (estimated concentration is ~2 mM) 
in this solution. The p-NPIC substrate was loaded into a 500 or 1000 µL gas tight syringe 
(Hamilton). The stainless steel, blunt tip removable needle was connected to a 250 µm x 
360 µm x 1 m fused silica capillary (Molex) and connected to the side of the coMESH 
microfluidic tee junction for the APO and 15 s delay and into the side of the Idex tee for 
the 5 minute delay. The syringe was driven by a syringe pump (KDS Legato 200) at 1-2 
µl/min while being charged at 3.1 kV (Stanford Research Systems, SRS PS300) at the 
wetted stainless-steel needle.  
The outer liquid focused the fluids ~500 µm away from the outer capillary 
towards the XFEL focus, of approximately 3 µm at the Macromolecular Femtosecond 
Crystallography (MFX) end-station. The charged meniscus was approximately 5 mm 
away from a grounded counter electrode to complete the electro kinetic focusing. The 
time delays were assumed to be sufficiently long as compared to the electro kinetic 
mixing phenomena and were determined simply by the time the bulk fluid would traverse 
the offset distance. The flow rates and voltages were held constant during each time point 
and the flow of the crystals were optically monitored with a 50x objective to assure 
minimal flow deviations. For the APO (no delay) time point, the flow was 0.5 µl/min for 
both the sample and outer flows. For the 15 s time delay, the capillaries were recessed 2 
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mm, and the flows were 1 and 2 µl/min for the sample and p-NPIC flow rates, 
respectively. The combined bulk flows (1+2 = 3 µl/min) and the 2 mm offset dictated the 
delay time of 15 s. For the 5 min time delay, the capillaries were offset 200 mm and both 
flow rates were held at 1 µL/min, for a combined bulk flow of 2 µL/min. Overall, ~0.5 
mL of sample crystals and 0.5 mL of 3 mM p-NPIC were consumed to gather this data. 
XFEL Data collection and Processing. Data were collected at the MFX endstation of 
the Linac Coherent Light Source (LCLS). X-ray pulses were 9.5 keV, ~1x1012 photons 
per 40 fs pulse at 30 Hz repetition. Beam size at sample was ~3 μm. Diffraction data were 
collected on a Rayonix MX340-XFEL CCD detector operated in 4x4 binning mode and 
hits were analyzed in real time using OnDA 269. The XFEL diffraction data were 
processed with cctbx.xfel551, to identify 76,174 crystal hits for the Free (Apo) 
data, 53,476 crystal hits for the 15 second delay data and 36,875 crystal hits for the 5 
minute delay data. A small fraction of multiple lattice hits (<0.01% of total) were shown 
to have little impact on data quality when included in the final post-refinement steps. For 
the Free (Apo) data, 23,669 frames were indexed and 21,834 of those had their intensities 
merged and integrated. For the 15s data, 26,507 frames were indexed and 24,286 of those 
had their intensities merged and integrated. For the 5min data, 16,893 frames were 
indexed and 14,483 of those had their intensities merged and integrated. To correct the 
intensity measurements and merge the data, postrefinement was carried out with three 
cycles of PRIME552 using model unit cell dimensions from a synchrotron wild type ICH 
structure31. The Lorentzian partiality model used parameters gamma_e = 0.001, 
frame_accept_min_cc = 0.60, uc_tolerance = 5, sigma_min = 2.5, and partiality_min = 
0.2. The X-ray crystallographic data statistics for all datasets are provided in Tables 2-3. 
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Selection of mix-and-inject X-ray time delays. We collected absorbance spectra of ICH 
crystals in reservoir solution supplemented with 1mM p-NPIC and 40% glycerol using 
UV-vis microspectrophotometry at SSRL BL 11-1 (Fig. 1B). We freeze-trapped the 
reaction in the cryostream at fixed time-delays after adding substrate to the crystal before 
collecting a spectrum. The p-NPIC absorption maximum is ~270 nm, while p-nitrophenyl 
formamide product absorption maximum is ~315 nm on this instrument. The lack of an 
isosbestic point suggests an intermediate accumulated. At a time delay of 15s, the 
substrate peak at 270 nm had disappeared, while the product peak at 315 nm had not 
formed yet. At 5 minutes, substrate is exhausted while the product peak at 315 nm had 
fully formed, informing the timing for the XFEL experiment.  The macroscopic (~2x106 
μm3) crystals from which these spectra were collected were damaged by exposure to 
substrate and did not diffract X-rays well after substrate was introduced, precluding a 
cryotrapping X-ray diffraction experiment. In contrast, the microcrystals used for the 
XFEL experiment (~2x103 μm3) were not damaged by substrate, necessitating a serial X-
ray crystallography approach. 
Crystallographic model refinement. All refinements were performed in PHENIX1.9 
against structure factor intensities using individual anisotropic ADPs and riding hydrogen 
atoms553.  Weights for the ADP refinement and relative weights for the X-ray and 
geometry term were optimized.  After convergence of the isotropic ADP refinements, 
translation-libration-screw (TLS) refinements554 with automatic rigid body partitioning 
were performed in PHENIX.  For the C101-SOH and G150A ICH synchrotron datasets, 
the alternate conformation for helix H (residues 148-173 in chain A) was modeled as a 
single occupancy group, reflecting the presumed correlated displacement of sidechain 
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and backbone atoms.  Other disordered regions were also built into multiple 
conformations manually in COOT555 if supported by 2mFo-DFc and mFo-DFc electron 
density maps.  Occupancies of these groups were refined but constrained to sum to unity 
in PHENIX.  Omit maps were calculated after removing the areas of interest from the 
model and refining for three macrocycles.  Final models were validated using 
MolProbity556 and the validation tools in COOT and PHENIX. Model statistics are 
provided in Table 3. Isomorphous difference maps (Fo(15s) – Fo(XFELAPO) and Fo(SR) – 
Fo(XFELAPO)) were calculated using data to the lowest high resolution of the data sets, 
1.55 Å. Structure factor data and refined coordinates are available in the Protein Data 
Bank with the following accession codes: 6NI4, 6NI5, 6NI6, 6NI7, 6NI8, 6NI9, 6NJA, 
6NPQ, 6UND, and 6UNF.  
Evidence of ICH in-crystallo catalysis.. A single crystal of ICH was mixed with 1 mM 
substrate, para nitrophenyl isocyanide (p-NPIC), incubated for the indicated times in 
seconds (Fig. 1B), mounted and cryocooled to 100 K in a nitrogen cryo-stream. 
Absorbance spectra were collected using the inline spectrophotometer at BL 11-1 at the 
Stanford Synchrotron Radiation Lightsource (SSRL).  
pH gradient wildtype ICH crystal growth, data collection and processing. For the pH 
screen, crystallization buffers were made with 23% PEG 3350, 0.2 M MgCl2, 2mM DTT 
and 0.1M Tris-HCl or 0.1M Na Acetate or 0.1M Na Citrate. Wildtype ICH was 
crystallized by hanging drop vapor equilibration by mixing 2 μL of protein at 20 mg/ml 
and 2 μl of the corresponding reservoir solution and incubating at 22°C.  The drops were 
streak seeded to facilitate the growth of the the better diffracting P21 space group.  
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Synthesis of para-nitrophenyl isocyanide (p-NPIC). ICH will accept diverse 
isocyanide substrates32. Due to its strong absorption in the visible range (λmax=320 nm), 
para-nitrophenyl isocyanide (p-NPIC) was used here. The p-NPIC substrate is not 
commercially available and was synthesized by the Dr. David Berkowitz and his group 
(University of Nebraska Lincoln, Department of Chemistry) via dehydration of the N-
formamide precursor. To synthesize N-(4-Nitrophenyl) formamide, a mixture of amine 
(10 mmol) and formic acid (12 mmol) was stirred at 60 °C for 2h. 
 
After completion of the reaction, as judged by Thin Layer Chromatography (TLC), the 
mixture was diluted with CH2Cl2 (100 mL), washed with saturated solution of NaHCO3 
and brine (100 mL), and then dried over anhydrous Na2SO4 and concentrated under 
reduced pressure. The residue was dissolved in hot acetone and crystallized, to yield N-
(4-Nitrophenyl) formamide (1.58 g, 96%) as a yellow solid.  The product was verified 
using 1H NMR, 13C NMR, IR, and Time of Flight (TOF) mass spectra. 
To synthesize p-Nitrophenyl isocyanide, the mentioned N-(4-Nitrophenyl) 
formamide product (8.0 mmol) and triethylamine (56 mmol) were dissolved in 
CH2Cl2 (30 mL) and cooled to -10 °C.  
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A solution of triphosgene (8.0 mmol) in CH2Cl2 (50 mL) was slowly added and stirring 
was continued at -10 °C for another 30 minutes. After completion of reaction (judged by 
TLC), the reaction mixture was passed through a pad of silica gel and washed with 
CH2Cl2. The filtrate was dried over anhydrous Na2SO4, and then concentrated under 
reduced pressure. The residue was triturated with cold hexane to yield para-nitrophenyl 
isocyanide (1.36 g, 92%) as a yellow solid. 1H NMR, 13C NMR, IR, and Time of Flight 
(TOF) mass spectra were collected to verify the product structure. The para-nitrophenyl 
isocyanide product was stored as a dry solid at -80°C 
until needed. 
ICH enzyme kinetics. Steady state ICH rate measurements were initiated by the addition 
of ICH (final concentration of 1 µM) to freshly prepared p-NPIC solutions ranging from 
0-60 µM in reaction buffer (100 mM KPO4 pH=7.0, 50 mM KCl, and 20% DMSO). p-
NPIC was diluted from a 0.5 M stock solution in dimethyl sulfoxide (DMSO), which was 
stored at -80 °C and protected from light.  A 200 µl reaction was maintained at 25 °C in a 
Peltier-thermostatted cuvette holder. The formation of the product, para-nitrophenyl 
formamide (p-NPF) was monitored at its absorption maximum of 320 nm for two 
minutes using a UV-Vis Cary 50 Spectrophotometer (Varian, Palo Alto, CA). A linear 
increase in A320 was verified and used to calculate initial velocities.  Isocyanides can 
spontaneously hydrolyze slowly in aqueous solutions, with the rate increasing as pH is 
lowered. To ensure that all measured product formation was due to ICH catalysis, the rate 
of spontaneous p-NPIC hydrolysis was measured without added ICH.  These values were 
near the noise level of the spectrophotometer and were subtracted from the raw rate 
measurements before fitting the Michaelis-Menten model. The extinction coefficient at 
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320 nm for p-NPF was determined by using ICH to convert known concentrations of p-
NPIC to p-NPF, followed by measuring the absorbance at 320 nm.  The slope of the 
resulting standard curve was defined as the extinction coefficient of p-NPF at 320 nm; 
ε320=1.33x104 M-1 cm-1.  This p-NPF ε320 value was used to convert the measured rates 
from A320/sec to [p-NPF]/sec. All data were measured in triplicate or greater and mean 
values and standard deviations were plotted and fitted using the Michaelis-Menten model 
as implemented in Prism (GraphPad Software, San Diego, CA). Reported Km and kcat 
values and their associated errors are given in Fig. 4E-F. 
Pre-steady state ICH kinetics were measured at 25 ˚C using a Hi-Tech KinetAsyst 
stopped flow device (TgK Scientific, Bradford-on-Avon, United Kingdom). Data were 
collected for each sample for two seconds (instrument deadtime is 20 ms) in triplicate. 
The final enzyme concentration after mixing was 10 M and final p-NPIC concentrations 
were 20, 40, 80, 120, 160, and 320 M. Product evolution was monitored at 320 nm 
using a photodiode array detector. Kinetic Studio software (TgK Scientific, United 
Kingdom) was used to analyze the kinetic data and to fit a mixed model containing a 
single exponential burst with a linear steady state component: -Aexp(-kt) + mt + C.  In 
this equation, t is time, k is the burst phase rate constant, m is the linear phase (steady-
state) rate, A is the amplitude of the burst component, and C is a baseline offset constant. 
The linear slope m was used to calculate steady state turnover numbers, which agree well 
with kobs values obtained from steady state kinetic measurements at comparable substrate 
concentrations.  Single turnover experiments were also performed using final 
concentrations of 40 M enzyme and 20 M p-NPIC after manual mixing. Spectra were 
collected using a Cary 50 spectrophotometer (Varian, Palo Alto, CA, USA).  Spectra 
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were collected every 10 seconds with a deadtime of ~30 seconds after manual addition of 
enzyme.  
Isocyanide (p-NPIC) toxicity assays. E coli BL21DE3 cells bearing the ICH containing 
pET15b recombinant plasmids were grown until OD600=0.5-0.6 at 37˚C and 250rpm 
shaking, upon which they were induced with 0.5mM IPTG. 1 ml of induced cells were 
mixed rapidly with 5mls of cooled autoclaved soft agar (0.8%) supplemented with 
100mg/ml Ampicillin and poured over 1.5% LB agar plates and incubated at room 
temperature (22-25˚C) for 1 hour.  Once the soft agar had solidified, stress chemicals 
were prepared fresh (500mM, 100mM and 10mM p-NPIC in 100%DMSO). Each LBA 
plate was divided into four quadrants and sterile autoclaved filter discs (1 cm diameter) 
were placed in the four sections. 10µl stress chemical was added to each disk and the 
plates were incubated at 37˚C overnight. Diameters of the developed zone of clearances 
were manually measured in triplicates after 24 hours and plotted as a function of substrate 
concentration using Prism (GraphPad Software, San Diego, CA). 
4.4 Results: 
4.4.1 ICH actively catalyzes hydration of isocyanides to formamides in crystallo.  
Prior to XFEL characterization of catalytic turnover of ICH, it is important to 
ensure that the enzyme is active in the crystal form as a pre-requisite to the planned 
XFEL MISC experiment. A single crystal of ICH was mixed with 1 mM p-NPIC, 
mounted and cryocooled to 100 K in a nitrogen cryostream. Absorbance spectra were 
collected using the inline spectrophotometer at BL 11-1 at the Stanford Synchrotron 
Radiation Lightsource (SSRL). On this instrument, the p-NPIC substrate has an 
absorption maximum of 270 nm and the p-NPF product has an absorption maximum of 
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315 nm. Note the absence of an isosbestic point (Fig. 1B).  
4.4.2 Formation of thioimidate reaction intermediate during ICH catalysis triggers 
active site conformational dynamics in ICH.  
Mix and Inject Serial Crystallography (MICS) at the LCLS XFEL at 298K allowed us to 
examine the role of active site structural dynamics in ICH turnover by directly 
monitoring catalysis in ICH microcrystals. We infused the substrate p-nitrophenyl 
isocyanide (p-NPIC) into a stream of unmodified ICH microcrystals (Methods) and 
collected diffraction data at carefully selected time delays (Fig. 1B). The concentration of 
p-NPIC in the stream allowed only a single turnover of crystalline ICH before substrate 
depletion. It is important to note here that due to the  “diffraction before destruction” 
principal, SFX data are minimally affected by X-ray radiation damage557, as a result of 
which the enzyme suffered no radiation-induced oxidation of C101 (Fig. 1D). It is 
essential to rule out radiation damage induced conformational switching in ICH from 
catalysis induced dynamics because both events are triggered by C101 covalent 
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modification.  The proposed reaction mechanism of ICH (Fig. 1F). states that the 
catalytic C101 nucleophile attacks organic isocyanides at the electron-deficient carbene-
Fig 1:(A) Hydration of isocyanides by ICH yields corresponding formamides. (B) In-crystallo ICH 
turnover monitored in a single crystal mixed with 1 mM p-NPIC, mounted, cryocooled to 100 K in a 
nitrogen cryostream. Absorbance spectra collected using the inline spectrophotometer at BL 11-1 at the 
Stanford Synchrotron Radiation Lightsource (SSRL). (C) The ICH dimer is shown as an overlay of WT 
ICH (purple) and C101A ICH (blue). The “B” protomer is shown in yellow. The mobile helix H in C101A 
and areas exhibiting correlated backbone–side-chain disorder are rendered opaque. Ile152 is a 
Ramachandran outlier (Inset) whose backbone torsion angles move with helical displacement.(D) ICH 
completes a full catalytic cycle in the crystal during MISC. Helix H is shown with 2mFo-DFc electron 
density (0.8 rmsd) prior to the introduction of substrate (blue) and after substrate has been exhausted 
(orange). These maps overlap almost perfectly, indicating that ICH is fully restored to its resting 
conformation after catalysis. The hydrogen bond between the peptide backbone of Ile152 and Cys101 is 
shown in a dotted line. The helix is not mobile in these resting structures, indicated by the absence of 
features in the mFo-DFc difference electron density (2.5 rmsd prior to substrate [green] and after catalysis 
is complete [purple]) (E) MISC confirms that ICH forms a covalent Cys101-thioimidate intermediate 15 s 
after substrate mixing. Difference mFo-DFc electron density contoured at 2.5 rmsd (green) supports 
sampling of shifted helix H conformations upon intermediate formation. (F) Postulated reaction 
mechanism for ICH, beginning with Cys101 thiolate attack at the electrophilic carbenic carbon atom of 
isocyanide substrates and proceeding in the direction of the arrows. A previously postulated thioimidate 
intermediate (red box) eliminates the charge on Cys101 and weakens the H-bond to Ile152 (dashed red 
line). This relieves backbone torsional strain at Ile152 and permits sampling of shifted helix H 
conformations (green curved arrow), allowing water access to the intermediate for hydrolysis. 
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like center, followed by proton abstraction from a nearby general acid to generate a 
covalent thioimidate intermediate. An enzyme-linked thioimidate, which has not been 
previously observed, eliminates the negative charge of the C101 thiolate (S−) and is 
proposed to reduce the strength of the C101-I152 hydrogen bond.  
 
 
After 15 s of mixing with substrate, 2mFo-DFc (Fig. 1E) and omit mFo-DFc electron 
density maps (Fig. 2A) unambiguously reveal the formation of a thioimidate covalent 
intermediate in both ICH protomers. Once the intermediate is formed, positive mFo-DFc 
difference electron density appears around helix H (Fig. 1E) and its B-factors increase 
(Fig. 2B-D), indicating that it samples a new conformational ensemble. This difference 
density and elevated B-factors are absent both prior to catalysis and after ICH has 
Fig 2: Observation of thioimidate intermediate formation and enhancement of ICH helix 
mobility. In (A), omit mFo-DFc electron density is shown at 3.0 rmsd (green) and 5.0 rmsd (purple), 
unambiguously demonstrating presence of the catalytic intermediate. In (B-D), anisotropic atomic 
displacement parameters (ADPs) from TLS models refined against the XFEL datasets are shown at the 
75% probability level and colored according to Beq value, from blue (7 Å2) to red (30 Å2). Starting 
with the resting enzyme before substrate is introduced (B), helical mobility is transiently elevated upon 
thioimidate intermediate formation during catalysis (C) and then is reduced again upon completion of 
catalysis (D) once substrate is consumed 5 minutes after mixing. 
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exhausted substrate 5 minutes after mixing (Fig. 1D, Fig. 2B-D). Therefore, helix H 
becomes transiently mobile upon intermediate formation during ICH catalysis, changing 
the active site microenvironment. 
Fig 3: X-ray induced cysteine oxidation drives helical motion in ICH.  (A-C) The top panels show 
the environment of Cys101 with varying degrees of oxidation to Cys101-sulfenic acid. 2mFo-DFc 
electron density is contoured at 0.7 RMSD (blue) and the hydrogen bond between the peptide backbone 
of Ile152 and Cys101 is shown in a dotted line. “Cryo” is synchrotron data collected at 100 K (PDB 
3NON), “RT less oxidized” is synchrotron data collected at 274 K with an absorbed dose of 2.4x104 Gy, 
and “RT more oxidized” is synchrotron data collected at 277 K with an absorbed dose of 3.7x105 Gy.  
The lower panels show helix H in its strained (black) and relaxed, shifted conformations (grey). 2mFo-
DFc electron density is contoured at 0.8 RMSD (blue) and omit mFo-DFc electron density for the shifted 
helical conformation is contoured at 3.0 RMSD (green).  At 274-277K, increased Cys101 oxidation 
disrupts the hydrogen bond to Ile152 and results in stronger difference electron density for the shifted 
helix conformation. (D) The refined occupancy of helix H for each X-ray dataset, indicating that 
increases in temperature and Cys101 oxidation result in higher occupancy for the shifted (relaxed) helix 
conformation. (E) Mechanism of X-ray induced covalent modification of C101 and weakening of the S—
-NH hydrogen bond. (F) Cys101 oxidation leads to a weakening of the Ile152-Cys101 H-bond. 
Electrostatic Poisson-Boltzmann surfaces (red negative, blue positive charge) calculated from the 
Cys101-Ile152 (A) and Cys-SOH-Ile152 (B) environments. Cysteine photooxidation neutralizes the 
negative charge of the sulfur atom, weakening the N-H ..S hydrogen bond. We calculated a reduction in 
the Cys101-Ile152 hydrogen bond energy from -2.2 kcal/mol under reduced conditions (i.e. with a 
thiolate acceptor) to -0.91 kcal/mol upon Cys101-SOH formation. 
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We reasoned that the on-pathway thioimidate intermediate weakens the interactions that 
hold helix H in a strained conformation similarly to the X-ray-induced C101-SOH 
modification in the resting enzyme. Consistent with this idea, the cryogenic dataset 
collected at 100K (Cryo) also shows evidence of radiation-driven C101-SOH formation 
and a corresponding increase in helical mobility31 (Fig. 3A). To enrich populations of the 
conformational shifts, we therefore collected a series of X-ray diffraction data sets of WT 
ICH at increasing doses of X-ray radiation (Fig. 3A-C). Two ambient temperature (274-
277K) synchrotron radiation datasets at 1.20-1.15 Å reveal a radiation-dose dependent 
C101 oxidation and helical displacement with increasing occupancy (Fig. 3D).  Refined 
occupancies of alternate conformations of helix H confirm a population shift towards the 
displaced helix position along this series of data sets that correlates with the extent of 
absorbed X-ray dose and concomitant C101 oxidation. The shifted helix conformations 
across data sets are highly similar, suggesting that the observed electron density features 
result from coupling between this helix and specific, radiation-induced photochemistry at 
C101.  
Notably, these stronger density peaks correspond to the difference electron 
density observed in the MISC experiment during ICH catalysis (Fig. 1E, Fig. 3A-C). In 
the ambient temperature synchrotron radiation datasets, the helical shift is caused by 
radiation-induced oxidation of the C101 eliminating the negative charge on Sγ thiolate 
and thus weakening the hydrogen bond between the amide H of Ile152 and C101 Sγ, 
from -2.2 kcal/mol with a thiolate acceptor to -0.91 kcal/mol with a C101-SOH acceptor 
(Fig. 3E-F). Similar loss of C101 thiolate negative charge occurs in the on-pathway 
thioimidate intermediate, which also weaken the C101-I152 hydrogen bond. (Fig. 1F). 
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4.4.3 Cysteine modification-gated motions increase ICH catalytic efficiency  
 To modulate helical mobility and measure the impact on ICH catalysis, we 
designed two mutations, G150A and G150T.  G150 is part of a highly conserved diglycyl 
motif that moves ~3Å to accommodate helical motion in ICH. Ambient temperature 
(274-277 K) crystal structures of G150A and G150T ICH show that the added steric bulk 
at this position biases the helix towards its relaxed conformation (Fig. 4A, B). In G150A 
ICH, helix H samples both conformations in both protomers (Fig. 4A, C-D).  By contrast, 
the G150T structure shows helix H constitutively shifted to its relaxed position (Fig. 4B).  
Both G150A and G150T have an alternate C101 sidechain conformation which conflicts 
with the unshifted conformation of Ile152 and helix H (Fig. 4A-B asterisk), indicating 
that the helix must move partially independently of C101 modification in these mutants.  
As in wild-type ICH, G150A shows evidence of C101-SOH oxidation in the electron 
density (Fig. 4A). In contrast, C101 in G150T ICH is not modified by comparable 
exposure to X-rays (Fig. 4B), indicating that the Ile152-NH-C101-S- hydrogen bond is 
important for enhancing C101 reactivity.  
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Fig 4: (A-B) (Top). 2mFoDFc electron density is contoured at 0.7 rmsd (blue) and the H-bond appears as a dotted 
line. Both G150 mutations permit unmodified Cys101 to sample conformations (asterisk) that sterically conflict 
with Ile152 in the strained helical conformation (black), requiring the helix to sample shifted conformations (gray) 
in the absence of Cys101 modification. (A and B, Lower) The helix in its strained (black) and relaxed, shifted 
conformations (gray). 2mFo-DFc electron density is contoured at 0.8 rmsd (blue) and omit mFo-DFc electron 
density is contoured at +3.0 rmsd (green).(C-D) Helical mobility is asymmetric in wild-type but not G150A ICH 
The top panels show the environment of Cys101 in the second protomer (“protomer B”) of wild-type (WT) and 
G150A ICH. 2mFo-DFc electron density is contoured at 0.7 RMSD (blue) and the hydrogen bond between the 
peptide backbone of Ile152 and Cys101 is shown in a dotted line. The lower panels show the helix in its strained 
(black) and relaxed, shifted conformations (grey). 2mFo-DFc electron density is contoured at 0.8 RMSD (blue) and 
omit mFo-DFc electron density for the shifted helical conformation is contoured at 3.0 RMSD (green). Wild-type 
ICH does not show strong evidence of a second conformation, even though Cys101 has been partially 
photooxidized to Cys101-SOH (top). In contrast, the helix in monomer B of G150A ICH shows strong evidence of 
a second, relaxed conformation, similar to monomer A. Steady-state (E) and pre-steady state (F) enzyme kinetics of 
wild-type (WT; blue circles), G105A (black squares), and G150T (red triangles) ICH. Both the G150A and G150T 
mutations result in similar decreases in steady-state kinetics compared to WT enzyme. (E) The burst rate constant 
in pre-steady state kinetics is linearly dependent on substrate concentration. This linear dependence indicates a 
second order rate process during the burst phase, consistent with thioimidate intermediate formation. WT and 
G150A have similar second order burst rate constants (G) Pre-steady-state enzyme kinetics of WT (blue circles), 
G105A (black squares), and G150T (red triangles) ICH at 160 μM p-NPIC shows a pronounced burst phase for 
each protein with differing burst and steady-state rate constants. (H) Single-turnover spectra of ICH enzymes with 
p-NPIC substrate shown from early (red) to later (blue) timepoints in 5-s increments. At early times, G105A and 
G150T accumulate a species with λmax = 335 nm, likely the thioimidate intermediate that resolves to product in the 
blue spectra with λmax = 320 nm. (I) The catalytic cycle of ICH (Summary figure).  
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Unlike the C101A mutant, which shows similar helical displacement but is 
catalytically inactive, G150A and G150T ICH are catalytically active. This allowed us to 
investigate the role of helical displacement in the ICH catalytic cycle. Steady-state 
enzyme kinetics of the G150A and G150T mutants measured using p-NPIC as the 
substrate show a ~6–fold reduction in kcat for both mutants compared to wild-type 
enzyme but largely unchanged KM values (Fig. 4E, F Table 1). In contrast to their similar 
steady-state kinetic behavior, the G150 mutants have divergent pre-steady state kinetic 
profiles in stopped-flow mixing.  ICH exhibits “burst” kinetics (Fig. 4G), indicating that 
the rate-limiting step for ICH catalysis comes after formation of the thioimidate 
intermediate. G150A ICH has a burst exponential rate constant k of ~11 s-1 that is 
comparable to the wild-type enzyme, but G150T has a reduced burst rate constant of ~4 s-
1, indicating a slower chemical step (Fig. 4E-G, Table 1). WT and G150A ICH have 
comparable second order rate constants for the burst phase, while G150T is markedly  
lower (Fig. 4E-F, Table 1). In addition, the burst amplitude of G150A is approximately 
twice as large as that of the wild-type ICH despite equal concentrations of enzyme (Fig. 
4G), which correlates with both protomers of G150A having a mobile helix H compared 
to only one protomer of wild-type ICH (Fig. 4C-D). This suggests communication 
between the two active sites in the ICH dimer that is dynamically gated by helix H. 
Although both the G150A and G150T mutations impair ICH catalysis, the kinetic effect 
of the G150A mutation is predominantly in steps after formation of the  
intermediate, while G150T impairs both the rate of intermediate formation and later, rate-
limiting steps.  Thus, modulation of helical dynamics by the G150A and G150T mutants 
have divergent effects on ICH catalysis, indicating that the active site helical switching is 
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essential to support efficient ICH catalysis. Furthermore, we observe spectral evidence 
for the thioimidate intermediate in single-turnover UV-visible spectra (Fig. 4H). G150A 
ICH accumulates a species whose absorbance maximum is 335 nm, while WT ICH 
completes a single turnover and accumulates the 320 nm formamide product in the ~30 
second deadtime of manual mixing (Fig. 4H). G150T ICH accumulates less of the 335 
nm intermediate than G150A ICH due to a closer match between the rates of formation 
and consumption of the intermediate in G150T ICH. In G150A ICH, the 335 nm species 
slowly converts to the 320 nm product over ~40 s, consistent with the slow rate of 
product formation observed after the burst in G150A pre-steady state kinetics (Fig. 4G). 
These data support the conclusion that the 335 nm species is the ICH-thioimidate 
intermediate observed in the MISC experiment and that G150A is impaired in 
hydrolyzing this covalent intermediate from the active site C101 due to perturbed 
dynamics of helix H. It will be interesting to use the lower G150A mutant ICH in a 
similar MISC experiment at LCLS at ambient temperature to potentially trap the other 
reaction intermediate (tetrahedral) during IC  
The impaired catalytic effects of the G150A and T mutations can also be demonstrated in 
in vivo p-NPIC toxicity assays performed with E.coli BL21DE3 cells bearing the pET15b 
constructs (Fig. 5A-D). BL21DE3 cells expressing the catalytically dead enzyme C101S 
was used as negative 
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control and pET15b only cells were used as the empty vector controls. DMSO vehicle 
controls were included in each run (n=3). Fig. 5 clearly demonstrates the loss of 
isocyanide (p-NPIC) remediation abilities in BL21DE3 cells expressing G150A and 
G150T (Fig. 5B-C) compared to wildtype ICH bearing cells (Fig. 5A) as seen by the 
increased diameters of their zones of clearances (Fig. 5D). 
4.4.4 Propagation of cysteine-gated conformational changes across the ICH dimer. 
 To characterize the extent of the conformational response of the entire ICH dimer to the 
Fig. 5: (A-C) LBA plates showing zones of clearances in wtICH, G150T and G150A respectively, in 
response to varying doses of isocyanide p-NPIC (DMSO vehicle control, 10mM, 100Mm, 500mM p-
NPIC). (D) Diameters of the zones of clearances formed by E. coli BL21DE3 cells bearing the various 
ICH-pET15b constructs linearly track the concentration of the stress chemicals  
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modification of C101, we calculated an Fo(SR) – Fo(XFELFree) isomorphous difference 
map,  phased with a structural model obtained from the XFEL data set. The Fo(SR) – 
Fo(XFELFree) isomorphous difference map provides an unbiased view of differences in 
molecular conformation between two data sets, reporting specifically on changes in ICH 
that occur in response to oxidation of C101. A Fo(15s) – Fo(XFELFree) map calculated 
using the thioimidate dataset after 15 s of mixing and the dataset prior to introduction of 
substrate (Free) reveals similar features to those seen in the Fo(SR) – Fo(XFELFree) map 
Fig. 6: (A) Isomorphous difference maps show widely distributed conformational changes upon 
cysteine modification. Fo(SR) – Fo(XFELFree) (top panels) and Fo(XFEL15s) – Fo(XFELFree) 
(bottom panels) difference maps are contoured at 2.75 rmsd. difference features (green, positive; red, 
negative) are nonuniformly distributed in both maps, radiating out from the site of the catalytic 
nucleophile (yellow spheres). This is more pronounced in the A protomer (slate blue) than the B 
protomer (grey) in the Fo(SR) – Fo(XFELFree) map (top panels). Difference features generally show 
the same, but weaker pattern in the Fo(XFEL15s) –Fo(XFELFree) map, where the 15 s timepoint 
corresponds to thioimidate intermediate formation. The maps are phased with the Free (no substrate) 
XFEL structure. (B) Isomorphous Fo(SR) – Fo(XFELFREE) difference map reveals broadly altered 
structure and dynamics upon formation of the Cys101-SOH in the 274-K synchrotron radiation 
(FoRT) dataset. Helices H and I are opaque in both conformers. The catalytic nucleophile is shown in 
spheres. Difference electron density features are nonuniformly distributed, with stronger features near 
helix H in the A protomer, and along region B169–B189, which contacts the N-terminal end of helix 
H. Maps are contoured at ±3.0 rmsd. (C) CONTACT analysis identifies allosteric coupling across the 
dimer interface, in striking agreement with isomorphous difference maps and rmsfs from (B). The A 
protomer is color-coded in blue; the B protomer, in red. Residues identified in the CONTACT analysis 
are projected onto the cartoon.  
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(Fig.6A) signifying that the widespread dynamic response observed in Fo(SR) – 
Fo(XFELFree) difference map is common to different types of C101 modification. We 
further examined the dynamical communication across the dimer interface in ICH using 
CONTACT network analysis of the electron density maps. CONTACT elucidates 
pathways of collective amino acid main- and sidechain displacements through mapping 
van der Waals conflicts that would result from sidechain conformational disorder if 
correlated motions are not considered 543. CONTACT identified a large network of 
correlated residues in protomer A (with the mobile helix) that connects with a smaller 
network in protomer B (Fig. 6C), corroborating the isomorphous difference map. The key 
residues in CONTACT analysis that bridge the dimer interface are Tyr181 and Thr153, 
which are also key residues identified in the isomorphous difference map. Our results 
indicate that the conformational changes upon C101-I152 H-bond modification in the 
synchrotron structure correspond to later steps in the catalytic cycle, allowing helical 
motion that facilitates intermediate hydrolysis and product release. At the same time, 
increased allosteric transmission during these later steps may prime the dimer for the next 
catalytic cycle. Ongoing work includes generation of Y181F and D157N mutants to 
eliminate or weaken an intra-dimer hydrogen bonding between Y181 and D157 residues 
to manipulate this dimer spanning allosteric network of corelated motions to better 
elucidate its impact on ICH catalysis.  
4.4.5 The charge on C101 in ICH modulates active site dynamics 
 pH can be used as a controlling parameter to modulate C101 gated active site 
helical dynamics in ICH, independent of X-ray induced oxidation or catalysis. The 
rationale behind this is, when the pH of the reservoir solution is lesser than the pKa of the 
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C101, it is protonated. Therefore, the protonated (neutrally charged) C101cannot 
effectively form the negative charge assisted H bond with Ile125, causing it to relax and 
adopt an outlier conformation, triggering helical mobility. In this study, wildtype ICH 
was crystallized at pH 4.2, 5.0, 5.4, 6.0 and 8.3 (Fig. 7). Upon optimization of pH in the 
crystallization buffer, ICH shows varying degrees of C101 protonation/deprotonation and 
corresponding helical mobility in both protomers. 
 At pH 4.2 and 5.0 (Fig. 7A-B), C101 is protonated and the Ile152 primarily 
adopts a relaxed conformation, in contrast to pH 6.0 and 8.3 (Fig. 7D-E), where the C101 
is deprotonated (negatively charged); the negative thiolate forms hydrogen bond with 
Ile152, holding it in the restrained conformation. It is to be noted here that the pH 5.6 and 
8.3 datasets show some positive density around the C101, indicating some oxidation of 
the C101, which potentially contributes to the Ile152 relaxed conformation (negligible). It 
would be beneficial to repeat these datasets, with properly handled crystal samples to 
ensure there is no oxidation. pH 5.0 (Fig. 7C), shows a mixture of both protonated and 
deprotonated C101 and a disordered active site with Ile152 occupying both restrained and 
relaxed conformations. These studies conclude that when the C101 is negatively charged, 
the negative thiolate can form H bond with Ile152 and hold it in the restrained 
configuration, whereas when the C101 is neutral or uncharged, it cannot form H bond 
with Ile152, releasing it to its relaxed configuration, triggering active site helical 
dynamics. This work is important because it confirms that the helical dynamics in ICH 
are dependent on the overall charge on the C101. It also shows that pH can be used as a 
control parameter to tune the internal ICH active site motions, thereby making this 
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enzyme an excellent model for the development of Diffuse Scatter (DS) data analysis and 
processing methods.  
Diffuse scattering occurs from an imperfect or disordered crystal, when the scattering 
amplitudes do not add up constructively as in Bragg diffraction. The amplitude of the 
Bragg peak decreases and this lost intensity is redistributed into diffuse scattering. Thus, 
Figure 7: pH can be used to control ICH helical motions (A) pH 4.2 and (B) pH 5.0 shows 
protonated (uncharged) Cys101 and Ile152 shifted to relaxed configuration. (C) pH 5.0 shows a 
mixture of protonated and deprotonated Cys101 and sampling of relaxed and restrained 
configurations by Ile152. (D) pH 6.0 and (E) pH 8.3 show deprotonated Cys101 and Ile152 
primarily occupying restrained configuration.  
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DS has the potential to inform on corelated motions inside crystals, but technological 
challenges prevent use of DS in protein crystallography. Currently there exist limited 
tools to interpret and process DS data, as a result of which, the DS portion of datasets are 
most often ignored when refining models. By manipulating the internal motions in ICH, 
we can develop DS data analysis and processing methods.  
4.5 Discussions: 
Covalent modification is a common and physiologically important perturbation to 
proteins.  Reactive residues such as cysteine are prone to diverse covalent modifications 
with catalytic or regulatory consequences. We found that cysteine modification in ICH 
remodels active site H-bonding networks and gates catalytically important changes in 
protein dynamics with a clearly defined mechanism. ICH catalyzes a reaction that can be 
divided into an early phase dominated by nucleophilic attack of the reactive C101 at the 
electrophilic carbenoid carbon of its isocyanide substrate and a later phase dominated by 
water attack at the thioimidate  and weaker nucleophilicity of C101 (i.e. a better leaving 
group) to release the N-formamide product (Fig. 1F). Modification of the active site 
cysteine thiolate upon formation of the thioimidate, during the first step of catalysis, 
neutralizes its negative charge and weakens a key H-bond, activating correlated motions 
that span the entire ICH dimer. After formation of the thioimidate, the helix samples the 
shifted conformation due to weakening of the I152-C101 H-bond, dynamically 
remodeling the ICH active site (Fig. 1F, Fig. 4I) and permitting water entry. This 
transient remodeling is required for hydrolysis of the thioimidate intermediate, because 
the active site containing the intermediate in occluded and does not contain room enough 
for a water to enter without motion.  Water attack at the C-S bond of the thioimidate is 
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proposed to form a tetrahedral intermediate (Fig. 1F).At this point, the H-bond between 
C101 and I152 that defines the strained conformation of helix H can reform, thereby 
stabilizing the nascent C101 thiolate and making it a better leaving group, thereby 
coupling dynamical changes in the enzyme to progress along the reaction coordinate (Fig. 
4I).With the strained helical conformation restored, the product is released and leaves the 
active site poised for another cycle of catalysis (Fig. 4I). 
   The divergent pre-steady state kinetics of the G150A and G150T mutants 
suggest a model where the strained helical conformation of ICH has the highest 
competence for the initial isocyanide attack by C101, forming the thioimidate 
intermediate (Fig. 1E, Fig. 2A).  This is also consistent with the diminished propensity of 
C101 for photooxidation in G150T, where the helix is constitutively shifted, suggesting 
that C101 is less reactive in this environment. The G150A/T mutants modulate helical 
dynamics and thus allow us to determine if the non-equilibrium helical motions that we 
observe in the thioimidate intermediate XFEL structure are incidental to or important for 
catalysis. Synchrotron X-ray crystallographic data indicate that the G150A mutation 
enhances sampling of shifted helical conformations even in the absence of C101 
modification, and this shifted conformation is further populated once the C101-Ile152 H-
bond is weakened by C101-SOH formation. In addition, G150A ICH accumulates a 
spectrally distinct 335 nm species that likely corresponds to the thioimidate intermediate 
detected by XFEL crystallography. Our interpretation of these data is that the thioimidate 
intermediate accumulates in G150A ICH owing to an impaired resetting of the strained 
helical conformation, which reduces the rate of thioimidate hydrolysis and enzyme 
turnover. Consistent with the pre-steady state kinetic data, this kinetic model for G150A 
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ICH predicts that the early chemical steps promoted by the strained conformation of helix 
H would not be impaired by the mutation but that the steady-state rate would be 
significantly diminished.   In contrast, the G150T mutation causes a constitutively shifted 
helix, reducing rates of both initial C101 attack at the isocyanide carbon atom in the first 
chemical step and thioimidate hydrolysis in later steps, as evidenced by the lower burst 
and steady state rates of G150T ICH.  Therefore, the G150A and G150T mutations have 
divergent effects on the early steps of ICH catalysis but similar detrimental effects on the 
later, rate-limiting steps.  
Protein structures fluctuate owing to thermal motion and in response to functional 
changes such as ligand binding. As a consequence, it is challenging to determine which 
protein motions are functionally most important at equilibrium. Enzymes that are 
transiently covalently modified during catalysis offer a way to identify functional 
motions, as the modification can trigger catalytically important conformational changes. 
The covalent modification of the active-site cysteine in isocyanide hydratase weakens a 
critical hydrogen bond required for reactivity. Hydrogen bond disruption triggers a 
cascade of conformational changes whose modulation by mutation is detrimental to 
enzyme turnover. Most enzymes that form catalytic intermediates will experience similar 
transient changes in active-site electrostatics, suggesting that modification-gated 
conformational dynamics is common in enzymes. Notably, all cysteine thiolates will 
experience a similar loss of negative charge upon covalent bond formation. Because 
cysteine residues can have multiple roles in a protein, including catalytic nucleophile, 
metal ligand, acylation target, redox target, and others, many different modification-
mediated signals may be transduced through altered cysteine electrostatics to impact 
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protein dynamics and function, expanding the ways in which cysteine can couple protein 
biophysical properties to cellular needs. Integrating recent developments in serial and 
conventional RT crystallography with advanced computational methods531 can offer new, 
exciting opportunities to reveal enzyme mechanism and interrogate the consequences of 
cysteine modification on protein dynamics. 
Modulation of protein dynamics is a powerful way to regulate protein function, as 
has been characterized in various systems.  Cysteine modification-gated conformational 
changes in ICH alter the active site environment, promoting progress along the reaction 
coordinate. To our knowledge, ICH is the first example of a non-disulfide cysteine 
modification regulating functional protein conformational dynamics. Nevertheless, 
conceptually similar examples of gated conformational dynamical changes exist. Redox-
gated changes in flavoprotein structure and dynamics may play a major role in electron 
transfer by these proteins558, and similar electron- or charge-coupled gating events occur 
in diverse systems 532,559,560. Photoactivatable tags that modulate sampling of active 
enzyme conformations have been used to create catalytically enhanced enzymes192. In the 
DJ-1 superfamily to which ICH belongs, C106 oxidation to C106-SO2
- in DJ-1 results in 
little change in global protein conformation but stabilizes the protein by over 12 °C561. 
This stabilization is thought to be due to a strong (2.47 Å) hydrogen bond between C106-
SO2
-and Glu18 that forms upon oxidation, reducing protein dynamics and stabilizing the 
protein. The many potential covalent modifications of cysteine make this residue of 
particular importance for understanding how cellular signaling states, metabolite pools, 
and stress conditions couple to functional protein dynamics through the modification of 
amino acids in proteins.  Future work on ICH and other cysteine-containing proteins will 
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illuminate the diverse mechanisms by which cysteine-gated conformational changes can 
regulate protein function. 
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CHAPTER 5: 
 
Purification, Kinetics and Structural Characterization of novel ICH 
homolog, RsICH from Ralstonia solanacearum GMI1000. 
 
 
 
 
Note: The results described in this chapter have not been published. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Strained residues (in yellow spheres) cluster near functionally important 
regions in the RsICH dimer. 
The mobile helices are labeled “A” and “B” near the top of the dimer, and the 
active site C121 residues shown in sticks. 
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5.1 Abstract: 
Isocyanide hydratase (ICH) catalyzes the conversion of isocyanide natural 
products to N-formamides by the addition of water.  ICHs are widely distributed in 
pseudomonad bacteria, where they play a protective role against antimicrobial isocyanide 
natural products. We have previously characterized the ICH from Pseudomonas 
fluorescens (PfICH) using structural and biophysical approaches.   PfICH exhibits 
collective motions that are activated by catalysis and permit water access to the catalytic 
thioimidate intermediate for hydrolysis.  To determine if this dynamical aspect of ICH 
was a general feature, we recently determined an ultra-high resolution (0.74Å) X-ray 
crystal structure of wildtype ICH from Ralstonia solanacaerum GMI1000 (RsICH).  Like 
PfICH, RsICH exhibits backbone torsional strain near the active site cysteine residue that 
is important for helix motion in PfICH.  In addition, RsICH also has an unusually large 
amount of side chain strain, including deviations from planarity of multiple residues near 
functionally important sites within the enzyme. Our working hypothesis is that fold-
induced structural strain in the backbone and sidechains of these residues undergoes 
changes during catalysis to support correlated, functional motions. We expect that 
geometric stain in RsICH will relax upon intermediate formation and concurrent helix 
displacement and then increase as the catalytic cycle is completed. This chapter of the 
thesis will include ongoing and planned future work, involving X-ray crystallography, 
enzyme kinetics and site directed mutagenesis to determine if conformational strain in 
RsICH is important for efficient catalysis. This model for the coupling between enzyme 
structure, dynamics, and function may provide general insight into how catalytic cysteine 
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covalent modification alters conformational ensembles and non-equilibrium motions in 
other cysteine-dependent enzymes.  
5.2 Introduction: 
Although enzyme catalysis is the central phenomenon of biochemistry, the 
relationship between their remarkable catalytic proficiency and structural and dynamical 
properties is not fully understood257,562,563. Because enzymes often catalyze complex 
reactions with one or more reaction intermediates, directly observing enzyme catalysis in 
real time and at atomic resolution has been a foundational goal of structural enzymology. 
Technical advances in X-
ray crystallography now 
permit the direct 
monitoring of enzyme 
turnover in crystalline 
samples, including 
identifying non-
equilibrium enzyme 
motions564–566 during 
catalysis. These new 
technologies allow enzyme motions to be mapped while progressing along the reaction 
coordinate, addressing a long-standing challenge of visualizing and identifying 
functionally relevant enzyme dynamics. The primary focus of this thesis is cysteine-
dependent ICH enzymes,  which form covalent catalytic intermediates that modify the 
structural, electrostatic, and dynamic environment of the active site567,568. Catalysis-
Figure 1: Clustal W pairwise sequence alignment. RsICH 
(WP_011001740.1) shares conserved catalytic residues with PfICH 
(3NON) (36% identity). 
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activated enzyme motions provide a general model to explain how enzymes that use 
covalent catalysis are transiently modified to aid substrate turnover. Therefore, what is 
learned from ICH will be relevant to a large class of biomedically important enzymes. 
The previous chapter (Chapter 4) discussed the formation of a catalytic cysteine (C101) 
covalent intermediate (thioimidate) in Pseudomonas ICH (PDB: 3NON). Formation of 
this cysteine covalent adduct alters active site electrostatics and induces dynamical 
changes that facilitate efficient substrate turnover and enzyme regeneration. To 
investigate how common cysteine-modification gated enzyme functional dynamics is, we 
identified a distant (36% identity) ICH homolog from Ralstonia solanacaerum GMI100 
(NCBI Reference Sequence: WP_011001740.1) (RsICH) (Fig. 1).  
5.3 Materials and Methods: 
Cloning and Mutagenesis of Ralstonia solanacearum GMI1000 ICH (RsICH): The 
RsICH gene was synthesized with E. coli codon optimization from Invitrogen (Thermo 
Fisher Scientific) and inserted using Infusion cloning (Takara Bio USA, Inc) between the 
NdeI and XhoI restriction sites of the bacterial expression vector pET15b (Novagen, 
Darmstadt, Germany) so that the expressed protein carries an N-terminal, thrombin-
cleavable hexa-histidine tag. The final recombinant RsICH protein is 224-amino acid 
long with a calculated molecular mass of 24,158 Da. All point mutations (E122Q, 
E122D, E122T, C121S) were generated by site-directed mutagenesis using Q5 Site 
Directed Mutagenesis (New England Labs) and High-Fidelity Phusion DNA polymerase 
(Thermo Fisher Scientific) and appropriate mutagenic primers from Eurofins (Oligo 
synthesis). All ICH constructs were verified by DNA sequencing (Eurofins, Genewiz). 
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Protein Expression and Purification: E. coli BL21DE3 cells bearing the RsICH-
pET15b construct were grown in LB medium supplemented with 100 μg/ml ampicillin, at 
37 °C with shaking at 250 rpm until the A600 reached 0.5–0.7. Overexpression of ICH was 
induced by the addition of 0.66 mM isopropyl β-D-thiogalactopyranoside (IPTG), 
followed by 4 h of incubation at 37 °C. Cells were harvested by centrifugation, frozen in 
liquid nitrogen, and stored at −80 °C until needed. Frozen cell pellet was thawed on ice 
and resuspended in lysis buffer (50 mM HEPES, pH 7.5, 300 mM KCl, 10 
mM imidazole). The suspended cells were lysed by the addition of hen egg white 
lysozyme (final concentration of 40 mg/ml) at 4 °C for 30 min, followed by sonication (5 
second pulse on, 15 seconds pulse off settings) and centrifugation to remove cell debris. 
The cleared supernatant (lysate) was applied to a His-select Ni2+ metal affinity column 
(Sigma-Aldrich) that had been equilibrated in lysis buffer and bound for 1 hour at 4°C. 
The recombinant hexa-histidine tagged RsICH was purified using Ni2+ metal affinity 
chromatography using 250 mM imidazole to elute bound protein. The eluted protein was 
dialyzed overnight at 4 °C against storage buffer (25 mM HEPES, pH 7.5, 100 mM KCl). 
The following day, the hexa-histidine tag used for protein purification was removed by 
thrombin cleavage (2 units of thrombin/mg of ICH) at room temperature for 2-3 hrs, 
followed by passage over Ni2+ metal affinity resin to remove any uncleaved protein that 
retained the histidine tag. Thrombin was removed by passage over benzamidine-
Sepharose resin (GE Healthcare). The eluted protein was then dialyzed overnight at 4 °C 
against 25 mM HEPES, pH 7.5, 2mM DTT to remove any salts. The following day the 
protein was passed through UnoQ ion exchange chromatography (Bio-Rad). The protein 
fractions were pooled together, and protein concentration was determined using a 
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calculated extinction coefficient of ϵ280 = 31,065 M−1 cm−1 based on the amino acid 
composition of R. solanacearum ICH. The final protein shows up as a ∼24 kDa single 
band on overloaded Coomassie Blue-stained 12 % SDS-PAGE. Purified RsICH was 
concentrated to 16-27 mg/ml using a centrifugal concentrator (Amicon, Billerica, MA), 
supplemented with 2 mM DTT, frozen in liquid nitrogen, and stored at −80 °C. The 
E122Q, E122D and E122T mutants were purified following the same protocol. 
Crystallization, preliminary X-ray data collection, and processing: All crystals of 
RsICH were grown at room temperature using the hanging drop vapor diffusion method. 
For wild-type, E122Q, E122D, E122T RsICH, drops containing 2 μl of protein at 16-27 
mg/ml and 2 μl of reservoir solution (16% PEG 3350, 0.1M MES, pH 6.5) were 
equilibrated against 500 μl of reservoir solution supplemented with 8% Dioxane or 8% 
Ethanol. The choice of the additive is significant because 8% dioxane supports plate-like 
crystals, while 8% ethanol supports rod like crystals in both wildtype and the mutants. 
Both plate type and rod type crystals were determined to be space group P 21 21 21. A 
third form of RsICH crystals were grown with 5-15% PEG 400 as additive; they were 
tetragonal in space group P 43 12 1. 
All the crystals were cryo-protected by passage through six solutions of 
incrementally increasing amounts of ethylene glycol to a final concentration of 30% (v/v) 
in the reservoir solution. The cryoprotected crystal was cooled by immersion into liquid 
nitrogen. Preliminary wildtype and E122 D,Q and T RsICH crystal X-ray diffraction data 
at 1.5 Å were collected at the University of Nebraska Macromolecular Structural Core 
Facility from single crystals maintained at 110 K using MicroMAX-007 rotating copper 
anode X-ray generator (Rigaku/MSC, The Woodlands, TX) operating at 40kV and 
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20mA, Osmic Blue confocal optics, and a Raxis IV++ image plate detector.  All data 
were indexed, scaled, merged and refined using iMosflm, Aimless, Pointless, and 
Refmac5 from the CCP4i suite, with final data statistics in Table 5.   
RsICH microcrystal growth and fixed-target serial crystallography data collection 
and refinement: wt RsICH microcrystals were grown by batch seeding.  Initial seeds 
were obtained by pulverizing macroscopic rod type crystals via vortexing with 0.5 mm 
stainless steel balls for 5-10 minutes.  A 1:1500 dilution of this seed stock was added to 
26% PEG 3350, 50 mM MES (pH 6.5), 16% Ethanol and 22% Ethylene glycol and then 
an equal volume of 38 mg/ml wtRsICH was added and rapidly mixed. The dilution of the 
seed stock dictated the final size of the microcrystals and was optimized to produce 
crystals measuring ~20x7x7 μm. The mixture was incubated at room temperature with 
shaking for ~20 minutes until microcrystal growth stopped. A 1.2 Å resolution serial 
crystallography dataset was collected at 100 K from microcrystals on a MiteGen mesh 
support using a fixed target strategy at SSRL beamline 12-2. This dataset comprised 
~1400 indexed frames with 99.43 (95.62) % completeness, 23.36 (5.90) multiplicity, and 
a CC1/2 of 0.93. (0.17) (values for highest resolution shell in parentheses). This is a 
remarkably high-quality dataset given the limited number of images and the fact that it 
was collected at a synchrotron rather than an XFEL. The future goal is to collect a higher 
resolution MISC dataset at an XFEL due to the higher X-ray flux per exposure. 
RsICH enzyme kinetics. The substrate used for all the kinetics experiments was para 
nitro-phenyl isocyanide (p-NPIC), synthesized by the Berkowitz group (University of 
Nebraska Lincoln, Department of Chemistry). Steady state RsICH rate measurements 
were initiated by the addition of ICH (final concentration of 0.1 µM) to freshly prepared 
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p-NPIC solutions ranging from 0-1000 µM in reaction buffer (100 mM KPO4 pH=7.0, 50 
mM KCl, and 20% DMSO, pH 7.6). p-NPIC was diluted from a 0.5 M stock solution in 
dimethyl sulfoxide (DMSO), which was stored at -80 °C and protected from light.  A 200 
µl reaction was maintained at 25 °C in a Peltier-thermostatted cuvette holder. The 
formation of the product, para-nitrophenyl formamide (p-NPF) was monitored at its 
absorption maximum of 320 nm for two minutes using a UV-Vis Cary 50 
Spectrophotometer (Varian, Palo Alto, CA). A linear increase in A320 was verified and 
used to calculate initial velocities. The extinction coefficient at 320 nm for p-NPF was 
determined by using ICH to convert known concentrations of p-NPIC to p-NPF, followed 
by measuring the absorbance at 320 nm.  The slope of the resulting standard curve was 
defined as the extinction coefficient of p-NPF at 320 nm; ε320=1.33x104 M-1 cm-1.  This p-
NPF ε320 value was used to convert the measured rates from A320/sec to [p-NPF]/sec. All 
data were measured in triplicate or greater and mean values and standard deviations were 
plotted and fitted using the Michaelis-Menten model as implemented in Prism (GraphPad 
Software, San Diego, CA).  
Pre-steady state ICH kinetics were measured at 25 ˚C using Hi-Tech KinetAsyst 
stopped flow device (TgK Scientific, Bradford-on-Avon, United Kingdom). Data were 
collected for each sample for two seconds (instrument deadtime is 20 ms) in triplicates 
and product evolution was monitored at 320 nm using a photodiode array detector.  
To ensure that the fixed target serial crystallography at SSRL beamline 12-2 was 
successful, as a pre-requisite, tests of catalysis were performed on RsICH microcrystals 
in the stabilization solution (26% PEG 3350, 50 mM MES (pH 6.5), 16% Ethanol and 
22% Ethylene glycol). The crystals were pelleted at 7.5 rpm for 1 minute and then 
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resuspended in stabilization solution to remove any free protein. Rate measurements were 
performed by the addition of the wt RsICH microcrystals (final concentration of 5-50 
µM) to freshly prepared p-NPIC solution at 500 µM in stabilization buffer (26% PEG 
3350, 50 mM MES (pH 6.5), 16% Ethanol and 22% Ethylene glycol).Total reaction 
volume was maintained at 200 µl at 25 °C in a Peltier-thermostatted cuvette holder. The 
formation of the product, para-nitrophenyl formamide (p-NPF) was monitored at its 
absorption maximum of 320 nm for five minutes at 20 second intervals using a UV-Vis 
Cary 50 Spectrophotometer (Varian, Palo Alto, CA). 
Isocyanide (p-NPIC) toxicity assays. E coli BL21DE3 cells bearing the wtRsICH 
containing pET15b recombinant plasmids were grown until OD600=0.5-0.6 at 37˚C and 
250rpm shaking, upon which they were induced with 0.5mM IPTG. 1 ml of induced cells 
were mixed rapidly with 5mls of cooled autoclaved soft agar (0.8%) supplemented with 
100mg/ml Ampicillin and poured over 1.5% LB agar plates and incubated at room 
temperature (22-25˚C) for 1 hour.  Once the soft agar had solidified, stress chemicals 
were prepared fresh (500mM, 100mM and 10mM p-NPIC in 100%DMSO). Each LBA 
plate was divided into four quadrants and sterile autoclaved filter discs (1 cm diameter) 
were placed in the four sections. 10µl stress chemical was added to each disk and the 
plates were incubated at 37˚C overnight. Diameters of the developed zone of clearances 
were manually measured in triplicates after 24 hours and plotted as a function of substrate 
concentration using Prism (GraphPad Software, San Diego, CA). The same protocol was 
followed for the mutants E122D, Q and T RsICH.  
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5.4 Results: 
5.4.1. RsICH is a faster and more potent ICH compared to PfICH. 
Like its homolog PfICH, Ralstonia ICH breaks down the isocyanide substrate p-
NPIC into the corresponding p-N formamide, which can be tracked spectrally at 320nm. 
However, RsICH is much faster, with a turnover number of ~ 75 s-1compared to 0.2 s-1 in 
PfICH (Fig. 9.A) (Tables 1,4). Pre-steady state kinetics of RsICH indicates an absence of 
a burst phase that is present with PfICH (Fig. 9 D-C). This indicates that the process of 
thioimidate hydrolysis and
 
Figure 2: (A). Impaired steady state Michelis Menten kinetics of (clockwise from left) wt, 
E122D, Q, T RsICH. (B). E. coli BL21DE3 p-NPIC toxicity assay reveals in vivo effects of 
impaired catalysis in E122 mutants. (C). Disk diffusion assay showing zones of inhibited E. 
coli growth near disks impregnated with the indicated concentrations (mM) of p-NPIC. (D). 
PfICH shows burst phase in stopped flow mixing experiment. (E). RfICH exhibits no burst 
phase, indicating faster rates of thioimidate formation/hydrolysis  
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product formation in RsICH must occur faster than in PfICH and the rates of formation 
and hydrolysis are more closely matched or that the rate-limiting step in RsICH is now 
thioimidate formation. It is possible that RsICH also has a burst phase that is within the 
~20 ms dead time of the instrument, although this seems unlikely. To test this hypothesis, 
we could perform the stopped flow experiment in a reaction buffer in which RsICH is 
slower to lengthen the pre steady-state rate. One potential way to do this is by optimizing 
the reaction buffer composition. We have measured catalytic turnover in microcrystals of 
RsICH in the crystallization buffer (16% PEG 3350, 0.5M MES/Citrate pH 6.5, 8% 
ethanol) (Fig. 6.B) (More details in section 5.4.4). The rate of turnover can be controlled 
by changing the relative concentrations of the MES or citrate buffers (both at pH 6.5) in 
the crystal (Fig. 6.D). MES decreases in crystallo reaction rates because it is loosely 
bound at a site that partially occludes a solvent channel to the active site in the 0.74 Å 
resolution crystal structure (Fig. 6.C). Although these experiments have not been 
conducted with the enzyme in solution, it will be worth investigating if tuning the MES: 
citrate ratio in the reaction buffer sufficiently slows down RsICH in solution catalysis to 
observe the intermediate formation/hydrolysis step. Another possible method would be to 
employ single-turnover kinetics, which would allow further isolation of the first catalytic 
turnover of the enzyme 
5.4.2. E122 D, Q and T mutations in the RsICH active site significantly impairs 
catalysis. E122 residue, immediately following the reactive C121, was mutated to a 
Threonine (E122T) to simulate the active site environment of the Pseudomonas ICH, to 
investigate the contribution of E122 to the faster rates of catalysis in RsICH. E122D 
mutant was generated to investigate the potential steric effects of E122 within the active 
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site, and finally, the E122Q mutant was made to disrupt the hydrogen bonding 
environment within the active site. The E122 D, Q, T mutants exhibit impaired steady 
state kinetics (Fig.2.A) (Table 4) with turnover numbers ~ 0.2 s-1, 0.4 s-1 and 0.3 s-
1respectively. p-NPIC toxicity assays performed on E. coli BL21DE3 cells bearing the 
wildtype RsICH construct show that these cells tolerate isocyanide much better than E. 
coli cells expressing PfICH (Fig. 2. B-C). The E122D, Q and T RsICH mutations, 
however, diminish isocyanide tolerance levels to 
comparable with wt and G150A and G150T PfICH (Fig. 5, Chapter 4).  
Although the E122 mutation seems to significantly impair catalysis, it is not yet 
obvious why. Neither is it clear why RsICH is a faster ICH than PfICH. In the 
Figure 3: (A-B). 0.74 Å dataset of RsICH. 2Fo-Fc electron density (blue 1.0σ) and Fo-Fc difference 
density (green +3σ, red -3σ) show deprotonated bond lengths of E122 (1.24-1.25 Å) and 3.48 Å 
hydrogen bond with C121 thiolate. (C) conserved C147-C220 disulfide bond in RsICH (2.08 Å). 
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Pseudomonas ICH, the reactive C101 (PfICH numbering) is immediately followed by a 
T102, while in Ralstonia ICH it is a Glu122 (RsICH numbering). Moreover, ultra-high 
resolution (0.74-0.9 Å) resolution dataset(s) of RsICH crystals reveal that E122 is 
deprotonated (hence negatively charged) with a Cδ-Oε1/2 bond lengths of ~1.25 Å 
(Fig.10. A) (Data statistics in Table 6).  Surprisingly, this ionized carboxylate is 3.48 Å 
away from the reactive C121 (RsICH numbering) in wt and E122D, Q, T RsICH. We 
know that for the catalytic reaction to occur, C121 must be a nucleophile, thus 
deprotonated to the thiolate. It is unclear how these two negatively charged neighboring 
residues (E122, C121) would stably exist so near to one another in the active site440 
(Fig.10. A-B). It is important to note here that a protein BLAST revealed several ICH 
homologs with a glutamic acid following the nucleophilic Cys; however it remains to be 
examined whether these glutamic acids are also deprotonated as seen in RsICH. 
It is possible that the negatively charged electrostatic environment created by both 
C121 and E122 interacts with the formal positive charge on the nitrogen atom of the 
isocyanide substrate and helps position the substrate for attack in the active site of the 
enzyme. In this case, RsICH has greater potential for electrostatically pre-organizing the 
Michaelis complex than the slower PfICH, which has a threonine (T102) (Pseudomonas 
numbering) at this position. It is also possible that the strong negative charge created by 
these two residues in RsICH electrostatically strains the active site prior to catalysis, and 
that formation of the thioimidate neutralizes the negative charge of C121 relieves this 
electrostatic strain and stabilizes the Michaelis complex. The restoration of the thiolate 
upon hydrolysis of the thioimidate may restore electrostatic strain that facilitates product 
release. Another hypothesis is that C121 is initially protonated as a thiol and binding of 
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the substrate p-NPIC leads to its ionization; the deprotonated C121 nucleophile then 
attacks the electrophilic isocyanide carbon and initiates the reaction. Additional 
experimental work is required to experimentally test these hypotheses. It would be 
interesting to see if making a T102E mutation in PfICH (PfICH numbering) speeds up the 
reaction to similar rates as seen in RsICH.   
 Another unusual structural feature observed in RsICH is the existence of a 
conserved disulfide bond between two of its cysteines (C147 and C220) near the C-
terminus of the enzyme (Fig.10. C), even though RsICH must folded in the reducing 
E.coli cytosol during recombinant protein expression573,574 . The high degree of 
conservation of the cysteine residues in this bond, as well as its robustness to DTT 
(1mM) to prevent oxidation during protein purification both suggest possible functional 
importance. Because disulfide bonds are typically formed and maintained within an 
oxidizing environment like the endoplasmic reticulum in eukaryotes574, one possibility is 
that the C147-C220 disulfide bond is formed in the more oxidizing E.coli periplasm 422. 
However, proteins are targeted into the periplasm by specific signal sequences575,575–577 
and it remains to be explored whether RsICH is targeted in a similar manner.  
 5.4.3. RsICH exhibits cysteine-gated active site helix dynamics similar to PfICH. 
We have obtained a 1.5 Å resolution rotating anode crystal structure of RsICH at pH 5.5 
(Table 5). This lower pH structure shows clear evidence of crystallographic disorder near 
the highly strained Ramachandran outlier I175 (corresponding to I152 in Pseudomonas 
ICH), indicating
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helical mobility (Fig. 4). We observe this disorder at pH 5.5 and not in the 0.74 Å 
resolution structure at pH 6.5 likely because the active site cysteine is protonated at 5.5, 
neutralizing its charge and weakening the H-bond with I175. This is the same charge-
gated H-bond mechanism that we propose for Pseudomonas ICH in chapter 4. 
5.4.4. Identification of side chain geometric strain in the ultrahigh resolution crystal 
structure of RsICH. 
 
Figure 4: (A). Ralstonia ICH shows mobility near the active site at pH 5.5. 2Fo-Fc electron 
density (blue 1.0σ) and Fo-Fc difference density (green +3σ, red -3σ) show clear evidence of two 
conformations of the active site C121 (A, B) and mobility of the strained I175 in the mobile helix. 
(B) No evidence of helix mobility in Ralstonia ICH pH 6.5. 2Fo-Fc electron density (blue 1.0σ) 
and Fo-Fc difference density (green +3σ, red -3σ). 
Figure 5: (A) 2Fo-Fc electron density (blue 1.0σ; purple 4.5σ) at 0.74 Å resolution for W85 shows the 
exceptional quality of the data. The protrusions at in the 2Fo-Fc electron density are hydrogen atoms. (B) 
Side view of W85 shows obvious deviations from planarity. (C) Strained residues (in yellow spheres) 
cluster near functionally important egions in the Ralstonia ICH dimer; the mobile helices are labeled “A” 
and “B” near the top of the dimer, and the active site C121 residues shown in sticks. 
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We have recently collected a synchrotron X-ray diffraction dataset of Ralstonia ICH 
(RsICH) at 100 K to 0.74 Å resolution (Table 6). This ultrahigh resolution dataset allows 
the well-ordered parts of the structure to be refined with no influence from geometric 
restraints, as the observation-to-parameter ratio for unrestrained refinement is ~13. Even 
when restraints are maintained, residues Y15, W37, W85, R162, Y163, and Y204 all 
exhibit pronounced planarity deviations. W85 in particularly is extremely distorted, with 
a clearly nonplanar indole ring (Fig. 5). In Ralstonia ICH (RsICH), most of the strained 
residues cluster near the active site or surround the helix that is mobile during catalysis in 
Pseudomonas ICH (PfICH). It is possible that this conformational strain in RsICH 
facilitates important conformational changes in the enzyme during catalysis, and as such, 
we strongly suspect a connection between these strained residues and RsICH catalysis.  
5.4.5. Future work will include tracking the origin and dynamics of conformational 
strain in RsICH during catalysis using MISC. 
Future work will involve the use of computational methods to identify the origin 
of the strain in the mentioned residues, allowing us to determine the physical origin of 
these effects, including the energetics of distortion and the major structural determinants 
of these deviations. Building from the computational results, we will mutate those 
residues identified as distorting the strained sidechains in order to reduce or eliminate 
strain. We will determine crystal structures of these designed mutants to validate the 
effects on geometric strain and then compare computationally predicted and observed 
sidechain geometries. Using these strain-modulating mutants, we will then perform 
steady and pre steady-state kinetic analysis using p-NPIC as substrate. By combining 
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computational, structural, and kinetics approaches, we will be able to determine the 
contribution of sidechain strain to Ralstonia ICH (RsICH) catalytic proficiency. 
We will also perform accurate measurement of the geometric strain in the non-
planar residues in RsICH. For this, we will need atomic resolution (≤1.2 Å) data for 
Ralstonia ICH, which will be the highest resolution MISC dataset ever collected. 
Preliminarily, we have established the feasibility of this experiment by reliably growing 
microcrystals (~20x7x7 μm) (Fig. 6.A) and collecting a 1.2 Å resolution serial 
crystallography dataset from a fixed target mesh at SSRL beamline 12-2 (Methods). 
These high-resolution time-resolved data will be used to investigate the changes in 
geometric strain that we hypothesize may facilitate motions that are important for 
turnover. This could potentially be the first experiment in which conformational strain 
will be directly observed in an enzyme during catalysis. To establish feasibility of the 
planned MISC component of the experiment, we measured catalytic turnover in 
microcrystals of Ralstonia ICH in the crystallization buffer (16% PEG 3350, 0.5M 
MES/Citrate pH 6.5, 8% ethanol) (Fig. 6.B). The rate of turnover can be tuned by 
changing the relative concentrations of the MES or citrate buffers (both at pH 6.5) in the 
crystal (Fig. 6.D). MES decreases in crystallo reaction rates because it is loosely bound at 
a site that partially occludes a solvent channel to the active site in the 0.74 Å resolution 
crystal structure (Fig. 6.C). 
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We expect that Ralstonia ICH will exhibit catalysis-gated motions that are coupled to 
intermediate hydrolysis, with geometric strain relaxing during intermediate 
formation/helix displacement and then increasing again as the catalytic cycle is 
completed. Importantly, the atomic resolution of the data will make this a first-of-kind 
MISC experiment, and the resulting data will allow the development of improved tools 
for all steps in the serial crystallography data processing and model refinement workflow 
that will benefit the structural biology community. 
 
 
 
 
Figure 6: (A) RsICH microcrystals. (B) Ralstonia ICH microcrystals are catalytically active. 
Spectra were collected every 20 s, from purple to red. The product absorbs at 320 nm. (C) MES 
bound in the active site of RsICH. 2Fo-Fc electron density (blue 1.0σ) and Fo-Fc difference density 
(green +3σ, red -3σ) (D) Rates of microcrystal catalysis can be altered by manipulating the Citrate: 
MES (pH 6.5) ratio in crystallization buffer. 
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5.5 Discussions: 
Preliminary kinetics and in vivo toxicity assays show that Ralstonia ICH (RsICH) 
is a faster ICH enzyme compared to its Pseudomonas (PfICH) homolog. Moreover, 
RsICH diffracts to ultra-high resolution (0.74 Å) and diffracts to atomic resolution (≤1.2 
Å) in a serial crystallography experiment. There are only about a dozen ultra-high 
resolution datasets (≤0.07 Å) in existence 582. Interestingly, the 0.74Å RsICH dataset 
shows fold-induced backbone and sidechain strain.  Particularly, amino acid residues 
Y15, W37, W85, R162, Y163, and Y204 all exhibit pronounced planarity deviations, 
which is highly unexpected. Other ultrahigh resolution datasets also exhibit aromatic 
planarity deviations, and these strained residues are typically in functionally important 
parts of those structures569–572. In RsICH, most of the strained residues cluster near the 
active site or surround the helix that is mobile during catalysis in PfICH, strongly 
suggesting a connection to ICH function, which remains to be explored.  
 Because of the exceptional resolution of the preliminary synchrotron X-ray 
dataset (0.74 Å), these deviations from planarity are well-determined by the data and thus 
residue geometry is confidently known. Similar geometric strain has been observed in 
other proteins that diffract to ultrahigh resolution583,584, but its origin is unknown. Future 
work will include determination of the origin of this strain and investigate how catalytic 
modification of the active site couples to strained residues throughout the protein to 
activate functional motions. The proposed work will elucidate general physical 
mechanisms by which cysteine modification alters protein structure and function, with 
potentially wide applicability to other biomedical important proteins, including the 
development of small molecules that covalently target key cysteine residues. 
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